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ABSTRACT
Incarcerated women report higher rates of sexual victimization and mental illness than
the average woman and incarcerated men. Researchers have argued that sexual victimization is a
pathway to prison for women, and that there is a lack of trauma-focused treatments in prisons.
Some researchers have evaluated trauma-focused group treatments for incarcerated women
(Bradley & Follingstad, 2003; Cole et al., 2007; Ford, Chang, Levine, & Zhang, 2013; Kubiak,
Kim, Fedock, & Bybee, 2012; Paquin, Kivlighan, & Drogosz, 2013; Roe-Sepowitz, Bedard,
Pate, & Hedberg, 2014; Zlotnick, Johnson, & Najavits, 2009), with mixed results and several
limitations. Most of these treatments are lengthy and resource intensive (cf. Ford et al., 2013)
and they provide few, if any, additional benefits compared to treatment as usual or support
groups. They also do not include exposure therapy, despite research supporting exposure’s
efficacy (Foa, Hembree, & Rothbaum, 2007). Future studies could benefit from evaluating
briefer treatments that target specific mechanism known to maintain posttraumatic stress disorder
(PTSD) and other common trauma outcomes. Although there are empirically-supported
treatments (ESTs) for PTSD that would fit these criteria, the prison context might provide
several unique contextual factors that are likely to make it difficult to implement and/or may
impact the efficacy of these treatments. The current group treatment for incarcerated women was
designed to overcome concerns with implementing ESTs in this population as well as limitations
with previous studies evaluating trauma treatments among female prisoners. Results from 58
incarcerated women showed significant reductions in PTSD, depression, and anxiety/worry
symptoms as well as trauma-related cognitions from pre-to post-treatment. Approximately 4050% of participants who were above the clinical cutoff for possible PTSD (n = 30), depression (n
= 25), and generalized anxiety disorder (GAD; n = 26) at pre-treatment were below at post-

treatment (PTSD: n = 14; depression: n = 18; GAD: n = 18). Additionally, 40-60% reported a
clinically significant improvement (reliable change index > 1.96; Jacobsen & Truax, 1991) in
depression (n = 21) and GAD symptom severity (n = 13). Results suggest that it is feasible to
implement a brief exposure-based group treatment with incarcerated women.
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I.

INTRODUCTION
Sexual victimization is disproportionally a women’s issue. Compared to men, women are
more likely to report being victims of sexual violence as children (child sexual assault; CSA;
Pereda, Guilera, Forns, & Gomez-Benito, 2011) and as adults (adult sexual assault; ASA; Black
et al., 2011; Elliott, Mok, &, Briere, 2004) and they are more likely to report being revictimized
as teenagers and/or adults (Black et al., 2011; Cloitre, 1998; Messman-Moore, Brown, &
Koelsch, 2005; Roodman & Clum, 2001; Ullman, Najdowski, & Filipas, 2009). Women are also
more likely to report symptoms of posttraumatic stress disorder (PTSD) and depression (Kessler,
Petukhova, Sampson, Zaslavsky, & Wittchen, 2012), which are the two most common mental
health problems associated with interpersonal trauma. This paper will review research on sexual
trauma, including mental health outcomes and trauma treatments. Sexual victimization and
related issues will first be described in the general population followed by a focus specifically on
female prisoners. This paper also includes findings from a brief exposure based group treatment
implemented in a sample of incarcerated women with sexual victimization histories.
A. SEXUAL VICTIMIZATION
Definitions of Sexual Victimization
Sexual victimization is a type of trauma. According to the Diagnostic and Statistical
Manual of Mental Disorders 4th Edition (DSM-IV; American Psychiatric Association, APA,
2000) a traumatic event is “involves actual or threatened death or serious injury, or other threat
to one’s physical integrity” (p. 463). The event can be experienced personally, by witnessing
someone else experience it, or by learning that the event happened to “a family member or other
close associate” (p. 463). Victimization implies that a person has experienced interpersonal
trauma (e.g., one person perpetrated violence onto the victim). This paper focuses on sexual
1

victimization, which are sexual acts of violence perpetrated by one or more individuals onto
someone else.
Sexual victimization can be defined in many different ways and researchers have
implemented a variety of methods for measuring it. Although the definitions vary, most
researchers use behaviorally specific terms to describe acts of sexual violence perpetrated by one
or more individuals onto another person. Age and developmental periods can further impact the
various definitions of sexual victimization, with the below definitions focusing on CSA.
Neumann, Houskamp, Pollock, and Briere (1996) stated that “most studies examined in [their]
meta-analysis defined CSA as involving physical contact of a sexual nature, ranging from
fondling to intercourse” (p. 8). Hillberg, Hamilton-Giachritsis, & Dixon (2011) defined CSA “as
an act in which the child/children are used to provide sexual gratification for the
perpetrator/perpetrators including inappropriate sexual touching, invitations, and/or
exhibitionism, inappropriate non-penetrative sexual interaction (digital penetration, fondling,
and/or masturbation), attempted or actual anal and/or vaginal penetration, incest, coerced or
forced penetration” (p. 39).
Sexual Victimization Rates
Although sexual victimization rates vary across studies and settings, research findings
suggest that a large number of women are at risk for being sexually assaulted in their lifetime.
Rates below are reported separately for CSA and ASA. Rates are also reported for
revictimization, which are women who report ASA in addition to CSA.
Childhood Sexual Victimization
Pereda and colleagues’ (2011) meta-analysis, which included data from 65 articles and 22
different countries (N = 37,904), found that 19.7% of women have been victims of CSA (95%
2

CI: 16.7-23.0%). In the U.S. 25.3% of women endorsed CSA (95% CI: 19.7-31.8%). CSA rates
were in general higher in local compared to national samples as well as in clinical compared to
non-clinical samples. Women were more likely to report CSA experiences than men (7.9%
worldwide and 7.5% in the U.S.). Overall, the researchers concluded that women are 2.5 times
more likely to be sexually victimized as children compared to men.
Adult Sexual Victimization
Studies have found high rates of sexual victimization among women. In a stratified
random national sample (N = 941) including 472 women, 22% of the women reported being
sexually assaulted since age 18 (Elliott et al., 2004). Another more recent national study found
that 18% of women report being raped at some point in their life, with 45% reporting being
victims of sexual assault other than rape (Black et al., 2011). Unfortunately in the Black et al.
(2011) the researchers did not specify at what age the sexual assault happened, and, it is therefore
unclear how many of these women were sexually victimized as children. The 12-month
prevalence rate for sexual assault other than rape was similar for women and men (5.6% and
5.3% respectively). One percent of the women reported being raped in the past 12-months; there
were no rates reported for men.
As with CSA rates, several studies have shown that women are more likely to report
being victims of sexual violence as adults than men. For instance, Black and colleagues (2011)
found that approximately 1% of men report being raped in their lifetime while 22% report being
victims of some sexual assault other than rape. These rates are substantially lower than the ones
reported by the female participants (18% and 45% respectively). Even when comparing rates of
ASA, Elliott and colleagues (2004) found significant differences between men and women. Four
percent of the men had been sexually assaulted since age 18 compared to 22% of women.
3

Sexual Revictimization
Women are also at increased risk for being revictimized. Several researchers have found
a link between CSA and ASA among women (Cloitre, 1998; Messman-Moore et al., 2005;
Roodman & Clum, 2001; Ullman et al., 2009). Additionally, women who report ASA without
CSA are also at heightened risk for revictimization (Messman-Moore et al., 2005; Ullman et al.,
2009). In Black and colleagues’ recent national study 35% of the women who had been raped as
children were revictimized as adults compared to 14% who were raped as adults but not as
children. Roodman and Clum’s (2001) meta-analysis found a medium effect size between CSA
and ASA rape with 15-79% of women with CSA experiences being revictimized as adults.
Altogether, research on sexual victimization suggests that women are at heightened risk.
Research findings suggest that approximately 1 in 5 women report being sexually assaulted as
children and/or as adults (Black et al., 2011; Elliott et al., 2004; Pereda et al., 2011), with even
higher rates in some studies. Women are also more likely to be sexually assaulted as children and
as adults compared to men (Black et al., 2011; Elliott et al., 2004; Pereda et al., 2011). Many of
these women will be revictimized (Black et al., 2011; Cloitre, 1998; Messman-Moore et al.,
2005; Roodman & Clum, 2001; Ullman et al., 2009). These rates are troubling, especially when
studies show the great negative impact that is oftentimes associated with sexual victimization.
B. HEALTH OUTCOMES ASSOCIATED WITH SEXUAL VICTIMIZATION
Studies have linked sexual victimization to a range of health issues and psychological
symptoms. The term sequelae is being used to indicate the broad cluster of problems associated
with sexual victimization, which include physical and mental health issues. Most studies have
focused on the CSA sequelae. Studies specifically focusing on physical health will be discussed
first followed by mental health and the sexual violence sequelae.
4

Physical Health
One recent meta-analysis specifically investigated the association between CSA and
physical health issues (Irish, Kobayashi, & Delahanty, 2010). The researchers included results
for 31 studies and assessed 6 different health categories: gastrointestinal (GI), pain, obesity,
gynecological, cardiopulmonary, and general health. Overall, they found small to medium effect
sizes. People with CSA experiences were 1.35-2.12 times more likely to report physical health
issues compared to those without these experiences. However, the researchers did not find a
significant association between CSA and GI and obesity when using continuous variables;
although results were significant when using dichotomous variables.
Mental and Psychological Health
Neumann and colleagues (1996) grouped health outcomes into five domains. The
affective domain included anger, anxiety, and depression, and the behavioral domain included
“revictimization, self-mutilation, sexual problems, substance use, and suicidality” (p. 9). The
third domain included identity and relational issues and included “interpersonal problems and
self-concept impairment” (p. 9). The fourth domain was labeled “other psychiatric sequelae” and
included dissociation, obsessions/compulsions, somatization, and traumatic stress symptoms (p.
9). The last domain was general symptomatology and included broad measures of psychological
distress and symptomatology. The researchers included 38 studies and 11,162 subjects in their
meta-analysis. Overall, they found a significant association between CSA and long-term negative
consequences, and the effect size was small to medium. The largest effect size was found for the
association between CSA and revictimization (d = +. 67; 95% CI: +. 50-+.84).
Chen and colleagues (2010) conducted a meta-analysis of 37 longitudinal studies (17
case-control and 20 cohort studies; N = 3,162,318) investigating the link between CSA and
5

subsequent mental health issues. They found a significant link between CSA and anxiety
disorders, PTSD, depression, eating disorders, sleep disorders, and suicide attempts. Victims of
CSA were 2.34 (PTSD) to 16.17 (sleep disorders) times more likely to develop mental health
issues compared to those without CSA experiences. The relation was stronger for CSA victims
who had been raped and the likelihood of developing depression, eating disorders, and PTSD.
CSA was not significantly related to schizophrenia and somatoform disorders.
Hillberg and colleagues (2011) did a systematic review of seven meta-analyses, including
248 published and unpublished articles that have investigated the association between CSA and
subsequent mental health problems as adults. Neumann and colleagues’ (1996) meta-analysis
was included among the seven studies. Hillberg and colleagues (2011) included a broad range of
mental health issues, such as emotional difficulties (e.g., anger, hostility), anxiety symptoms and
disorders (e.g., obsessive compulsive disorder, OCD; phobia, PTSD), depressive symptoms,
somatization and eating disorders, substance use, dissociation, paranoia and psychotic symptoms,
suicidality and self-harm, personality characteristics and disorders (borderline personality
disorder, BPD; interpersonal sensitivity), and broad assessments of functioning (e.g.,
interpersonally, socially, sexually). The effect sizes varied between .04 (.10 is cutoff for small
effect) and .28 (.30 cutoff for medium effect).
Another systematic review of meta-analyses (Maniglio, 2009) included the seven metaanalyses that were in Hillberg and colleagues’ (2011) review in addition to another seven.
Maniglio included meta-analyses investigating “medical, neurobiological, psychological,
behavioral, sexual, [and] other health problems following [CSA]” (p. 648). Maniglio also
concluded that the association between CSA and its sequelae is small to medium in magnitude
with weak effects for sexually transmitted diseases (STDs; e.g., genital herpes). The researcher
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concluded that CSA “should be considered as a general, nonspecific risk factor for
psychopathology (including psychologically, behaviorally, and sexually related problems and
later revictimization as well as certain medical problems which are psychological in origin)” (p.
654).
Several researchers have investigated possible moderating factors between CSA and
subsequent health issues. A common finding is larger effect sizes in studies with larger samples
and/or clinical samples (Hillberg et al., 2011; Irish et al., 2010; Maniglio, 2009; Neumann et al.,
1996). Hillberg and colleagues (2011) found great variability between the different metaanalyses in terms of moderators. They stated that women consistently perceive that they are more
affected by the CSA than men, although both groups report heightened levels of mental health
issues. Other researchers have found little support for moderators included in their study.
Neumann and colleagues (1996) did not find any significant differences for a range of
moderators (e.g., publication year, publication type, statistical method, assessment method, age
of subject). Likewise, Irish and colleagues (2010) did not find any significant moderating effects
(e.g., sex, CSA definition and assessment, and type of comparison group) in the association
between CSA and physical health issues. Chen and colleagues (2010) did not find any significant
differences based on subjects’ sex and age as victims.
Several researchers suggest that the association between CSA and its sequelae is likely
affected by a range of additional factors such as family dysfunction/environment and other types
of maltreatment and trauma. This implies that CSA can be seen as one risk factor out of several
(Hillberg et al., 2011; Maniglio, 2009). However, results from a study with 1,411 female adult
twins suggest that the association between CSA and subsequent health issues cannot be
accounted for by family context and parents’ psychopathology (Kendler et al., 2000). The
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researchers found that the female twin who reported CSA experiences had an increased risk for
developing mental health issues compared to her twin who had not been sexually victimized as a
child. This suggests that CSA experiences as well as other types of childhood traumas and the
general environment are all important factors that increases risk for a range of health issues.
The high rates of sexual victimization and the negative consequences of the CSA
sequelae are fairly well established in the research literature, but there has been less focus on
these factors among a specific subgroup, incarcerated women. Indeed Cole, Sarlund-Heinrich, &
Brown (2007) among others, have described incarcerated women as a neglected population. This
is troubling, as research suggests that incarcerated women are at a heightened risk for sexual
victimization and mental health issues. Researchers have also suggested that sexual victimization
is a pathway to prison for women (Belknap, 2007; Bloom, Owen, & Covington, 2004; Browne,
Miller, & Maguin, 1999; Cole et al., 2007; Salisbury & Van Voorhis, 2009; van Wormer &
Kaplan, 2006). Below follows a review and discussion of the research literature on incarcerated
women, with a focus on sexual victimization, mental health issues, and treatment needs. First,
statistics will be presented about the female prison population in the United States.
C. THE U.S. CORRECTIONAL SYSTEM AND THE FEMALE PRISONER
According to the ninth edition of the World Prison Population List published by the
International Centre for Prison Studies, approximately 10 million people are incarcerated around
the world with the largest prison population being in the United States (743 out of 100,000 U.S.
adults; Walmsley, n.d.). Walmsley’s report is based on available prison statistics from 218
different countries and territories in May of 2011. The most recent Bureau of Justice (BJS)
statistics (Glaze & Herberman, 2013) show that 6.9 million people were under the supervision of
the U.S. correctional system at the end of 2012. These numbers include people incarcerated in
8

state or federal prisons (n = 1,483,900) and local jails (n = 744,500) as well as those under
probation or parole (also includes minors prosecuted as adults; n = 4,781,300). Overall this
means that 2.9% of the United States adult population was involved with the correctional system
at the end of 2012. This translates to 1 in 108 adults in prison or jail (920 inmates per 100,000
adults) and 1 in 50 adults on probation or parole (1,980 per 100,000 adults). These rates have
been fairly consistent since 2000, with a slight decrease observed from year to year (40,900
fewer in 2012 compared to 2011). Separating out the prison population from those in jails, 626 in
100,000 U.S. adults were imprisoned by the end of 2012 (Carson & Golinelli, 2013). Men were
more likely to be imprisoned compared to women (910 per 100,000 compared to 63 per
100,000). This resulted in 108,866 women and 1,462,147 men being imprisoned by the end of
2012.
Lower rates of female prisoners are supported by Walmsley’s (2006) prison statistics.
Worldwide, female prisoners comprise of between 2 and 9% of the world prison population
(Walmsley, 2006). Again, the United States has the highest number of incarcerated women in the
world (Walmsley, 2006). Recent studies in the United States have also shown that the rate of
female detainees is growing at a faster pace than the rate of male detainees. In 1977, 10 in
100,000 women were incarcerated in the United States, but, in 2004, that number had increased
to 64 in 100,000 (Frost, Greene, & Pranis, 2006). As described by Frost and colleagues (2006)
“[t]he number of women serving sentences of more than a year grew by 757 percent between
1977 and 2004 – nearly twice the 388 percent increase in the male prison population” (p. 9).
Increase in female detainees in the state of Arkansas follows the same trend as what has
been report on the United States female prison population (Frost et al., 2006). Eight in 100,000
women were incarcerated in Arkansas in 1977 while 65 out of 100,000 were incarcerated in
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2004. This was an increase of 900% with a 9.5% annual increase since 1977 and a 17% increase
since 1999. In 2004, Arkansas had the 19th highest female prison rate in the United States. At the
end of 2012, of the 14,615 adults imprisoned in the state of Arkansas, 1,048 of those were
women (Carson & Golinelli, 2013).
According to Frost and colleagues (2006), the greater rate of increase of female detainees
has been consistent since the 1980s, with somewhat equal rates in the beginning of the 1990s.
Researchers have argued that this increase in female detainees can partially be explained by the
war on drugs (e.g., Bloom et al., 2004; Frost et al., 2006), and some researchers have argued that
women are more likely than men to be incarcerated due to drug charges (e.g., Haywood, Kravitz,
Goldman, & Freeman, 2000; Jordan et al., 2002). BJS statistics show that, at the end of 2011,
female prisoners were fairly equally likely to be convicted for violent crimes (36.8%), property
crimes (27.8%), and drug crimes (25.1%; Carson & Golinelli, 2013). Comparably, more than
half of the male prison population was convicted for violent crimes (54.3%) with fairly equal
rates of property (18.3%) and drug crimes (16.8%). These statistics would potentially support a
disproportional rate of women being incarcerated for drug charges (25.1% compared to 16.8%).
Numerous researchers have provided descriptions of incarcerated women in the U.S. In
Haywood and colleagues’ (2000) review article describing characteristics of women in jails, they
stated that “female detainees are often young, single minorities who have children and are
unemployed and undereducated” (p. 309). They also described female detainees as “hav[ing]
experienced prolonged social disadvantage, suffer[ing] from drug and alcohol addiction, and
hav[ing] unmet needs for mental health treatment [italics added]” as well as “ victims of abuse
[italics added],…hav[ing] experienced family fragmentation, economic instability, and social
isolation” (p. 321). Others have made similar comments. Bloom and colleagues (2004) describes
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female prisoners as “disproportionately women of color…in their early-to-mid-thirties…most
likely to have been convicted of a drug or drug-related offense…fragmented family histories
…survivors of physical or sexual abuse as children and adults [italics added]…significant
substance abuse problems…multiple physical and mental health problems [italics added]
…unmarried mothers of minor children…limited vocational training and sporadic work
histories” (p. 36). Lewis (2006) described the incarcerated woman as “a polysubstancedependent minority single mother in her childbearing years with a history of psychiatric
treatment, physical or sexual abuse often dating to childhood [italics added], and socioeconomic
hardship” (p. 782).
In sum, female prisoners constitute a small but growing segment of the U.S. prison
population. They tend to be a disadvantaged group with numerous health issues, and they tend to
be the primary caregiver of children below the age of 18. While researchers have argued that this
increase in female detainees can partially be explained by the war on drugs (e.g., Bloom et al.,
2004; Frost et al., 2006), other factors also play a role. One of those factors for women is sexual
victimization. Several researchers have described sexual victimization as a pathway to prison for
women (Belknap, 2007; Bloom et al., 2004; Browne et al., 1999, Cole et al., 2007; Salisbury &
Van Voorhis, 2009; van Wormer & Kaplan, 2006). Below follows research on sexual
victimization among incarcerated women.
D. SEXUAL VICTIMIZATION AMONG INCARCERATED WOMEN
Incarcerated women are disproportionally at risk for being sexually victimized at some
point in their life. Overall, they report high rates of trauma, especially interpersonal trauma.
More specifically, they are at heightened risk for sexual victimization compared to the general
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female population and compared to incarcerated men. This includes higher rates of sexual
revictimization both inside and outside of prison.
Interpersonal Trauma
Studies have overall found high rates of trauma, especially interpersonal victimization,
among female prisoners. Cook, Smith, Tusher, and Raiford (2005) found that 99% of a sample of
incarcerated women had experienced at least one traumatic event (N = 403). On average, the
women reported that they had experienced 8.43 traumatic events out of 21. The highest rates
were found for unexpected death of loved one (84%), physical abuse by partner (78%), threat to
kill (60%), family violence as child (57%), stalked (47%), motor vehicle accident (MVA; 46%),
and CSA (43%).
Similarly, Green, Miranda, Daroowalla, and Siddique (2005) found that 98% of the
female prisoners in their study (N = 100) had experienced at least one traumatic event. The rates
varied by type of trauma, with the highest rates for domestic violence (71%), witnessed someone
injured or killed (58%), family member killed (58%), and raped as an adult (58%). Forty-eight
percent reported CSA experiences. In another randomized sample of 85 incarcerated women,
87% reported experiencing at least one traumatic event in their lifetime (Zlotnick, 1997). Most of
the women had experienced multiple traumas, with the highest rates for being physically
assaulted as an adult (63%), physically abused as a child (55%), raped as an adult (53%),
witnessing violence as an adult (48%), and CSA (40%). Forty-one percent fell in the category of
“other trauma.” In Wolff and colleagues’ (2011) sample of trauma exposed female felons, they
found that women had experienced on average 14 traumatic events in their lives. Ninety-nine
percent of the women had experienced a general disaster, 87% physical and/or sexual abuse, and
58% crime-related trauma (measured by the Trauma History Questionnaire, THQ; Green, 1996).
12

In general, these studies suggest that female prisoners have been exposed to a high number of
traumas and that most of them have been exposed to interpersonal trauma.
Sexual Victimization
Incarcerated women represent a high-risk group for sexual victimization, with high rates
of CSA. In a sample of 436 incarcerated women, 68% reported being sexually assaulted during
their lifetime (Blackburn, Mullings, & Marquart, 2008). Similar rates were found in a study of
214 female prisoners (Abrams, Etkind, Burke, & Cram, 2008). Fifty-five percent had been
sexually assaulted and most of the women had been sexually victimized before age 16 (65% of
those sexually assaulted). In another study, more than one-third of 150 female detainees reported
being victims of sexual assault by their partner and almost 60% were sexually abused before age
18 (Browne et al., 1999).
Additional studies have reported high rates of CSA among female detainees. In a large
sample of 1,198 incarcerated women, 33% reported being victims of CSA (Mullings, Marquart,
& Hartley, 2003). Two other studies found rates of CSA between 26% (N = 500; Mullings,
Marquart, & Brewer, 2000) and 50% in samples of incarcerated women (N = 49; Martin &
Hesselbrock, 2001). Moreover, McDaniels-Wilson and Belknap (2008) interviewed a sample of
391 female prisoners about their sexual violence experiences. They found that 70% of the
women reported that they had experienced more severe sexual assault such as rape. They also
found that half of the women had been sexually abused before age 18. Of those women, 10%
were victimized before age 6 and 34% before age 12. Most perpetrators were family members
and males. Most of the women reported having had more than one perpetrator.
Some studies divided the sexual abuse rates by additional age categories. In Cook and
colleagues’ (2005) sample (N = 403), more than 40% of the women reported being sexually
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abused as children, 27% as teenagers, and 27% as adults. Half of the women in Raj and
colleagues’ (2008) sample of 484 women reported being victims of sexual assault; 35% as
children, 14% as teenagers, and 22% as adults. Richie and Johnsen (1996) recruited 258
incarcerated women and found that 10% had been sexually abused as children, 9% as teenagers,
and 21% as adults. In a treatment-seeking sample of female inmates with trauma histories (N =
97), 58% reported that they had sexually abused as children and 34% as adults (Wolff et al.,
2010). These rates were similar when the researchers included a larger treatment-seeking sample
of incarcerated women with a trauma history (N = 209; Wolff et al., 2011). Fifty-five percent
reported CSA and 35% ASA.
Studies have found that incarcerated women are reporting higher rates of interpersonal
trauma compared to the general female population. Tusher and Cook (2010) compared a sample
of 188 incarcerated women to a sample of 171 non-incarcerated women. They found that the
incarcerated sample had higher rates of sexual abuse as children (42.0-58.0% vs. 25.7-45.0%)
but not as teenagers (22.9% vs. 20.5%). Logistic regression analyses determined that the
incarcerated women were also at heightened risk for ASA compared to the non-incarcerated
sample. Another study compared a sample of 157 incarcerated women with 109 women from the
community (Severson, Postmus, & Berry, 2005). They found that the incarcerated women were
more likely to report sexual assault as an adult (89% vs. 76%), rape as an adult (73% vs. 55%),
and CSA (68% vs. 47%) compared to the community sample.
Sexual victimization rates of incarcerated women are also higher than those of
incarcerated men, which mirrors the findings from national studies that have shown that women
are at increased risk for sexual victimization compared to men (e.g., Black et al., 2011). One
study utilizing a large prison sample (N = 19,422) found that white (26.5%) and African-
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American (16.0%) women reported higher rates of sexual victimization compared to white and
African American men (4.0% and 1.1% respectively; Clark et al., 2012). Another sample of 500
female prisoners and 1,030 male prisoners found that the women were more likely to report
sexual victimization as children (26% vs. 4.5%) and as adults (30.8% vs. 1.1%) compared to men
(McClellan, Farabee, & Crouch, 1997). Two other studies that focused on childhood abuse
reported similar discrepancies between female and male prisoners. One sample of 6,964 male
prisoners and 564 female prisoners found that approximately 1 in 2 women reported CSA
experiences compared to approximately 1 in 10 men (Wolff, Shi, & Siegel, 2009). Another study
with 318 female prisoners and 1,326 male prisoners who participated in a substance use program
showed that the female prisoners were “nearly six times more likely to report that they had been
physically or sexually abused as children” (Langan & Pelissier, 2001, p. 297).
Overall, these studies suggest that incarcerated women represent a high-risk group for
sexual victimization. Although studies have reported sexual abuse rates by victims’ age and
developmental period, it is unclear whether the same women are included in multiple categories.
Some researchers have studied this in more detail and therefore clarified that many of the women
are revictimized.
Revictimization
As with women in the general population, incarcerated women are also at heightened risk
for revictimization. In Walsh, DiLillo, and Scalora’s (2011) sample of 160 female inmates, 50%
of the women were victims of CSA and 57% reported sexual assault as teenagers and adults.
CSA victims were in general at increased risk for subsequent sexual victimization compared to
women without these experiences. Walsh and colleagues found that 36.9% of the women had
been revictimized (CSA and rape since age 14) compared to 13.7% who were CSA victims only
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and 18.8% who were rape victims as teenagers or adults. Another study found that 58% of
female inmates had experienced both CSA and rape as adult (Severson et al., 2005).
Tusher and Cook (2010) compared female inmates to non-inmates in terms of their risk
for revictimization. Overall, they found that the inmates were at heightened risk for sexual
revictimization. Although all women who reported sexual abuse as children were at an increased
risk for revictimization, female inmates were at an even greater risk for being revictimized as
teenagers (90.7% vs. 71.4%) and adults (79.8-83.9% vs. 59.1-68.3%) compared to non-inmates.
In their logistic regression analyses, Tusher and Cook found that CSA as well as incarceration
status significantly predicted ASA, such that women with a history of CSA as well as women
with a history of prior incarceration were at greater risk for sexual victimization as adults.
However, the researchers did not find any significant interactions in their regression analyses
between CSA and incarceration status, indicating that the strength of the relationship between
CSA and ASA did not differ between the two groups of women.
Sexual Victimization in Prison
Not only do female prisoners report higher rates of sexual victimization than the general
female population and than male prisoners prior to incarceration, they are also at heightened risk
for being sexually victimized while in prison. In a BJS report (Beck & Johnson, 2012) with
18,526 former prisoners the researchers reported that close to 10% of prisoners have been
sexually victimized while incarcerated. Female prisoners were three times more likely to report
being sexually victimized by another inmate (13.7% vs. 4.3%) and they were more likely to
report “unwilling” sexual activity with a staff member (2.5% vs. 1.1%) compared to men. Since
many female prisoners have sexual abuse histories prior to their incarceration, this means that
women may be sexually revictimized while in prison.
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Wolff and colleagues have investigated prison sexual violence experiences of a large
sample of male and female inmates (Wolff, Blitz, & Shi, 2007a; Wolff & Shi, 2011; Wolff, Shi,
& Backman, 2008; Wolff et al., 2009). They recruited 7,785 inmates (564 women) in one state
from 14 different prisons (12 adult prisons for men, 1 prison focusing on male sex offenders, and
1 adult prison for women). In one study 24.5% of the female detainees reported sexual
victimization by an inmate and/or a staff member in the past 6 months (Wolff et al., 2007a).
Close to 70% had been victimized by another inmate only, 13% by a staff member only, and the
remaining percentage by both a staff member and another inmate. Wolff and colleagues (2008)
found that female detainees were more likely to report being sexually victimized by other
inmates and staff compared to male detainees (2.5-26.4% compared to 1.7-10.7%). For the
female prisoners, the most commonly reported sexual victimization experiences perpetrated by
another inmate were being touched or grabbed in sexually threatening ways and being touched
on the genitals or sex organs (13.3-15.9%; Wolff & Shi, 2011). These types of sexual violence
experiences were also most common among those who reported being victimized by staff, but
the percentages were lower (approximately 5%). Interestingly, female prisoners reported equal
rates of sexual and physical victimization while in prison (24%), while men were more likely to
report physical victimization compared to sexual (35% vs. 10%; Wolff et al., 2009).
Other studies have also investigated sexual victimization rates in prisons. In one study
9.5% of the female inmates reported being victims of sexual coercion and 24.2% victims of
forced sexual contact while incarcerated (Walsh, Gonsalves, Scalora, King, & Hardyman, 2012).
In another study, 17.2% of the women had been sexually assaulted while incarcerated
(Blackburn et al., 2008). Yet another study that included 263 female prisoners from three
different facilities found that 14% of the women had been sexually victimized by someone while
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in the current prison and 19% while incarcerated at some point in their life (Struckman-Johnson
& Struckman-Johnson, 2002). In a later publication, the researchers reported, using the same
sample, that 57% of the female prisoners who had been victimized while in prison had been
victimized more than once, reporting an average of 3.9 times (Struckman-Johnson & StruckmanJohnson, 2006). Also, almost half of the women reported more than one perpetrator.
In conclusion, studies have found alarmingly high rates of sexual victimization in
samples of incarcerated women. Female inmates report higher rates of sexual victimization than
male inmates (Clark et al., 2012; Langan & Pelissier, 2001; McClellan et al., 1997; Wolff et al.,
2009) as well as higher rates than community samples of women (Severson et al., 2005; Tusher
& Cook, 2010). Many incarcerated women report CSA experiences (Abrams et al., 2008;
Browne et al., 1999; Cook et al., 2005; Martin & Hesselbrock, 2001; McDaniels-Wilson &
Belknap, 2008; Mullings et al., 2000, 2003; Raj et al., 2008; Wolff et al., 2010, 2011), and
oftentimes perpetrators are family members (e.g., McDaniels-Wilson & Belknap, 2008). Female
inmates are also at heightened risk for revictimization both inside (Beck & Johnson, 2012; Wolff
et al., 2008) and outside of prison (Severson et al., 2005; Walsh et al., 2011). Furthermore, they
are at increased risk for revictimization compared to the average woman (Tusher & Cook, 2010).
In addition to the high rates of interpersonal trauma both inside and outside of prison,
some research findings suggest that incarcerated women with sexual abuse experiences are
experiencing more difficulties compared to those without or with fewer sexual abuse
experiences. Herbert, Rose, Rosengard, Clarke, and Stein (2007) recruited 149 incarcerated
women for a randomized control study evaluating “a brief motivationally based intervention on
post-release drinking and sexual risk behaviors” (p. 31). Women who had reported dangerous
drinking levels in combination with engaging in risk behaviors related to contraction of human
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immunodeficiency virus (HIV; e.g., unprotected vaginal sex and sharing needles) prior to
incarceration were recruited for the study. Using latent cluster analysis on a range of variables,
Herbert and colleagues identified two clusters of women. One group reported experiencing a
larger number of traumas than the other group (12.9 vs. 5.4 types of traumas). In addition to
experiencing more sexual trauma than the other group, this group of women also experienced
more physical (e.g., attacked with a weapon, attacked without a weapon but with serious injury,
hurt or beaten by a family member that caused injury), general (e.g., accident, disasters, death or
serious injury to self or others, life-threatening illness, military combat), and crime-related
trauma (e.g., used force to take something from them, robbed, burglary). They were also more
likely to report that they had been raped by a stranger (35.2% vs. 13.7%). The group that had
experienced more traumas, including sexual traumas, also reported more difficulties
psychologically (e.g., mental health, drug issues). These findings suggest that although female
inmates tend to have experienced more trauma than the general population, those with sexual
trauma experiences report even higher numbers of traumas. Although Herbert and colleagues’
study did not address the temporal order of the different traumas, these findings suggest that
incarcerated women with sexual abuse histories may be experiencing more difficulties than those
without these experiences. Numerous studies support the heightened rates of mental health issues
among female prisoners, especially among those with sexual abuse histories.
E. HEALTH OUTCOMES IN INCARCERATED WOMEN
As with the sexual victimization rates, incarcerated women are reporting
disproportionally high rates of physical and mental health problems. In general, they report
higher rates of health problems than community samples, and they report higher rates of health
problems compared to male prisoners. The majority of the studies have investigated mental
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health problems, while the physical health studies are fewer and tend to focus on sexual health
and risk behaviors. The term sexual victimization sequelae is not used as much among studies of
incarcerated women, but there are a great deal of similarities between the sexual violence
sequelae literature and health and psychological difficulties reported by female detainees.
Physical Health
Most of the physical health studies with incarcerated women have investigated sexual
health behaviors and diseases. Abrams and colleagues (2008) found that 52% of the female
inmates in their study had been diagnosed with an STD at least once. Similar results have been
reported by other researchers. Richie and Johnsen (1996) included 258 incarcerated women in
their study and found high rates of STDs and risky sexual behaviors. Fifty-six percent of the
women who completed a STD test (n = 110) were diagnosed with at least one STD. In another
study with 100 incarcerated women, 40% reported having had abnormal Pap smear tests
(Nijhawan, Salloway, Nunn, Poshkus, & Clarke, 2010). Another sample of 30 female detainees
completed a series of questionnaires in addition to a physical examination (Kane & DiBartolo,
2002). Close to half of the women reported a history of at least one STD. Twenty-two women
underwent a gynecological examination and one third of them had either an abnormal pap smear
or an STD.
Other researchers have found that female prisoners with sexual abuse histories are more
likely to report sexual health issues compared to those without these experiences. Abrams and
colleagues (2008) reported that incarcerated women with a history of sexual victimization were
almost 3 times more likely to be diagnosed with an STD. Richie and Johnsen (1996) also found
that women who had been sexually abused at some point in their life were more likely to be
diagnosed with an STD.
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Two of the studies that reported sexual health issues also investigated other physical
health issues. In Nijhawan and colleagues’ (2010) study, 37% tested positive for hepatitis C. In
Kane and DiBartolo’s study (2002) two of the women had HIV (7%), two seizure disorder, two
diabetes, two delirium tremens, and 10 had asthma (33%).
Additional studies have focused specifically on risk behaviors that have been linked to
contracting HIV. In Mullings and colleagues’ (2000, 2003) two samples of incarcerated women,
those with a CSA history were more likely to have been involved in risky behaviors that were
linked to contracting HIV (e.g., prostitution, unprotected sex with 2 or more partners,
unprotected sex for drugs or money, unprotected sex with crack user, intravenous drug use, and
sharing dirty needles). Having a CSA history was a significant predictor for HIV risk factors
related both to sexual and drug related risk behaviors (Mullings et al., 2000). Similarly, Herbert
and colleagues’ (2007) sample of female inmates could be divided into two groups based on the
amount of traumas (sexual and other types of traumas) and psychological difficulties they were
experiencing. The more traumatized group, with more sexual trauma as well, were more likely to
engage in risky behaviors that could lead to HIV (e.g., unprotected vaginal intercourse and
sharing needles). This group also reported more medical conditions than the less traumatized
group.
Although these studies suggest that female inmates experience a range of physical health
issues, the research has mostly been limited to small samples and sexual health. No systematic
studies have been conducted with female inmates to determine prevalence of physical health
issues. Furthermore, no studies have compared physical health rates between community and
prison populations or between male and female detainees. Substantially more research has
investigated mental health concerns among incarcerated women.
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Mental and Psychological Health
Several studies have focused on mental health issues among female prisoners. Two larger
studies with representative samples have been completed with incarcerated women; one focused
on women in jail and one on women in prison. These studies have found high rates of mental
health issues among incarcerated women, with rates higher than in community samples. Teplin,
Abram, and McClelland’s (1996) sample of 1,272 female jail detainees who had been arrested in
Illinois over a 2-year period was selected and stratified by race/ethnicity and their legal charge.
Teplin’s team assessed for lifetime and current axis I disorders as well as antisocial personality
disorder (ASPD). They found that 81% of the women met criteria for at least one lifetime
psychological disorder and 70% of the women met criteria for a current psychological disorder
(in the past 6 months). When comparing the rates to data from the Epidemiological Catchment
Area program (ECA; U.S. Department of Health and Human Services), the incarcerated women
reported higher rates for all disorders except for schizophrenia and schizophreniform disorder.
Substance use/dependence disorder (SUD; lifetime: 70.2%; past 6 months: 60.1%) and PTSD
(lifetime: 33.5%; past 6 months: 22.3%) were the most prevalent disorders.
Jordan, Schlenger, Fairbank, and Caddell’s (1996) sample of 805 female inmates reported
a lifetime rate of mental illness to be 64% with a current rate of 46%. The researchers included
six Axis-I (major depressive disorder, MDD; dysthymia, generalized anxiety disorder, GAD;
panic disorder, PD; alcohol abuse/dependence, and SUD) and two Axis-II disorders (ASPD and
BPD). They found that alcohol (38.6% lifetime and 17.1% current) and substance related
disorders (44.2% lifetime and 30.2% current) as well as BPD (28.0% current) were the most
prevalent disorders. When dividing the sample by age (18-25 and 26-50) and ethnicity (White
and African-American) and comparing the incarcerated women to the general population (i.e.,
ECA), Jordan and colleagues (1996) found that the incarcerated women reported higher
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prevalence rates in 16 out of 20 comparisons. Some of the lowest odds ratios were reported for
anxiety (white female inmates age 26-50 were 1.2 times more likely to meet criteria for PD or
GAD) and mood disorders (female inmates between 1.7 - 3.0 times more likely to meet criteria
for MDD and dysthymia) while some of the highest were found for alcohol abuse/dependence
(female inmates 15.5 – 47.3 times more likely), SUD (female inmates 8.1 – 46.8 times more
likely), and ASPD (females inmates 10.6 – 15.4 times more likely). It is important to note that
the researchers did not include PTSD rates.
Other studies with incarcerated women have also found high rates of mental illness.
Trestman, Ford, Zhang, and Wiesbrock (2007) recruited 201 female jail detainees. Seventyseven percent of the women had at least one lifetime axis I or axis II disorder, with 74.1%
meeting criteria for a lifetime axis I, 10.2% lifetime Cluster A personality disorder, 37.4%
lifetime Cluster B, and 18.1% lifetime Cluster C. More than half of the women met criteria for a
lifetime mood disorder, with the highest rate for MDD (49.3%). Close to half of the women also
met lifetime criteria for an anxiety disorder (not including PTSD) and 41.8% met lifetime criteria
for PTSD. The most common lifetime personality disorders were ASPD (27.0%) and BPD
(23.2%). According to the researchers the patterns were the same for current diagnoses even
though the rates were lower (32.2% mood disorder, 35.9% anxiety disorder excluding PTSD, and
21.5% PTSD). They did not report current rates for the other disorders. The researchers also did
not report on substance use disorders, and it is unclear if they excluded those disorders or did not
report on them. This is noteworthy since other researchers have reported high rates of substance
use disorder among incarcerated women.
Several studies suggest high rates of SUDs, MDD, and PTSD among incarcerated
women. Green and colleagues (2005) found that 74% of the women in their sample currently met
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criteria for SUDs, 22% PTSD, and 25% MDD (N = 100). In a sample of 49 incarcerated women,
80% of the women reported a history of psychological disorders (Martin & Hesselbrock, 2001).
Among Axis I disorders, substance dependence (69%), MDD (62%), and PTSD (45%) were the
most common disorders. ASPD was the only axis II disorder assessed; 33% met criteria. In Vik’s
(2007) sample of 100 female felons, 45% met criteria for dependence on two or more drugs and
38% were dependent on one drug during their lifetime. The highest rates were found for
methamphetamine (67%), alcohol (32%), cannabis (19%), and cocaine (15%). More than half of
the sample met criteria for a mood disorder and close to half for an anxiety disorder. More
specifically, 31% met criteria for MDD, 23% dysthymia, 19% bipolar disorders, 24% GAD, 23%
PD, and 29% PTSD.
Furthermore, studies have found high rates of comorbidity among female inmates.
Trestman and colleagues (2007) focused on lifetime comorbidity among incarcerated women.
Approximately 56% of the women met criteria for more than one Axis I lifetime diagnosis, with
the highest rates for comorbid PD and depression (24.3%). Twenty-seven percent met criteria for
more than one lifetime axis II diagnosis, with the highest rates for BPD and ASPD (12.9%).
Forty-two percent of the women met criteria for comorbid lifetime axis I and II diagnoses
(highest rates for depression and BPD; 22.1%).
Other researchers have also found high rates of comorbidity. In Blitz, Wolff, Pan, and
Pogorzelski’s (2005) sample of 1,267 female detainees, 474 were classified as special need
individuals due to psychological treatment needs. Three-thirds of the 474 women met criteria for
an axis I or II disorder in addition to their primary axis I diagnosis. Fifty-seven percent of the
women with a primary axis I disorder also met criteria for a SUD, 23% an additional axis I
disorder, 11% axis II disorder. In Martin and Hesselbrock’s (2001) sample of 49 incarcerated

24

women, 55% met criteria for at least two psychological disorders. Sixty-three percent had
comorbid substance use problem and axis I or II (i.e., ASPD) disorder. Among the substance
users, 51% met criteria for dependence on one drug while 18% were dependent on two or three
drugs. Depression was highly related to alcoholism. PTSD was most likely to be comorbid with
anxiety or depression.
Vik (2007) was specifically interested in the comorbidity rates between substance use
(i.e., alcohol, cannabis, cocaine, and methamphetamine) and mood and anxiety disorders among
incarcerated women. Participants were more likely to report cocaine dependence if they had a
lifetime diagnosis of mood and/or anxiety disorder (MDD, dysthymia, bipolar disorders, GAD,
PD, and PTSD). Thirteen percent of the women with a mood disorder also met criteria for
cocaine dependence while 32% of women with both a mood and an anxiety disorder also met
criteria for cocaine dependence.
Moreover, studies comparing female and male inmates generally indicate that female
inmates report higher rates of mental health problems, but that the rates vary by the type of
disorder. One study with 1,267 female inmates and 16,700 male inmates found that the women
were more likely to be classified as “special needs,” indicating that they needed and/or received
psychological treatment, compared to the men (37% vs. 16%; Blitz et al., 2005). Women were
more likely to meet criteria for a depressive disorder (58% vs. 45%) while men were more likely
to meet criteria for a psychotic disorder (28% vs. 12%). Other studies support these findings.
Trestman and colleagues (2007) compared 201 female detainees to 307 male detainees in
terms of their lifetime prevalence rates of psychiatric disorders. Women were more likely to
meet criteria for any mental illness during their lifetime compared to men (77.0% vs. 64.9%),
including higher rates for mood (56.5% vs. 24.3%) and anxiety disorders (excluding PTSD;
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49.7% vs. 37.6%). In terms of specific mood and anxiety disorders reported by the researchers,
women reported higher rates of MDD (49.3% vs. 21.2%) and PTSD (41.8% vs. 20.0%). For
personality disorders, women were more likely to be diagnosed with a Cluster C personality
disorder compared to men (18.1% vs. 11.5%). As for specific personality disorders reported by
the researchers, women were more likely to be diagnosed with BPD (23.2% vs. 12.9%) while
men were more likely to be diagnosed with ASPD (39.5% vs. 27.0%). There were no gender
differences for psychotic disorders. According to the researchers, women were more likely to
meet criteria for lifetime, current, and comorbid diagnoses, but they did not report all of these
statistics or specific rates.
Cloyes, Wong, Latimer, and Abarca (2010) included 2,112 male and female prisoners
who met criteria for serious mental illness (SMI), which was defined as “a major thought
disorder, mood disorder, or organic brain syndrome that fits well-established DSM-IV
categories, substantially impairs functioning, and requires treatment” (p. 5). These incarcerated
individuals who met criteria for SMI constituted 23% of the total number of prisoners in Utah
during a 5-year period. The researchers found that women were more likely than men to meet
criteria for an SMI. The most common diagnoses were MDD (72%) followed by bipolar I and II
disorders (30%). The researchers concluded that incarcerated women were more likely to meet
criteria for a mood disorder while incarcerated men were more likely to meet criteria for a
thought disorder. Importantly, the researchers found that women with SMI returned to prison
sooner than women without an SMI (on average 169 days sooner).
As suggested by Herbert and colleagues’ (2007) findings, there are certain subgroups
within the larger population of incarcerated women that are at heightened risk for health issues.
Using latent class analysis, Herbert and colleagues’ (2007) found support for two groups of
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women. One group reported experiencing more sexual and other types of trauma and they also
reported more mental health issues. More specifically, the more traumatized group reported more
depressive symptoms and they were more likely to meet the cutoff for GAD (88.9% vs. 66.7%)
and PTSD (90.3% vs. 48.0%). This group also reported more difficulties with alcohol and drugs
as well as engaging in more risky behaviors related to sex and drugs. Other researchers have
found that female inmates with a trauma history seem to be at increased risk for mental health
issues, especially those with sexual abuse histories.
In Zlotnick’s (1997) sample of 85 incarcerated women, those with current or prior PTSD
diagnosis were more likely to meet criteria for current MDD, past substance use, and BPD. They
also reported more affect dysregulation, dissociation, and somatization compared to those
without PTSD diagnosis. Women with histories of sexual and/or physical child abuse were more
likely to have been diagnosed with PTSD. Salgado, Quinlan, and Zlotnick (2007) recruited 69
female inmates who met criteria for current PTSD and substance abuse or dependence (1 month
prior to their incarceration). Close to half of the sample also met criteria for lifetime
polysubstance dependence. The polysubstance group reported a higher number of traumatic
events (mean of 13.18 compared to mean of 10.72) and trauma symptoms (e.g., dissociation,
anxiety, sexual difficulties).
Another sample of 81 female inmates with HIV diagnosis showed that two-thirds of the
women met criteria for lifetime PTSD (Lewis, 2005). Comparing those with PTSD to those
without, the PTSD group was more likely to report comorbid diagnosis (axis I and/or II). More
specifically, the women with PTSD diagnosis were more likely to meet criteria for lifetime
MDD, ASPD, and cannabis abuse or dependence. All women who met criteria for BPD also met
criteria for PTSD, but this trend was not significant (only seven women met criteria for BPD).
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The women who met criteria for PTSD and were HIV positive were more likely to report
experiencing severe sexual abuse (e.g., penetration, multiple occurrences of sexual abuse, and
multiple occurrences of rape) and to report that their perpetrator(s) were first- or second-degree
relatives. The women who met criteria for PTSD were more likely to report prior suicide
attempts, taking psychotropics in the past, and being treated in an outpatient mental health
facility.
Wolff and colleagues (2010) found that more than half of the sample of 97 female
inmates who had experienced at least one traumatic event in their life met criteria for more than
one axis I disorder. When excluding SUDs, the most frequent combinations were PTSD and
depression, or PTSD and another anxiety disorder. In Wolff and colleagues’ (2011) larger
sample, they found even higher rates of mental illness. Eighty-five percent met criteria for at
least one axis I disorder, 88% full or threshold PTSD, and 87% a SUD.
Two-thirds of Wolff and colleagues’ (2010) sample met criteria for severe mental illness
(e.g., psychotic disorder, bipolar disorder, or MDD). Those who had been diagnosed with a
severe mental illness reported even higher rates of sexual trauma than the total sample (61%
compared to 52%). Sixty-four percent of the women with severe mental illness had a history of
CSA compared to 55% of the total sample. Importantly, Wolff and colleagues (2010) found that
the sexual victims were more distressed and were more likely to meet criteria for PTSD, MDD,
and alcohol abuse/dependence compared to those reporting physical trauma. The rates for
distress and PTSD were similar for victims of CSA, ASA, and those with revictimization
experiences (i.e., sexual abuse both as children and as adults).
Other researchers have also reported results suggesting that sexual abuse victims are at
increased risk for a range of health related concerns. Clark and colleagues (2012) found that
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female and male felons who had experienced sexual abuse were significantly more likely to
report “histories of suicide attempts or ideations, be unemployed or on disability, have lived in a
shelter, received medication for a mental problem, traded sex for drugs, and met criteria for
alcohol and cocaine dependence” (p. 1849). In Mullings and colleagues’ (2000) sample of 500
female inmates, those with CSA histories were more likely to have lived in “a marginal living
context” (e.g., lacking adequate food, clothing, and shelter, been attacked with a weapon, and/or
felt unsafe or in danger) than those without CSA histories (p. 681). Likewise, Richie and Johnsen
(1996) found that incarcerated women who had been sexually abused were more likely to have a
history of suicide attempts.
Wolff, Shi, Blitz, and Siegel (2007b) showed that mental health problems and CSA
history were risk factors for female inmates to be revictimized while in prison. Prisoners (N =
7,785; 564 women) were 1.8-2.6 times more likely to report that they had been sexually
victimized by another inmate while in prison if they also reported prior treatment for depression,
anxiety, and/or PTSD. Prior treatment for mental health issues was also a risk factor for being
sexually victimized by a staff member while in prison. Moreover, the inmates were 3-5 times
more likely to report sexual victimization while in prison if they had a history of CSA (either by
an inmate or by a staff member).
Altogether, research studies investigating health issues among incarcerated women have
found disproportionally high rates of health problems in this population. Several researchers
have found high rates of STDs and other sexual health issues (Abrams et al., 2008; Kane &
DiBartolo, 2002; Nijhawan et al., 2010; Richie & Johnsen, 1996), with even higher rates among
female inmates with a sexual abuse history (Abrams et al., 2008; Richie & Johnsen, 1996). Most
studies have focused on mental health issues. Again, incarcerated women appear to be at
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heightened risk compared to the average woman (Jordan et al., 1996; Teplin et al., 1996) and
compared to incarcerated men (Blitz et al., 2005; Cloyes et al., 2010; Trestman et al., 2007).
Some of the most common axis I disorders reported by female inmates are SUD, PTSD, and
MDD (Jordan et a., 1996; Martin & Hesselbrock, 2001; Teplin et al., 1996). Incarcerated women
also report high rates of comorbidity (Blitz et al., 2005; Martin & Hesselbrock, 2001; Trestman
et al., 2007; Vik, 2007). Researchers have found that incarcerated women with sexual abuse
histories are more likely to report mental health issues compared to those without these
experiences (Herbert et al., 2007; Lewis, 2005; Wolff et al., 2010, 2011).
While female inmates with sexual victimization histories are at increased risk for
debilitating mental health problems such as SUD, PTSD, and MDD, common sequelae among
victims of sexual abuse (Chen et al., 2010; Hillberg et al., 2011), more importantly, sexual
victimization may be a causal factor linked to women’s subsequent imprisonment. Indeed, many
researchers have argued that sexual victimization is a pathway to prison for women (Belknap,
2007; Bloom et al., 2004; Browne et al., 1999, Cole et al., 2007; Salisbury & Van Voorhis, 2009;
van Wormer & Kaplan, 2006), with many possible combinations and interactions between
variables. Next, research specifically investigating sexual victimization as a pathway to prison
for women will be discussed as, well as gender specific, trauma focused treatment needs among
incarcerated women.
F. FACTORS ASSOCIATED WITH HIGH RATES OF SEXUAL VICTIMIZATION
AMONG INCARCERATED WOMEN
Several researchers have proposed mechanisms that could explain women’s pathway to
prison and the link between sexual victimization and incarceration (Belknap, 2007; Bloom et al.,
2004; Browne et al., 1999, Cole et al., 2007; Salisbury & Van Voorhis, 2009; van Wormer &
Kaplan, 2006). Belknap (2007) described these as “feminist pathways” (p. 70) and van Wormer
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and Kaplan (2006) stated that women’s pathway to prison include “physical health, mental
health, and social components” (p. 135). Bloom and colleagues (2004) suggested that “women’s
most common pathways to crime are based on survival of abuse, poverty, and substance abuse”
(p. 34). They also stated that “pathway research has identified such key issues in producing and
sustaining female criminality as histories of personal abuse [italics added], mental illness tied to
early life experiences, substance abuse and addiction, economic and social marginality,
homelessness, and destructive relationships [italics added]” (p. 37). Browne and colleagues
(1999) proposed a rather complex interaction among several factors when discussing links
between sexual victimization and imprisonment for women.
According to Browne and colleagues (1999), substance use, prostitution, and violent
relationships are common experience of incarcerated women and can have potential legal
consequences. In general, studies have shown that sexual abuse victims are more likely to use
alcohol and drugs (e.g., Kilpatrick, Acierno, Resnick, Saunders, & Best, 1997). Studies with
female inmates have shown that female prisoners with sexual abuse histories were more likely to
report a substance use history (Richie & Johnsen, 1996). One study with incarcerated women
showed that female inmates with sexual victimization histories were four times more likely to
report a history of drug use compared to female inmates without those experiences (Abrams et
al., 2008). Women with CSA histories were more than eight times as likely to report that they
had used drugs at some point. In a series of studies, Mullings and colleagues (2000, 2003, 2004)
have found evidence for a link between CSA and drug issues. In their sample of 500 female
inmates, those with CSA histories reported higher likelihood of smoking crack cocaine and
injecting drugs in the past compared to those without CSA histories. In their larger sample of
1,198 female inmates, those with a CSA history were more likely to report that they started using

31

a gateway drug (i.e., alcohol, marijuana, or inhalants) before age 16 compared to those without a
CSA history (Mulling et al., 2003). Using the same sample, Mullings, Hartley, and Marquart
(2004) found positive associations between alcohol dependence and CSA; however, CSA was
not a significant predictor of alcohol dependence. Childhood neglect and father’s alcohol and
drug use behaviors were significant predictors.
As for substance use, research has shown that victims of sexual abuse are more likely to
exchange sex for money or drugs (Kramer & Berg, 2003; Widom & Kuhns, 1996). Similar
findings have been reported in samples of female inmates. Richie and Johnsen (1996) found that
female inmates who had been sexually abused were more likely to report that they had
exchanged sex for money. Another study found that incarcerated women with sexual
victimization histories were almost seven times more likely to report exchanging sex for money
or drugs compared to those without sexual victimization histories (Abrams et al., 2008). Using
two different samples of female inmates, Mullings and colleagues (2000, 2003) found that those
with a CSA history were more likely to have been involved in prostitution and to have traded sex
for drugs or money than those without a CSA history. In Herbert and colleagues’ (2007) sample
of female inmates, the more traumatized group also reported being more likely to exchange sex
for drugs or money than those who reported fewer traumas. In a sample of HIV positive female
inmates, those with a PTSD lifetime diagnosis were more likely to report a history of prostitution
than those without PTSD diagnosis (Lewis, 2005).
Moreover, sexual victims are more likely to report experiencing intimate partner violence
(IPV; e.g., McCartan & Gunnison, 2010). Again, similar results have been reported from studies
with incarcerated women. Close to 90% of a sample of 57 incarcerated women had been abused
by their intimate partners at some point (49% sexually abused and 70% physically abused; Fogel
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& Belyea, 1999). Another study found that 55% of 500 incarcerated women had been physically
abused by their partners (McClellan et al., 1997). In Severson and colleagues’ (2005) study with
157 incarcerated women, 97% had experienced IPV. Twenty-five percent of the women had
experienced physical IPV only, 2% rape only, and 71% both physical IPV and rape. These rates
are much higher than IPV rates reported by community women (approximately 33%; Black et
al., 2011).
Even though several studies support the relation between substance use, prostitution,
violent relationships, and incarceration among women, the direction of the relations are unclear.
The possibility for bi-directional or circular relations is part of what makes the associations
complex (Browne et al., 1999). Not only are sexual abuse victims at heightened risk for
substance use, prostitution, and involvement in violent relationships, women who are involved
with drugs and prostitution are also at heightened risk for being sexually assaulted (e.g., Browne
et al., 2008; Mulling et al., 2003). Similarly, women abusing drugs are at risk for being abused
by their partners (e.g., Chermack, Walton, Fuller, & Blow, 2001), including sexual victimization.
Furthermore, even though researchers have found a link between sexual abuse and substance use
issues, there could be other explanations for why incarcerated women with sexual abuse histories
are more likely to be substance users. For instance, studies have shown that incarcerated women
with substance use problems are more likely to have family members and current partners with
substance use issues compared to incarcerated men (see Lewis, 2006 for a review). Langan and
Pelissier’s (2001) study with 318 female prisoners and 1,326 male prisoners who participated in
a substance use program showed that female prisoners “were nearly seven times more likely than
men to report being married to a drug user” and they were more likely to report growing up in a
home with drug use (p. 297).
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Despite these complex relations among variables, several researchers have suggested that
it is likely that women’s sexual abuse histories preceded their involvement with substance use,
prostitution, violent relationships, and the legal system. Since many incarcerated women report
being sexually abused as children (Abrams et al., 2008; Browne et al., 1999; Cook et al., 2005;
Martin & Hesselbrock, 2001; McDaniels-Wilson & Belknap, 2008; Mullings et al., 2000, 2003;
Raj et al., 2008; Wolff et al., 2010, 2011), this would suggest that victimization often precedes
issues with the legal system (e.g., Browne et al., 1999). Researchers have also suggested that
CSA experiences increase the likelihood of engagement in risky sexual experiences (Mullings et
al., 2003), which can lead to further sexual victimization and problems with the legal system. It
is possible that women who have been sexually abused as children are more likely to cope with
these experiencing using drugs, which heighten their risk for prostitution and violent
relationships as well as imprisonment. Multiple studies have shown that people sometimes selfmedicate their PTSD symptoms by engaging in behaviors such as taking different substances
(Dansky, Saladin, Brady, Kilpatrick, & Resnick, 1995; Epstein, Saunders, Kilpatrick, & Resnick,
1998; McFarlane, 1998). Langan and Pelissier (2001) also found that female prisoners were
more likely to report using drugs “to alleviate physical or emotional pain” (p. 295).
Findings from some studies support the hypothesis that sexual victimization and/or
substance use precede imprisonment. McGee and colleagues (2012) found that 75% of their
sample of incarcerated women (N = 200) reported a history of drug and alcohol abuse, 52% were
under the influence from drugs during their arrest, and 60% had committed the crime because
they wanted money for buying drugs. McClellan and colleagues (1997) reported that
incarcerated women were more likely than incarcerated men to have been dependent on
substances prior to incarceration. The female participants were also more likely to have started
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using drugs before any other criminal activity, and substance use was a better predictor for
property crimes for women than for men.
Moreover, Grella, Stein, and Greenwell (2005) recruited 440 female inmates to
investigate potential links between childhood trauma (physical and sexual child abuse,
witnessing family violence, and witnessing or experiencing different types of traumatic events;
serious accident, sudden death, robbery, mugging, or physical assault), adolescence risk
behaviors (e.g., substance use and conduct disorder), and adulthood functioning (e.g.,
psychological distress and criminal behaviors). Victims of childhood abuse were more likely to
report abusing substances as teenagers, which further increased the risk for psychological
distress and criminal behaviors as an adult. Most of the criminal behavior was related to drugs
and property crimes. Grella and colleagues also found a direct relationship between childhood
sexual abuse and engaging in crimes related to drugs, property, sex work, and violence as an
adult.
Another possible explanation for the link between sexual victimization and imprisonment
for women is mental health. This has been discussed less among researchers who suggest that
sexual victimization is a pathway to prison for women. Women with mental health issues might
in general be at risk for being sexually victimized. This would be supported by Teplin and
colleagues’ (Teplin, McClelland, Abram, & Weiner, 2005) study with 936 severely mentally ill
individuals (diagnosed with “psychosis or major affective disorder,” p. 913; 453 women)
recruited from outpatient and inpatient mental health units. They found higher rates of criminal
victimization among their sample of severely mentally ill patients compared to participants from
the National Crime Victimization Survey (N = 32, 449). All comparisons were significant except
for attempted motor vehicle theft. Sexual victimization rates were between 7.2 and 61.2 times
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higher for the participants with a severe mental illness compared to the national sample. This
suggests that women with mental health issues are at increased risk for being sexually victimized
in addition to being a victim of a range of other crimes.
The link between mental illness, sexual victimization, and imprisonment can be multidirectional. Mental illness can increase the risk for imprisonment for several reasons. As Jordan
and colleagues (1996) point out, several of the psychological disorders that are elevated among
incarcerated women may lead to issues with the legal system (e.g., ASPD, BPD, SUD).
Moreover, as previously discussed, psychological trauma can lead to the development of these
and other disorders that are elevated among female detainees (e.g., BPD, ASPD, SUD, PTSD).
Jordan and colleagues (1996) suggest that the differences in exposure to trauma between
incarcerated women and women in the community seem to, at least partly, explain the temporal
order of these variables. They suggest that incarcerated “women’s exposure to extreme events”
(e.g., trauma) seem to precede their mental health issues and imprisonment (p. 518).
Basically, findings of current research studies support the hypothesis that sexual
victimization increases women’s risk for developing health issues and related problems.
Research findings also suggest that poor coping strategies increase their risk for substance use
issues, prostitution, violent relationships, and sexual revictimization. The sexual victimization in
combination with difficulties in coping ultimately put them at risk for imprisonment. Therefore,
the temporal order appear to be that sexual victimization occurs first, which increases the risk for
mental health complications, which ultimately increases the risk for imprisonment. Of course,
the interactions among these variables can be bidirectional and even circular. Growing up in a
chaotic family environment increases the risk for sexual victimization and other types of child
maltreatment. Family members might suffer from mental illness, which increases the risk for
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their children to develop psychological difficulties, both through genetic and environmental
pathways. Their children are already at risk for developing mental health issues, and sexual
victimization can trigger the onset of mental illness and/or exacerbate the symptoms. Following
sexual victimization, a range of psychological problems can unfold such as PTSD and
depression, but also a range of emotional difficulties like anger and disgust. These symptoms
might increase the risk for developing maladaptive coping skills such as substance use. Over
time substance use might increase the symptoms in addition to creating a dependence on the
substance. This might lead to engagement in other risky behaviors such as selling drugs,
spending time with drug addicts and drug dealers, stealing money to buy drugs, and exchanging
sex for drugs. Any of these scenarios can lead to imprisonment.
Salisbury and Van Voorhis (2009) specifically tested pathways to prisons for women
using path analyses to compare 3 models. They recruited 313 women on probation and tested
three models, which might explain continuous offending among women. The first model, the
childhood victimization model, tested the interplay among childhood victimization, history of
mental illness, history of substance abuse, current depression and/or anxiety, dynamic substance
abuse, and admission to prison. The researchers used both an interview as well as self-report
measures. Most of the assessment tools were developed by the researchers. They included items
that had a factor loading of .5 or higher for their final measures. The researchers used two
interview questions in addition to a self-report measure to address childhood victimization. In the
interview they asked if participants had ever been sexually or physically abused as children
(score ranging from 0 - 2). The self-report measure consisted of 19 behaviorally specific
questions. It is unclear if the researchers measured any child victimization besides physical abuse
in the self-report. Mental illness was measured by asking in the interview about suicide attempts,
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psychotic symptoms, psychological diagnoses, hospitalization for mental health issues, and
experiences with psychological treatment (e.g., therapy and/or medication). Anxiety and
depressive symptoms were addressed in the interview by asking six questions about “current
mood swings, loss of appetite, trouble sleeping, fearing the future, trouble concentrating, and
difficulty functioning as a result of worrying” (p. 552). History of substance abuse was addressed
in the interview by asking 10 dichotomized items about substance and alcohol, including
impairment as a result of using substances. The dynamic substance use was addressed in the
interview, and it was supposed to reflect current substance use issues. This scale included six
items asking about current/recent positive or diluted urinalysis (past 6 months), current/recent
legal violations due to substance use (past 6 months), current/recent associations with other
users, missed meetings (individual or group treatment), and absence of drugs in the home.
The second model, the relational model, tested the interplay among relationship
dysfunction, adult victimization, self-efficacy, current depression/anxiety, dynamic substance
abuse, and admission to prison. The relationship dysfunction self-report measure was supposed
to assess for dysfunctional relationships that resulted in women’s “loss of personal power” (p.
533). The measure included six items about “loss of sense of self in relationships; getting into
painful, unsatisfying, and unsupportive relationships; and a greater tendency to incur legal
problems when in an intimate relationship than when not in one (p. 553). The researchers used
the same two interview questions to address adult victimization as they used for childhood
victimization (e.g., if they had ever been sexually or physically abused as adults). They also used
three different self-report measures: physical (15 items), emotional (16 items), and harassment
(e.g., stalking behaviors; 11 items). Self-efficacy was addressed using Sherer’s (1982) SelfEfficacy scale (17 items).
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The third model, the social and human capital model, tested the associations among
educational strengths, relationship dysfunction, family support, self-efficacy, employment and
financial difficulties, and admission to prison. Educational strength was assessed by four
interview questions inquiring about highest level of educational achievement (high school or
GED, some college or post-high school training, job-related licenses or certificates, or obtained a
college degree). Family support was measured by four interview questions addressing
relationships with family members (e.g., level of conflict, amount of communication, assistance
from family members with child care, finances etc.). Lastly, employment and financial
difficulties was addressed by asking two questions about employment status and stability as well
as five questions about socioeconomic status (e.g., owner of a car, owner of a checking/savings
account, receiving financial aid, and homelessness).
Overall, Salisbury and Van Voorhis (2009) found support for all three models. Childhood
victimization was indirectly linked to repeated offending through current and past psychological
symptoms and substance use. This would suggest that victimization precedes mental health and
substance use issues, which subsequently increase the likelihood for repeated offending. Of
interest, evidence from the relational model suggested that women’s dysfunctional intimate
relationships were indirectly related to repeated offending “through adult victimization, reduced
self-efficacy, depression and anxiety, and addiction” (p. 557). Unfortunately the researchers did
not include adult sexual victimization. Taken together, these findings support the premise that
there is a complex interplay among the variables of childhood trauma, mental health, abusive
relationships, and legal issues as has been suggested by other researchers (e.g., Belknap, 2007;
Bloom et al., 2004; Browne et al., 1999; Cole et al., 2007; Grella et al., 2005; Jordan et al., 1996;
van Wormer & Kaplan, 2006). It is important to note, as the researchers pointed out, that the link
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between childhood victimization and first or initial legal problems was not tested (Salisbury &
Van Voorhis, 2009). Furthermore, separate models for sexual and physical childhood
victimization were not tested. However, the researchers stated in their discussion that the
findings did not vary by type of victimization.
In sum, research has shown that incarcerated women are more likely to report substance
use problems (e.g., Abrams et al., 2008; Mullings et al., 2000, 2003, 2004), exchanging money
for sex and drugs (Abrams et al., 2008; Mullings et al., 2000, 2003; Richie & Johnsen, 1996),
and involvement in abusive relationships (Fogel & Belyea, 1999; McClellan et al., 1997;
Severson et al., 2005), especially incarcerated women with sexual abuse histories. Less attention
has focused on the association between mental health issues and imprisonment (cf. Jordan et al.,
1996; Salisbury & Van Voorhis, 2009). In general, researchers have suggested a complex
interplay among these variables and women’s path to prison (Belknap, 2007; Bloom et al., 2004;
Browne et al., 1999; Cole et al., 2007; Grella et al., 2005; Jordan et al., 1996; Salisbury & Van
Voorhis, 2009; van Wormer & Kaplan, 2006), with most suggesting that sexual victimization
experiences precede the other issues. This pattern would suggest that female inmates could
benefit from treatment targeting sexual trauma and its sequelae.
Incarcerated women could benefit from a range of psychological treatments targeting any
one of their mental health diagnoses or comorbidities. However, sexual trauma-related
difficulties might be especially important to treat in this population. One reason, which has been
discussed, is the high rate of sexual trauma in this population and the many associated health
concerns. Furthermore, sexual trauma is more likely to lead to PTSD than other types of traumas
(Norris, 1992). Sexual trauma has also in general been associated with great distress and
impairment (Chen et al., 2010; Hillberg et al., 2011; Irish et al., 2010; Maniglio, 2009; Neumann
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et al., 1996). Additionally, sexual victimization has been linked to depression and substance use
problems (Chen et al., 2010; Hillberg et al., 2011), which are common issues for female inmates
and appear to be related to their incarceration (e.g., Salisbury & Van Voorhis, 2009). Thus,
targeting the sexual sequelae in female felons might have the largest impact on their level of
functioning, which could benefit these women as well as their families, especially their children.
G. SEXUAL VICTIMIZATION TREATMENTS
There are several trauma-focused treatments that have been shown to successfully reduce
symptoms and maladaptive cognitions common to sexual victimization and other types of
traumas. Most of these therapies have focused on treating PTSD symptoms. An important
development for psychological treatments is the establishment of empirically-supported
treatments (ESTs). These are treatments that have been shown to be efficacious in treating
specific psychological disorders or problems. Next, ESTs for PTSD will be discussed as well as
psychological treatments for incarcerated women.
Empirically-Supported Trauma Treatments
Several researchers and psychological organizations have developed criteria for ESTs for
a range of psychological disorders and problems (e.g., Chambless & Ollendick, 2001). In terms
of ESTs for PTSD, two cognitive-behavioral treatments are currently viewed as the “gold
standard.” Foa and colleagues’ (Foa, Hembree, & Rothbaum, 2007; Foa & Rothbaum, 1998)
prolonged exposure (PE) and Resick and colleagues’ (Resick & Schnicke, 1992, 1993) cognitive
processing therapy (CPT) have been found to be efficacious and effective in treating PTSD,
depression, and trauma-related cognitions in both individual and group settings.
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Individual Versus Group Treatments
The ESTs for PTSD discussed above were originally implemented in individual therapy
settings, but some of them have been implemented in group settings as well. In Sloan, Feinstein,
Gallagher, Beck, and Keane’s (2013) meta-analysis of PTSD group treatments with 17
randomized control trials (RCTs), they found a small between-group effect size and a small to
large within-group effect size. These findings suggest that although PTSD group treatments are
effective in reducing PTSD symptoms they are not as effective as individual treatments.
Moreover, Sloan and colleagues did not find any treatment outcome differences between PTSD
groups and supportive counseling groups suggesting that they are equally effective in reducing
PTSD symptoms. Interestingly, the effect sizes were smaller for CSA and military trauma
groups. Most of the treatments included in the meta-analysis were cognitive behavioral therapies
(CBT) but not all of them (e.g., interpersonal treatment, anger management, and eye movement
desensitization and processing therapy, EMDR). In general, Sloan and colleagues (2013) stated
that more research is needed to determine the efficacy of PTSD group treatments.
Another meta-analysis of group treatments for PTSD compared treatments with and
without in-group session exposure (e.g., imaginal exposure conducted in front of other group
members; Barrera, Mott, Hofstein, & Teng, 2013). Barrera and colleagues’ meta-analysis
included nine research studies with a total of 12 treatment conditions (N = 651). All treatments
were CBT group based treatments. Of note, treatments that utilized imaginal exposure outside of
the group setting (e.g., individual sessions or between session assignments) were included in the
NON-exposure based group treatment category (four out of seven non-exposure based groups).
Overall, Barrera and colleagues found a large pre-to post-treatment effect size change in PTSD
symptoms. Reductions in PTSD symptoms were maintained during the follow-up period.
Although the effect size was large, it is smaller than what has been reported for individual PTSD
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treatments. There was no difference in effect sizes between treatment with or without in-group
exposure. However, when dividing treatments based on including any exposure (in group or
individual sessions or between session homework) and no exposure, the exposure treatments had
large effect sizes while the no exposure treatments had small to medium effect sizes. This was
not a statistically significant difference, which could have been due to the study being
underpowered. The researchers also found higher attrition rates in treatments with in-group
session exposure compared to those without (26.4% vs. 18.9%). Barrera and colleagues
concluded that their “results suggest that concerns about the negative impact of in-group
exposure on GCBT [group CBT] treatment effectiveness and tolerability may be unwarranted”
(p. 29).
In addition to these meta-analyses of group treatments, several studies have evaluated
PTSD group treatments with veterans. These studies might be important to consider since they
include a highly traumatized population and a setting that tends to utilize group treatments.
Schnurr and colleagues (2003) conducted an RCT with 360 male veterans. Participants were
randomly assigned to 30 weekly 1.5-2 hour sessions of either trauma-focused group therapy
(TFGT) or present-centered group therapy followed by five booster sessions. The researchers
found that both treatments were effective in reducing PTSD symptoms but there were no
differences between the group treatments. In addition to Schnurr et al.’s study, several articles
have been published about group-based exposure therapy (GBET) for veterans, which is a
biweekly 24 sessions treatment comprised of group and individual sessions (Ready, Vega,
Worley, & Bradley, 2012; Mott et al., 2013; Sutherland et al., 2012). The treatment program
includes both in vivo and imaginal exposure. Ready and colleagues’ (2008; Ready, Sylvers, et
al., 2012) initial studies evaluated a more extensive version of GBET (32 sessions) without
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individual sessions. Approximately 80% of the participants reported a clinically meaningful
reduction in PTSD scores from baseline to post-treatment as well as from baseline to the 6month follow-up assessment (n = 102; Ready et al., 2008). In the 2012 publication, Ready,
Sylvers, and colleagues included a sample of 30 male veterans. They found significant
reductions in PTSD and depression symptoms from pre-to post-treatment, which were
maintained during the 7-11-month follow-up assessment. It is unclear if the samples from these
studies overlap.
In 2012, Ready, Vega and colleagues published some preliminary data from the shorter
GBET program (24 sessions) that included group and individual sessions (N = 8). Participants
reported significant reductions in PTSD symptoms from pre-to post-treatment, and seven out of
eight participants no longer met criteria for PTSD at post-treatment. Sutherland and colleagues
(2012) also published results from the shorter GBET program (N = 10). Seven participants no
longer met criteria for PTSD at post-treatment, and the treatment gains were maintained during
the 3-month follow-up period. It is unclear if the samples from the GBET studies overlap or if
they are different samples.
Mott and colleagues (2013) included 20 male veterans in their GBET outcome study (10
of the participants were also in Sutherland and colleagues’ sample, 2012). Mott and colleagues
evaluated tolerability and perceived effectiveness of GBET. Only one participant dropped out of
treatment but 14 of them reported considering dropping out. The main reasons they continued the
group was their commitment to the other members, hoping the treatment would work, and
commitment to the process and the staff. When asked about the impact of group based exposure
(e.g., hearing others’ stories), participants’ most frequent response was that it normalized their
own experiences, followed by that it created group cohesion. Importantly, none of the
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participants reported that the imaginal group based exposure had an aversive or negative impact.
In terms of what the participants believed was most helpful with the treatment, their most
frequent response was the “feedback/support from the group members on imaginal exposures”
followed by “feedback/support from group leaders on imaginal exposures” (p. 457). Participants
also self-reported that the treatment had the greatest impact on “trust, relationships with family
members, and relationships with friends” (p. 458). Overall, the GBET outcome studies have
reported low attrition rates (0-5%; Mott et al., 2013; Ready et al., 2008; Ready, Sylvers et al.,
2012; Ready, Vega et al., 2012; Sutherland et al., 2012).
Castillo, C’de Baca, Qualls, and Bornovalova (2012) evaluated PE as a group treatment
for female veterans with PTSD (N = 88). Each group consisted of three participants who met
weekly for six 90-minute sessions. Participants wrote detailed scripts of their trauma and shared
their script with the group for four consecutive sessions. Each participant had 30 minutes for her
imaginal exposure. Participants were encouraged to rewrite their script every week and to read it
between sessions. Participants reported significant reductions in PTSD symptoms from pre-to
post-treatment and 22% no longer met criteria for PTSD at post-treatment. Importantly, the
researchers reported a fairly low attrition rate (12.5%).
Overall, studies evaluating group based PTSD treatments with veterans have shown
positive outcomes, with fairly low attrition rates. Participants report significant reductions in
PTSD symptoms. Some also report that the treatment gains are maintained during a follow-up
period (Ready et al., 2008; Ready, Sylvers et al., 2012; Sutherland et al., 2012), but the sample
sizes were small. Only one study included a control group and found no differences between the
groups (Schnurr et al., 2003). Although these findings are somewhat encouraging, they are at
best preliminary. More research is needed on group treatments for PTSD.
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Despite the smaller effect sizes found in PTSD group treatments compared to individual
treatments and the limited research on PTSD group treatments (e.g., Sloan et al., 2013), Sloan,
Bovin, and Schnurr (2012) suggested that there might be other important aspect with PTSD
group treatments. A group setting might encourage clients to become more socially engaged and
less isolated. They might also benefit from building trust and increase their sense of safety. By
sharing and listening to others, clients might also benefit from normalizing their experiences and
symptoms as well as challenging each other. Group treatment is also beneficial because it
requires fewer resources. Essentially, fewer therapists can treat more clients in less time. Castillo
(2004) report from their experiences with implementing PE in a group format with female
veterans. They stated that group participants tend to “gain perspective through the concept of
universality,”…”develop a strong sense of empathy for one another,” and…”form close bonds
with one another due to the intense emotional experience and validation of sharing without
rejection” (p. 357). Also, the results from Mott and colleagues’ (2013) study would support some
of these ideas. Nevertheless, Sloan and colleagues (2012) state that the potential benefits to
group treatments have not been adequately researched. Some settings and populations might
benefit more from a group treatment than others. There might be several benefits to
implementing group treatments in prisons. Before considering some of those benefits, treatment
options for comorbid PTSD will be discussed.
Treating Comorbid PTSD
PTSD commonly co-occurs with other disorders, especially, anxiety, mood, and
substance-use disorders. Clients with comorbid disorders are usually treated using a sequential, a
parallel, or an integrated treatment model (see Mueser, Noordsy, Drake, & Fox, 2003, for an
overview). In the sequential treatment, one of the client’s diagnoses is treated first followed by
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treatment of a second diagnosis, oftentimes by a different mental health professional and
potentially in a different mental health clinic. In the parallel model, the two disorders are treated
simultaneously by different mental health professionals. In the integrated treatment model two or
more disorders are treated simultaneously by the same mental health professional. The
discussion below will focus on sequential, parallel, and integrated treatment models for comorbid
PTSD and SUDs. Specific considerations for incarcerated women with comorbid PTSD and
SUDs will also be discussed.
Sequential Models
Clients with comorbid PTSD and SUDs tend to receive treatments sequentially (e.g.,
Back, Waldrop, Brady, & Hien, 2007). There is no consensus among mental health professionals
about which disorder should be treated first or how much clients need to improve before
receiving the second treatment (Mueser et al., 2003). In some cases, clients might not receive any
treatment following this model because the treatment providers want the client to stabilize before
they receive treatment (Mueser et al., 2003). The PTSD treatment provider might want the client
to stabilize his or her substance use prior to receiving treatment and the SUDs treatment provider
might want the client to stabilize his or her PTSD symptoms prior to treatment, which leaves the
client without any treatment.
When treatments are implemented sequentially, clients tend to receive the SUDs
treatment first (e.g., Back et al., 2007), which might be problematic for several reasons. First,
clients with comorbid PTSD and SUDs tend to report poorer treatment outcomes after receiving
SUDs treatment (e.g., Ouimette, Ahrens, Moos, & Finney, 1997; Ouimette, Finney, & Moos,
1999; Read, Brown, & Kahler, 2004). This is concerning because another limitation with
sequential models is that clients might never receive the second treatment. Most of the time they
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have to be referred to a different mental health clinic, which decreases the likelihood that the
client will receive the second treatment (e.g., referral might not happen or client might not follow
through; Mueser et al., 2003). Moreover, SUD treatment providers do not always assess for
trauma and PTSD, which further decreases the likelihood that clients with comorbid PTSD and
SUDs are referred to a PTSD treatment (see Ouimette, Moos, & Brown, 2003 for an overview).
Another issue with implementing a SUDs treatment first is that research has shown that
reduction in PTSD symptoms is associated with reduction in SUDs, but reduction in SUDs is not
associated with reduction in PTSD symptoms (e.g., Back, Brady, Sonne, & Verduin, 2006;
Brown, 2000). This would further be supported by studies showing that PTSD oftentimes
precedes or triggers SUDs (Kessler, 2000; Ouimette, Read, Wade, & Tirone, 2010). These
findings would suggest that clients with comorbid PTSD and SUDs might benefit from receiving
the PTSD treatment first, if using the sequential model.
There is limited research on implementing PTSD and SUDs treatments sequentially.
Ouimette, Moos, and Finney (2003) evaluated outcomes from a sequential treatment model
implemented with male veterans diagnosed with comorbid PTSD and SUDs (N = 176). All
participants received inpatient SUD treatment prior to receiving PTSD treatment. Participants
who received PTSD treatment within 3 months of completing the SUD treatment were 3.6 times
more likely to be in SUD remission 5 years later. No studies to date have evaluated outcomes
from patients receiving a PTSD treatment first followed by a SUDs treatment.
Parallel Models
In the parallel model, clients receive PTSD and SUDs treatments at the same time by two
different treatment providers. Compared to the sequential model, using the parallel model might
increase the likelihood that the client receives treatment for both disorders (Mueser et al., 2003).
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However, there are some other limitations to this model. The two treatment providers might not
communicate well with each other and they might have different or even competing theoretical
orientations, which could negatively affect the client’s progress (Mueser et al., 2003).
As for sequential models, research on implementing separate treatments for PTSD and
SUDs simultaneously is limited. Berenz, Rowe, Schumacher, Stasiewicz, and Coffey (2012)
implemented PE to clients with comorbid PTSD and alcohol dependence. Participants were
receiving PE while they were completing a 6-week residential SUD treatment program (e.g., 12step program). Preliminary outcome data from four clients showed that none of the clients met
criteria for PTSD at post-treatment and they maintained their treatment gains during a 6-month
follow-up period (e.g., no changes in PTSD and SUD symptoms). These findings would suggest
that clients with comorbid PTSD and SUDs could benefit from receiving treatments for the two
disorders at the same time.
Integrated Treatments
One of the limitations with both the sequential and the parallel models is that they ignore
the interaction between two or more disorders (Mueser et al., 2003). Therefore, some researchers
have developed integrated treatments that target PTSD and SUDs simultaneously by the same
treatment provider. Torchalla, Nosen, Rostam, and Allen (2012) conducted a meta-analysis of 17
studies evaluating integrated PTSD and SUDs treatments. Nine of these studies were RCTs. The
researchers found that integrated treatments significantly reduced PTSD and SUD symptoms
(effect sizes were large). However, there were no differences between the integrated treatments
and control groups (e.g., treatment as usual, psychoeducation, SUD treatment, and relapse
prevention). Torchalla and colleagues conclude that “there is insufficient evidence to conclude
that [integrated treatment] is any more effective than nonintegrated programs” (p. 73).
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Altogether, there are several different models for how to treat comorbid PTSD. Clients
with comorbid conditions can receive step-like or sequential treatment, parallel treatment, or
integrated treatment (see Mueser et al., 2003, for an overview). Each model has pros and cons
with limited research support. There might be some additional reasons beyond what has
previously been discussed for why some models might be preferred, which could be relevant to
treating comorbid PTSD and SUDs in incarcerated women. One factor might be the setting and
the kind of treatment resources the clients have access to at the setting. For instance, in a setting
in which the client is already receiving a SUD treatment (e.g., Berenz et al., 2012), it might make
most sense to offer a sequential or parallel treatment for PTSD. Another factor might be to
determine the primary diagnosis and/or using case conceptualization to decide mechanisms that
maintain both disorders. There is evidence suggesting that PTSD oftentimes precedes SUDs
(Kessler, 2000; Ouimette et al., 2010) but that the two disorders might maintain each other (see
Ouimette, Moos, & Brown, 2003 for an overview). Therefore, several researchers have
suggested that comorbid PTSD and SUDs should be treated using an integrated treatment (e.g.,
Mueser et al., 2003). However, integrative treatments tend to be resource intensive (e.g.,
Zlotnick, Najavits, Rohsenow, & Johnson, 2003). Additionally, no studies have evaluated PTSD
and SUDs outcomes from implementing a PTSD treatment. If PTSD symptoms are underlying
the substance use then it is possible that treating the PTSD would also reduce the substance use.
This might be a more cost and resource effective approach than implementing an integrated
treatment. Best-case scenario the PTSD treatment helps the client recover from both PTSD and
SUD, which would require the least resources. If the client is still suffering from SUD at the end
of the PTSD treatment then a SUD treatment can be offered. Future studies should evaluate
PTSD and SUDs outcomes from implementing a PTSD treatment with clients who have
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comorbid PTSD and SUDs. Studies should also compare PTSD treatments versus SUDs
treatments versus integrated PTSD-SUDs treatments for treating comorbid PTSD and SUDs.
Psychological Treatments for Incarcerated Women
Most prison programs have been developed for men, and several researchers have argued
that there is a need for gender specific, sensitive, and responsive treatments for incarcerated
women (Blackburn et al., 2008; Bloom et al., 2004; Grella, 2008; Lewis, 2006; Mullings et al.,
2003; van Wormer & Kaplan, 2006). According to Bloom and colleagues (2004) “genderresponsive policy and practice target women’s pathways to criminality by providing effective
interventions that address the intersecting issues of substance abuse, trauma, mental health, and
economic marginality” (p. 42). Lewis (2006) describes the differences between incarcerated men
and women as “substantial” and points out that differences between the sexes “include pathway
of entry into the correctional system, patterns of substance use and mental illness, parenting
responsibilities, trauma history, and level of risk” (p. 782).
Most of the arguments in favor of developing gender specific programs for incarcerated
women are based on research showing differences between men and women in terms of their
substance use problems. These differences have been found in both prison and non-prison
populations. Review studies with non-prison populations have shown that men are more likely to
develop a substance use problem, especially alcohol abuse or dependence (Brady & Randall,
1999). Kessler and colleagues (1996) found that both women and men are more likely to develop
substance use disorders second to another axis I or II disorders. However, women are more likely
than men to report comorbidity with SUDs and other axis I disorders. Additionally, women are
more likely to report growing up in a household with substance use problems as well as having
partners with substance use problems (see Lewis, 2006 for a review). In Brady and Randall’s
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review (1999) they also stated that “studies…suggest that women experience greater medical,
physiologic, and psychological impairment earlier in their drinking careers” (p. 248). These
differences, among others, between the sexes have been used by researchers to argue that
treatments need to be gender specific to address the different treatment needs among men and
women.
Differences have also been found among male and female substance users who have been
involved with the legal system. In Lewis’ (2006) review article she argues that there are several
differences between incarcerated men and women when it comes to substance problems.
According to Lewis (2006) incarcerated “[w]omen are likely to be addicted to multiple
substances, to suffer comorbid psychiatric pathology, including depression and anxiety, and to
use ‘hard drugs,’ such as heroin and cocaine” (p. 778). Incarcerated women are also “more likely
to be intravenous drug users, more likely to be introduced to drug use by men, more likely to
have substance-using partners and partners who use intravenous drugs, more likely to have
positive family histories for drugs/alcohol use, and more likely to prostitute themselves for
drugs” (p. 778). Because men and women differ in their substance use behaviors, researchers
have argued that female inmates would benefit from treatments developed to address their
specific needs. There is some evidence suggesting that gender specific substance use treatments
are more beneficial for female prisoners than generic treatment options (Messina, Grella, Cartier,
& Torres, 2010).
Trauma Specific Treatments for Incarcerated Women
In addition to substance treatments, researchers have argued that there is a general need
for trauma-focused treatments in prisons (Blackburn et al., 2008; Browne et al., 1999; Jordan et
al., 1996; van Wormer & Kaplan, 2006; Wolff et al., 2010, 2011). Browne and colleagues (1999)
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stated that researchers should identify “what types of early interventions or interventions during
incarceration might offset negative effects of trauma and promote a positive readjustment to the
community upon release” (pp. 318-319). Harner, Budescu, Gillihan, Riely, and Foa (2013) call
for the need to implement evidence-based treatments such as PE to incarcerated women.
Researchers have further indicated that prison settings might provide a good opportunity for
interventions targeting sexual victimization plus substance use (e.g., Browne et al., 1999;
Mullings et al., 2003). Some have referred to female inmates as a “captive audience” that could
benefit from gender specific treatments, including treatments targeting sexual victimization
(Mullings et al., 2003, p. 459).
Overall, researchers have argued that female prisoners need gender sensitive treatments
and that there is a general shortage of trauma focused treatments in prisons. However, some
researchers have suggested that efficacious trauma treatments such as exposure therapy might
not be appropriate for incarcerated women since their environments tend to be stressful and
traumatic (Wolff et al., 2010, 2011). Lewis (2006) cautioned health professionals to generalize
the results from treatment outcome studies to incarcerated women, as most studies have focused
on community samples. Despite these potential concerns, several researchers have implemented
and evaluated trauma-focused treatments among female prisoners, with mixed findings. The
discussion of these treatments will be categorized into three domains: trauma treatments without
an exposure component, trauma treatments with an exposure component, and treatments
targeting comorbid PTSD and SUDs.
Treatments without Exposure
Three different research teams have evaluated three separate trauma-informed group
treatments without an exposure component in samples of incarcerated women. Roe-Sepowitz,
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Bedard, Pate, and Hedberg (2014) evaluated Esuba, which is a 12 2-hour sessions manualized
psychoeducational group that aims at addressing trauma-related symptoms and difficulties.
According to Roe-Sepowitz and colleagues (2014), Esuba is based on the first stage of Herman’s
(1992) trauma model (i.e., safety and stabilization). It is a psychoeducation group that focuses on
“domestic violence, childhood abuse, and traumatic stress symptoms” (p. 6). For the evaluation
study, Roe-Sepowitz and colleagues (2014) included 320 incarcerated women who participated
in 34 separate groups. They reported significant reductions in the Trauma Symptom Inventory
subscales (TSI; Briere, 1995) from pre-to post-treatment with small effect sizes.
Kubiak, Kim, Fedock, and Bybee (2012) evaluated Covington’s (2011) Beyond Violence
program with 35 incarcerated women. Similarly to the Esuba program, Beyond Violence is based
on Herman’s (1992) trauma theory. However, it is also based and Dahlberg and Krug’s (2002)
social-ecological framework (i.e., individual, relationship, community, societal). The treatment
program consists of 20 2-hour group sessions that covers four modules (mimics the socialecological framework). Beyond Violence was specifically developed for incarcerated women
and includes “a variety of evidence-based therapeutic strategies (i.e., psychoeducational, roleplaying, mindfulness activities, cognitive behavioral restructuring, and grounding skills for
trauma triggers)” (Kubiak et al., 2012; p. 199). All participants in Kubiak and colleagues’ (2012)
study received treatment in a residential substance use program in the correctional facility. The
researchers reported a significant reduction in PTSD (as measured by PTSD short-screen;
Breslau, Peterson, Kessler, & Schultz, 1999), depression (as measured by the Patient Health
Questionnaire, PHQ-9; Kroenke, Spitzer, & Williams, 2001), and anxiety (as measured by the
PHQ Anxiety subscale; Spitzer, Kroenke, & Williams, 1999) symptoms from pre-to posttreatment. They had a 17% attrition rate.
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Paquin, Kivlighan, and Drogosz (2013) evaluated another manualized, trauma-informed
group treatment with incarcerated women called TREM (Trauma Recovery and Empowerment
Model; Fallot & Harris, 2002). TREM consists of 33 75-minute sessions. It was designed “to
address the long-term cognitive, emotional, and interpersonal consequences of sexual and
physical abuse” and “the needs of women trauma survivors with severe mental disorders, many
of whom also have significant substance use problems” (Fallot & Harris, 2002, p. 476). Fallot
and Harris (2002) state that “TREM is designed to integrate skill development with symptom
reduction” (p. 480). The 33 topics are broadly categorized into “empowerment, trauma
education, and skill-building…with an emphasis on trauma recovery skills” (p. 477). The
specific therapeutic techniques used in TREM are cognitive restructuring, skills training,
psychoeducation, peer support, and “contained exposure” (p. 480). According to Fallot and
Harris (2002), “TREM does not emphasize the importance or value of detailed recall and
retelling of trauma narratives” (p. 482). Group participants may disclose information about their
trauma memories but it is not encouraged or necessary.
In Paquin and colleagues’ (2013) study, they modified TREM to consist of 22 75-minute
sessions that they implemented biweekly with six different groups of incarcerated women. They
did not specify how their modified version differed from the original 33 sessions TREM
program. Participants were 51 incarcerated women who either “reported a history of trauma or
met criteria for PTSD” (p. 99). Nine participants had a primary diagnosis of PTSD. Participants
reported significant reductions in PTSD symptoms from pre-to post-treatment (as measured by
the PSS-SR; Foa, Riggs, Dancu, & Rothbaum, 1993). These were large effects.
There are several strengths and weaknesses with these outcome studies. They are all
manualized, time-limited treatments, which increase the ability to research and disseminate these
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programs (e.g., Onken, Blaine, and Battjes, 1997). All three programs include a psychoeducation
component and two of them also include skill-building components (e.g., coping skills and
cognitive restructuring; Kubiak et al., 2012; Paquin et al., 2013). The results from these studies
suggest that participants experienced a decrease in trauma-related symptoms from pre-to posttreatment. Paquin and colleagues (2013) reported a large effect. Overall, these results show some
positive benefits to these treatments. However, there are also several limitations to these studies.
Kubiak and colleagues (2012) had a relatively small sample (N = 35), and they did not report an
effect size. Roe-Sepowitz and colleagues (2014), on the other hand, had a large sample (N = 320)
but reported a small effect size. Moreover, although the researchers provided some statistical
significant findings, they did not provide any information about clinical significance. Paquin and
colleagues (2013) reported on their participants’ primary diagnoses, which were obtained from
the prison’s intake procedure. However, no additional information was provided in terms of
changes in diagnostic profiles from pre-to post-treatment. Also, none of the studies provided any
information about the amount of symptom reduction participants experienced. The absence of a
control group in these studies also decreases the strength of the evidence.
In addition to the above-mentioned strengths and limitations, there are some other factors
that might be important to consider when implementing trauma treatments in correctional
settings. Two of the treatments were fairly lengthy, ranging from 27.5 to 40 hours (Kubiak et al.,
2012; Paquin et al., 2013). Resources are limited in correctional facilities and therefore
treatments should be as brief as possible so that more women can benefit from them. Briefer
treatments might also lower the attrition rates. Kubiak and colleagues (2012) reported an attrition
rate of 17%, but the attrition rates are unknown for the other studies. In addition to
implementing brief treatments, it is important to implement effective treatments. Although these
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studies provided some evidence for their effectiveness, none of them included an exposure
component, which researchers have shown is an effective component of PTSD treatments (Foa et
al., 2007). Trauma-informed treatments for incarcerated women could benefit from including an
exposure component.
Treatments with Exposure
To date, two research teams have evaluated trauma informed group treatments that
include an exposure component with samples of incarcerated women. Cole and colleagues
(2007) included 13 female inmates in their trauma treatment. They randomly assigned
participants to a treatment group (n = 7) or a waitlist control (n = 6). The treatment group
received 16 sessions of therapy (2.5 hours twice a week for 8 weeks), which was divided into
four phases: (1) learning skills related to setting boundaries, self-esteem, identity formation, and
relaxation (2) psychoeducation about trauma, sexual abuse, addiction, interpersonal patterns, and
assertiveness, (3) processing (e.g., writing about the trauma), and (4) termination. Cole and
colleagues did not find any significant changes from pre-to post-treatment in trauma (i.e., TSI;
Briere, 1995) or psychological symptoms (i.e., Symptom Checklist 90 Revised, SCL-90-R;
Derogatis, 1994). Moreover, they did not find any differences between the treatment group and
the control group.
In another study, by Bradley and Follingstad (2003), they randomly assigned incarcerated
women to a treatment (n = 24) or a no-contact control group (n = 25). The researchers
implemented 18 sessions (2.5 hour sessions) in two phases: (1) psychoeducation and DBT skills
and (2) exposure (writing about the trauma). The treatment group reported significant fewer
depressive and trauma symptoms as well as reduction in interpersonal problems from pre- to
post-treatment compared to the control group.
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These two studies showed mixed results. The findings from Cole and colleagues’ (2007)
study suggest that their treatment was not effective in reducing symptoms from pre-to posttreatment. There were also no differences between the treatment group and the control group.
However, findings from Bradley and Follingstad’s (2003) study suggest that their treatment
outperformed the control group. Cole and colleagues’ (2007) non-significant findings might be
due to several factors. They utilized a small sample of female offenders with a history of CSA.
Only four women in the treatment group and five women in the control group completed pre-and
post-treatment assessments. Moreover, although the researchers claimed that both the control and
the treatment group had elevated levels of trauma symptoms, none of the TSI subscale scores for
the treatment group was above a T score of 65 at pre-treatment, suggesting that these were not
clinically significant elevations. Therefore, it is possible that the PTSD symptom severity at pretreatment in their sample of CSA victims was too low to expect a decline as a result of the
treatment. Similarly to Cole and colleagues’ (2007) study, Bradley and Follingstad (2003) also
included participants with CSA experiences (all participants had experienced CSA in addition to
71% experiencing physical child abuse). However, in addition to CSA experiences, the
participants in Bradley and Follingstad’ study had to report elevated symptom levels (i.e., T
scores above 65 on at least two TSI subscales or above 65 on one TSI subscale in addition to 18
or higher on the BDI; Beck Depression Inventory; Beck, Steer, & Brown, 1996) to be included in
the study. This further supports the hypothesis that the lack of support for Cole and colleagues’
treatment might partly be due to low levels of PTSD symptoms at pre-treatment.
Another possible reason for the non-significant findings in Cole and colleagues’ (2007)
study could be the limited amount of exposure therapy that participants received. Cole and
colleagues included one session of writing about the trauma while Bradley and Follingstad
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(2003) included nine sessions. It is possible that the additional processing of trauma led to
significant outcomes. This would further strengthen the previous argument that trauma informed
treatment with incarcerated women would benefit from including an exposure component.
There are some additional considerations that might be important to consider when
implementing treatments in correctional facilities. Again, both research teams implemented fairly
lengthy group treatment (16-18 2.5 hour sessions; Bradley & Follingstad, 2003; Cole et al.,
2007). Although Cole and colleagues (2007) referred to their treatment as “brief” (p. 105), there
may be some benefits to implement an even briefer, more targeted treatment. Both of the
research teams also reported high attrition rates (43-46%). Moreover, Bradley and Follingstad
suggested that participants might need additional “affect regulation skills” prior to writing about
the trauma since five of the 11 women who dropped out of the treatment stopped coming after 12 sessions of writing about the trauma (p. 340). Similarly, Cole and colleagues (2007) claimed
that although their treatment was not effective in reducing symptoms from pre-to post-treatment,
it prevented elevation of symptoms during the duration of the treatment. The researchers also
argued that their treatment effects might be subtler, and therefore not detectable by measures
assessing symptom change. However, they did not provide any statistical analyses supporting
these claims. Overall, these researchers are suggesting that there might be a benefit to increasing
the dose of treatment. Instead of lengthening treatment and make it more resource intensive,
future studies evaluating trauma treatments with incarcerated women could benefit from
evaluating briefer treatments that target specific mechanism known to maintain PTSD and other
common trauma outcomes.
Treatments for Comorbid PTSD and SUDs
Several research teams have implemented group treatments with incarcerated women that
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aim at targeting comorbid PTSD and SUDs. Both Seeking Safety (Najavits, 2002) and TARGET
(Trauma Affect Regulation: Guide for Education and Therapy; Ford & Russo, 2006) are
manualized treatments developed to address co-occurring PTSD and SUDs and can be
implemented with individuals or groups. Seeking Safety includes 25 topics related to PTSD
symptoms and SUDs that can be implemented in any order. Main focus is on “psychoeducation
and the development of coping skills to help clients attain safety from both PTSD and SUD”
(Zlotnick, Johnson, & Najavits, 2009, p. 328). Clients do not have to meet criteria for PTSD but
should have a history of trauma. TARGET focuses on using affect regulation skills to cope with
PTSD and SUDs (Ford & Russo, 2006). In addition to psychoeducation about PTSD and affect
regulation, clients are taught affect regulation skills based on the acronym FREEDOM (i.e.,
“Focusing, Recognizing triggers, Emotion awareness, Evaluating thoughts, Defining goals,
choosing Options, and Making a positive contribution to the world by regulating emotions,” p.
7). The treatment consists of 12 weekly 75-minute sessions in addition to between session
assignments (“creating an autobiographical narrative that incorporates, but does not primarily
focus upon, trauma, PTSD, and SUD,” Ford & Russo, 2006, p. 342). The narrative is “an
experiential exercise designed to enable clients to reengage autobiographical or narrative
information processing and memory by safely accessing, containing, and organizing emotionally
charged personal memories” (p. 347). The goal of TARGET “is to rediscover the personal goals,
choices, and abilities that have been obscured by the problematic aspects of PTSD and SUD
symptoms—not to "get rid of" the symptoms, or to simply "substitute" adaptive ways of coping,
but to find and rebuild adaptive skills that the survivor possesses and values within her/himself”
(Ford & Russo, 2006, p. 343).
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Ford, Chang, Levine, and Zhang (2013) randomly assigned 80 incarcerated women with
full or partial (at least one symptom from each PTSD cluster) PTSD from interpersonal
victimization to receive TARGET (n = 41) or supportive group therapy (n = 39). Approximately
80% of the participants had a history of SUD. The researchers randomly assigned cohorts of 1012 women to the two treatment conditions. All participants had the option of eventually
participating in both treatments. Results were based on assessments from the first group
participants were assigned to. The supportive group therapy consisted of 12 sessions of a
manualized treatment (Wallis, 2002), which focused on “experiential self-expression activities
and nondirective assistance in identifying stresses and effective coping strategies” (Ford et al.,
2013, p. 7).
Ford and colleagues (2013) found that both treatments were successful in reducing PTSD
symptoms (as measured by the Clinician-Administered PTSD Scale, CAPS; Blake et al., 1995;
and the TSI; Briere, 1995) and other psychosocial outcomes (measured by Clinical Outcomes in
Routine Evaluation-Outcome Measure, CORE-OM; Barkham et al., 2001) from baseline (within
4 weeks prior to treatment) to post-treatment (after completing treatment) with small to medium
effect sizes. Although the effect sizes were in general slightly larger for TARGET compared to
the support group, most of the time these differences were not statistically different. The only
statistically significant difference between the two treatments was on a measure of forgiveness.
TARGET participants were more forgiving at the end of treatment than the women in the support
group.
There are several strengths and limitations with Ford and colleagues’ (2013) study. They
reported fairly low attrition rates for both treatment groups (TARGET: 7.3%; support group:
12.8%). The treatments were successful in reducing PTSD symptoms while offering a smaller
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dose of treatment (12 75-minute sessions) compared to the other PTSD/trauma treatment
outcome studies with incarcerated women. The positive findings from Ford and colleagues’
study suggest that it is feasible to implement a briefer treatment protocol in this population.
However, they found few differences between their active treatment and a support group.
Ford and colleagues (2013) argued that future studies could benefit from evaluating a
treatment with incarcerated women that utilizes affect regulation skills in addition to exposure
therapy. They also suggested that maybe future studies should expand on the number of sessions
and affect regulation training. In contrast, one could argue that future treatment efficacy studies
with incarcerated women might benefit from evaluating a brief group treatment targeting specific
and maintaining factors of PTSD and common trauma symptoms. Treatments could benefit from
including an exposure component, which has been shown to specifically reduce PTSD and other
trauma-related symptoms and difficulties. Although TARGET includes creating an
“autobiographical narrative” that “incorporates” memories of participants’ traumas (Ford &
Russo, 2006, p. 342), it is not designed to be exposure therapy and it is not based on Foa and
Kozak’s (1986) emotional processing theory. Instead of doing affect regulation training in
addition to exposure therapy, which would further lengthen the treatment and require more
resources, incarcerated women might benefit from a brief exposure based treatment that
specifically targets trauma symptoms and difficulties.
Moreover, TARGET participants write their narrative autobiography between sessions.
As previously discussed, most ESTs for PTSD include between session assignments, which
might not be desirable in samples of incarcerated women since they have limited privacy and
autonomy. Instead of doing between session work, incarcerated women might benefit from doing
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exposure therapy during the group sessions where they have the support from other women with
similar experiences as well as the support from group therapists.
Three groups of researchers have evaluated the efficacy of the Seeking Safety program
(Najavits, 2002) in groups of incarcerated women (Lynch, Heath, Mathews, & Cepeda; 2012;
Wolff, Frueh, Shi, & Schumann, 2012; Zlotnick et al., 2009; Zlotnick et al., 2003). Wolff and
colleagues (2012) recruited 111 incarcerated women who met criteria for a SUD and full or
partial PTSD (“one re-experiencing symptom and either three or two arousal symptoms with the
presence of co-occurring significant distress and impairment,” p. 705) to participate in Seeking
Safety. The treatment consisted of 28 90-minute sessions (met biweekly for 14 weeks). The
group leaders covered 23 out of 25 topics (excluded Community Resources and the Life Choices
Game). Two group participants were excluded from the group because they had two or more
“unexcused absences” (p. 705). Seventy-four women completed the group (had two of fewer
unexcused absences) and they attended on average of 23 sessions (range 13-27). Wolff and
colleagues (2012) reported a significant change from pre-to post-treatment in PTSD symptoms
and other psychological symptoms (as measured by the Brief Symptom Inventory, BSI;
Derogatis, 1983). Effect sizes were medium.
Zlotnick and colleagues (2003) conducted a pilot study evaluating Seeking Safety with 18
female inmates who met criteria for PTSD and SUD. The treatment consisted of approximately
24 sessions (biweekly 1.5 hour sessions). They received the Seeking Safety treatment in addition
to treatment as usual (TAU; e.g., “a voluntary, residential therapeutic program” that is
“abstinence-oriented” and based “on the 12-step program;” p. 101). Participants attended
between six and 24 sessions with a mean of 14. They reported a significant decrease in PTSD
symptoms from pre-to post-treatment and from pre-treatment to 6 and 12 weeks after being
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released from prison. They also reported less substance use from pre-treatment to the 6- and 12week post-prison release date. No descriptive data were provided.
In 2009, Zlotnick and colleagues reported on the larger RCT in which they had randomly
assigned female inmates to Seeking Safety treatment (n = 27) or TAU (n = 22). TAU consisted
of 3-6 months of a residential substance use treatment primarily focusing on abstinence
following the 12-step program. The Seeking Safety group received the Seeking Safety treatment
in addition to TAU. Treatment participants met criteria for a SUD and full or partial criteria for
PTSD (one or more symptoms from each cluster of PTSD symptoms; symptoms were associated
with clinical levels of distress and/or impairment). They met three times a week for 6-8 weeks
for a total of 25 sessions (1.5 hour sessions). They also received weekly booster sessions that
lasted for 1 hour for a maximum of 12 weeks post-prison release. Participants attended on
average 15.6 Seeking Safety treatment sessions and 3 booster sessions.
Zlotnick and colleagues (2009) found that both treatment groups had a significant
improvement in PTSD and psychological symptoms (as measured by the Trauma Symptom
Checklist 40, TSC-40; Briere, 1996; positive symptom scale of BSI; Derogatis, 1983) as well as
a reduction in substance use from pre-treatment to subsequent assessments at 12 weeks after
intake and 3 and 6 months after release from prison. They found few differences between the
Seeking Safety and TAU groups, suggesting both were effective in reducing symptoms.
In another treatment study with incarcerated women, Lynch and colleagues (2012)
assigned 114 incarcerated women to a Seeking Safety treatment group (n = 59) or a waitlist
control (n = 55) taking into consideration “anticipated release or transfer dates” (those assigned
to the waitlist control had on average 447 days left while those in the treatment group had on
average 295 days; p. 93). The Seeking Safety group met twice a week for a total of 24 sessions

64

(2-hour sessions). Participants were included in the study if they reported “a trauma history, a
history of SUD, and moderate to severe PTSD symptoms (score of 30 or greater on the [PTSD
Checklist, PCL; Weathers, Litz, Herman, Huska, & Keane, 1993]” (Lynch et al., 2012; p. 93).
On average, participants attended 18 sessions.
Lynch and colleagues (2012) found a significant decrease in PTSD symptoms in both
groups from pre- to post-treatment. However, the treatment group reported a significantly greater
decrease in PTSD symptoms than the control group. Similarly, both groups showed decreases in
depressive symptoms and maladaptive coping as well as an increase in interpersonal functioning
and adaptive coping, but the Seeking Safety group reported a significant greater change in these
symptoms compared to the control group.
Overall, results from these four studies suggest that Seeking Safety can be an efficacious
treatment for incarcerated women with comorbid PTSD and SUD. However, of note, there was
little additional benefit to receive Seeking Safety in addition to TAU (Zlotnick et al., 2003,
2009). Lynch and colleagues (2012) reported some additional benefit to the Seeking Safety
treatment compared to the waitlist control group. It is unclear if their waitlist control received
TAU, and, if so, what that entailed. Zlotnick and colleagues (2003, 2009) reported fairly low
attrition rates (11-22%). Wolff et al. (2012) reported higher attrition rates (33.3%); however,
only 13.5% (15 out of 111) had dropped out of treatment voluntarily. Attrition rates are unknown
for Lynch and colleagues’ (2012) study. One of the bigger issues with implementing Seeking
Safety in prison settings is how resource intensive this treatment is. As Zlotnick et al. (2003)
point out, it is uncertain if Seeking Safety “would be feasible in a prison setting” due to the
resources required in the current studies (“intensive training, supervision, and schedule of
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sessions,” p. 104). Future studies could benefit from evaluating the efficacy of brief, targeted
treatments in samples of incarcerated women.
In conclusion, although some researchers have argued that correctional facilities might be
an optimal place to implement trauma focused treatments (Browne et al., 1999; Mullings et al.,
2003), others are skeptical (Wolff et al., 2010, 2011). More research is needed to clarify the
specific types of trauma-focused treatments incarcerated women could benefit from (Browne et
al., 1999). Sexual trauma might be especially important to target since incarcerated women with
sexual abuse histories are reporting more difficulties compared to those without these
experiences (Abrams et al., 2008; Clark et al., 2012; Herbert et al., 2007; Mullings et al., 2000,
2003; Wolff et al., 2010; Zlotnick, 1997). Some researchers have evaluated trauma focused
group treatments in samples of incarcerated women (Bradley & Follingstad, 2003; Cole et al.,
2007; Ford et al., 2013; Kubiak et al., 2012; Lynch et al., 2012; Paquin et al., 2013; RoeSepowitz et al., 2014; Wolff et al., 2012; Zlotnick et al., 2003, 2009), with mixed results and
several limitations. Some of the main issues with these treatments, besides the mixed outcome
results, are the amount of resources required (cf. Ford et al., 2013). In addition, several ESTs for
sexual trauma have been established through clinical research; however, incarcerated women
may be in a unique situation that could necessitate adaptations to already established treatments.
It may be valuable to review some of these considerations in addition to considering how a brief
exposure based trauma treatment focusing on sexual violence for groups of incarcerated women
might best be implemented.
H. FUTURE DIRECTIONS IN SEXUAL VICTIMIZATION TREATMENTS FOR
INCARCERATED WOMEN
Prison settings provide several unique contextual factors that are likely to make it
difficult to implement and/or may impact the efficacy of trauma-focused ESTs. For instance,
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treatments such as PE (Foa et al., 2007; Foa & Rothbaum, 1998) and CPT (Resick & Schnicke,
1992, 1993) require that clients are actively involved in completing between-session
assignments, which require privacy (e.g., listen to session tapes, complete worksheets) and
autonomy (e.g., complete exposure activities). Incarcerated women have little if any privacy and
autonomy. They also have limited options for self-care and self-soothing, which are important
components to trauma treatment.
Moreover, treatments such as PE and CPT were developed to target PTSD, which would
require that the women be assessed prior to the treatment. It might not be possible for the
women, the prison staff, or the clinicians to do extensive assessment of all the women that enter
the correctional system. The women might be in need of the treatment despite not meeting
diagnostic criteria. Also, using assessments would potentially be time-consuming and costly for
the clinicians and the prison staff.
Additionally, being in prison can be stressful and at times might even mimic
victimization experiences (e.g., being controlled and told what to do, being unable to leave
situations when feeling distressed, anxious, or scared). As Covington (2008) describes there are
“standard management practices - such as searches, seclusion, and restraint” that could mimic
victimization experiences (p. 382). Other researchers have also commented on the possible
reenactment of victimization experiences while in prison. Heney and Kristiansen (1998) stated
that prisons “have the potential to recapitulate [a female prisoner’s] abuse experience, including
the traumatic violation of physical and sexual boundaries, the dichotomy of the powerful and the
powerless, stigmatization and devaluation, and issues of trust and betrayal” (p. 37). Moreover,
Lewis (2006) brought attention to incarcerated women’s risk for being revictimized by staff and

67

other inmates while in prison and the need for additional training of prison staff to prevent these
incidents.
Despite all the limitations to providing treatment in correctional facilities, there are also
several benefits. There are fewer barriers to treatment such as childcare and transportation needs
as well as differing work schedules (e.g., finding a time that works for all participants).
Incarcerated women might also have greater access to health care while in prison compared to
living in the community. The World Health Organization in collaboration with the United
Nations Office on Drugs and Crime (2009) reported that few female prisoners have had contact
with the health services prior to being sentenced to prison. Availability of health care
professionals and the lack of privacy while in prison could also be beneficial in the case of
someone being suicidal or extremely distressed. They would have someone to turn to if needed
and they would have fewer opportunities for harming themselves.
Importantly, research suggests that incarcerated women want treatment for their
difficulties. One study found that the majority of female inmates reported they would like to
receive psychological treatment and that most of them report greater access to that type of
treatment while in prison compared to in the community (Blitz, Wolff, & Paap, 2006). Out of
908 incarcerated women, 56% reported that they needed behavioral health treatment prior to
incarceration but 30-45% did not receive it (percentage varied by type of mental health service
needed). A major barrier identified was lack of health insurance. While in prison more than 80%
of the women who identified that they needed mental health treatment received it. The rates were
lower for receiving substance use treatment (45% who needed it did not receive it).
Based on the potential pros and cons of implementing ESTs in prison settings, and the
limited research on trauma treatments among incarcerated women, several considerations are
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suggested. In general it might be beneficial to implement treatments in a group setting. The
potential benefits of group treatments outlined by Sloan and colleagues (2012) might play a
greater role in certain settings and populations. Female prisoners share many common
characteristics including low socioeconomic status (SES), social isolation, single parenthood,
high trauma exposure, and a range of health issues (e.g., Bloom et al., 2004; Haywood et al.,
2000; Lewis, 2006). They are also experiencing imprisonment together and can potentially relate
to one another through these shared experiences. By implementing the treatment in a group,
participants are able to relate to each other’s similarities and shared experiences as well as learn
from each other’s differences.
Incarcerated women might also benefit from a group treatment that does not require
between session work since they have limited privacy and autonomy. Keeping homework
assignments confidential and out of sight from staff and other prisoners may prove difficult and
time to complete homework assignments may be limited. Even if time is not an issue, privacy
may be difficult. Since homework assignments often involve some form of exposure (e.g.,
writing or listening to their traumatic stories), participants are likely to have emotional and
physical reactions to completing the homework. It may be stressful and even counterproductive
for incarcerated women to complete these homework assignments if they are concerned about
not being able to be alone to process and regulate their reactions.
It may also be beneficial to implement a brief treatment protocol. This would allow for
more women to participate in the group during a shorter period of time. It may also reduce the
attrition rates affected by release dates and transfers to other facilities. More women might be
able to complete the group if the number of sessions was reduced. This is an important
consideration as previously evaluated trauma treatments for incarcerated women have included
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12-28 sessions (i.e., 24 – 48 hours) plus booster sessions (Bradley & Follingstad, 2003; Cole et
al., 2007; Kubiak et al., 2012; Lynch et al., 2012; Paquin et al., 2013; Roe-Sepowitz et al., 2014;
Wolff et al., 2012; Zlotnick et al., 2003, 2009). The exception is Ford and colleagues (2013) who
implemented a 12 75-minute treatment (15 hours).
Altogether, future efficacy studies of trauma-focused treatments with incarcerated women
may benefit from considering using a group format. As suggested by Sloan and colleagues
(2012), group treatments may be beneficial for participants because the group format has the
potential to decrease isolation and increase a sense of belonging, increase trust and a sense of
safety, and normalizing symptoms and experiences. Group treatments may also reduce costs.
Implementing treatments in a group format might be especially beneficial in prison settings.
Incarcerated women represent a “captive audience” (Mullings et al., 2003, p. 459) with high rates
of sexual victimization and mental health issues. When asked, incarcerated women also say that
they would like to receive treatment (Blitz et al., 2006). Incarcerated women may benefit from
being able to share their experiences with other incarcerated women in a group to increase their
sense of belonging, trust, and safety in addition to normalizing their experiences. They may
never have had the chance to share their trauma experiences with other women who struggle
with similar issues. Trauma-focused treatments in women’s correctional facilities could benefit
from eliminating between-session work due to limited privacy and autonomy while in prison.
Lastly, a brief treatment may be beneficial in a prison setting to limit attrition and increase the
number of women who can participate in the group.
I. SUMMARY AND RATIONALE FOR CURRENT STUDY
Women are disproportionally at risk for being sexually victimized at some point in their
lives. Compared to men, they are at higher risk for both CSA and ASA (Black et al., 2011; Elliott
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et al., 2004; Pereda et al., 2011), which have been associated to a range of physical and mental
health issues (Chen et al., 2010; Hillberg et al., 2011; Irish et al., 2010; Maniglio, 2009).
Incarcerated women have been, at large, an ignored group within this area of research despite the
high rates of sexual victimization and mental health issues reported by female prisoners.
Research findings show that incarcerated women have higher rates of sexual victimization and
mental illness than the average woman (Jordan et al., 1996; Severson et al., 2005; Teplin et al.,
1996; Tusher & Cook, 2010) and than incarcerated men (Blitz et al., 2005; Clark et al., 2012;
Cloyes et al., 2010; Langan & Pelissier, 2001; McClellan et al., 1997; Trestman et al., 2007;
Wolff et al., 2009). Incarcerated women are a high-risk population for a range of interpersonal
trauma and health issues, and they are in great need of treatment that can target these issues.
Although researchers have suggested a complex interplay among sexual victimization,
mental health, and imprisonment, sexual victimization is oftentimes framed as a pathway to
prison for women (Belknap, 2007; Bloom et al., 2004; Browne et al., 1999, Cole et al., 2007;
Salisbury & Van Voorhis, 2009; van Wormer & Kaplan, 2006). Browne and colleagues (1999)
suggest a complicated interaction among factors such as sexual victimization, substance use,
prostitution, violent relationships, and imprisonment for incarcerated women. Although these
interactions are complex and multi-directional, several researchers suggest that sexual
victimization precedes the other variables and increases women’s risk for imprisonment (e.g.,
Belknap, 2007; Bloom et al., 2004; Browne et al., 1999; Cole et al., 2007; Grella et al., 2005;
Jordan et al., 1996; Salisbury & Van Voorhis, 2009; van Wormer & Kaplan, 2006). Mental
illness has received less focus in the relation between sexual victimization and imprisonment (cf.
Jordan et al., 1996; Salisbury & Van Voorhis, 2009). Mental illness is likely to moderate or
mediate the relation between sexual victimization and imprisonment.
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Most treatment programs in prisons have been developed based on men’s needs.
Although, men are imprisoned at higher rates than women (Carson & Golinelli, 2013), the
number of female prisoners is increasing at a faster pace than the number of male prisoners
(Frost et al., 2006). There is also substantial evidence suggesting that incarcerated women’s
treatment needs are different from men’s. Most of this research has focused on substance use
treatments (see Lewis, 2006 for review). These gender differences, in addition to the
disproportionally high rates of sexual victimization among female prisoners, have resulted in
several researchers suggesting a need for gender specific treatments in prisons (Blackburn et al.,
2008; Bloom et al., 2004; Grella, 2008; Lewis, 2006; Mullings et al., 2003; van Wormer &
Kaplan, 2006). One gender specific treatment need is the development, implementation, and
evaluation of trauma-focused treatments (Blackburn et al., 2008; Browne et al., 1999; Jordan et
al., 1996; van Wormer & Kaplan, 2006; Wolff et al., 2010, 2011).
Researchers have implemented trauma-focused treatments among incarcerated women
(Bradley & Follingstad, 2003; Cole et al., 2007; Ford et al., 2013; Kubiak et al., 2012; Lynch et
al., 2012; Paquin et al., 2013; Roe-Sepowitz et al., 2014; Wolff et al., 2012; Zlotnick et al., 2003,
2009), with mixed results and several limitations. Most of the treatments are resource-intensive
(cf. Ford et al., 2013) and lack an exposure component (cf. Bradley & Follingstad, 2003; Cole et
al., 2007), despite research supporting exposure’s efficacy (Foa et al., 2007). In general, more
research is needed to determine the types of treatments from which incarcerated women can
benefit.
Based on established ESTs for PTSD and the potential uniqueness of the prison setting,
several suggestions have been made for future development and implementation of traumafocused treatments among incarcerated women. Correctional facilities provide an opportunity for
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mental health professionals to intervene with a largely ignored population who report high rates
of interpersonal trauma and associated complications. By targeting incarcerated women’s sexual
victimization, a pathway to prison for women, their functioning can be improved. Their
improved functioning might have a lasting effect on themselves as well as others (e.g., their
families and children, the community). Incarcerated women could benefit from a treatment that
is brief and implemented in a group setting. They may not be able to complete between-session
assignments due to insufficient privacy and autonomy while in prison. This study evaluated the
efficacy of a brief (eight sessions) sexual trauma group treatment developed for incarcerated
women. Preliminary findings from 14 participants showed positive treatment outcomes
(Karlsson, Bridges, Bell, & Petretic, in press), but the sample size was small and therefore
generalizability was limited. This study will expand on these findings by including a larger
sample of incarcerated women.
J. HYPOTHESES
For the current study, it was predicted that participants would report significant declines
in PTSD, depressive, and anxiety/worry symptoms from pre- to post-treatment. It was also
predicted that they would report significant decreases in maladaptive trauma-related cognitions
from pre-to post-treatment.
II.

METHOD
A. PARTICIPANTS
Research participants were a subset of incarcerated women who attended a voluntary 8-

session weekly therapy group focused on sexual trauma (refer to Table 1 for a session by session
outline of the treatment content). Data was collected from eight separate groups. Each group
consisted of 8-12 women and two group leaders/therapists. A total of 76 participants attended at
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least one session. Importantly, this number includes 10 women who repeated the group at least
once (one woman repeated the group twice so there were nine repeaters in total). Excluding the
repeaters, 66 women participated in the group treatment. Seven of the 66 women were not
approached about the research study. Majority of these (n = 5) were from group 1 as the first
group started before the research study was approved (i.e., no pre-treatment data from group 1).
The other two participants attended at least one session but they were absent during the pretreatment assessment and they, for unknown reasons, did not complete the group, and, therefore,
were also absent from the post-treatment assessment. One participant did not consent to the
study, which leads to a total of 58 incarcerated women who participated in at least one session,
consented to the study, and completed the pre-and/or post-treatment assessment. Refer to Table 2
for an overview of number of participants in each group, number of repeaters, and number of
completers and non-completers. Treatment completers are defined as participants who attended
at least five sessions including at least one of the first two sessions, at least one session in which
they shared their sexual trauma memories, at least two sessions of listening to other participants
sharing their memories, and completed the pre-and/or post-treatment assessment. A subset of the
treatment completers completed both pre-and post-treatment assessments (n = 34).
The participants are incarcerated at a minimum-security community correctional facility
for non-violent felonies. Most of the women have been charged with felonies related to using or
selling illegal substances and/or money fraud. The maximum stay in the facility is two years;
most women are incarcerated for 10-15 months. Some residents have longer prison sentences and
serve the remainder of their sentence in a different facility. The community facility has a
maximum of 100 female residents. The residents have access to a range of programs while in
prison including abstinence focused substance use treatment (e.g., Alcohol Anonymous, AA).
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The therapy group is implemented in the evenings when volunteer based groups are allowed in
the correctional facility. During the duration of this study, the group was implemented on
Monday evenings and was co-occurring with other non-therapy groups led by volunteers. There
was typically at least one faith-based group in addition to at least one more non-faith based
group.
B. MEASURES
The following measures were selected to assess for PTSD and other common trauma
symptoms (i.e., depression and anxiety/worry) and cognitions that are expected to change from
pre-to post-treatment (Primary Care PTSD screen, PC-PTSD; Prins et al., 2003; Patient Health
Questionnaire, PHQ-9; Kroenke et al., 2001; 2-item Generalized Anxiety Disorder scale, GAD2; Kroenke, Spitzer, & Williams, 2007; Posttraumatic Cognitions Inventory, PTCI; Foa, Ehlers,
Clark, Tolin, & Orsillo, 1999). The measures were also selected based on good reliability and
validity. In addition to considering the psychometrics of the measures, brevity and level of
reading difficulty were a priority in selecting measures because of limited available time for
participants to complete measures in this setting and potentially low literacy rates of this sample.
Treatment alliance was assessed in addition to the trauma symptoms and cognitions
(Group Climate Questionnaire Short Form, GCQ-S; MacKenzie, 1983). Since few studies have
evaluated the efficacy of group trauma treatments implemented in correctional facilities,
treatment alliance was measured to assess for participants’ perception of the relationship between
themselves and other group members as well as between themselves and the group leaders/
therapists.
Trauma histories were not formerly assessed in self-reports due to time constraints in
completing pre-and post- assessments. This decision was also based on previous studies
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showing high rates of interpersonal trauma among incarcerated women, specifically sexual
trauma (Clark et al., 2012; Langan & Pelissier, 2001; McClellan et al., 1997; Severson et al.,
2005; Tusher & Cook, 2010; Wolff et al., 2009). All participants disclosed at least one of their
sexual traumas during treatment.
PTSD
Participants’ PTSD symptoms were assessed using the Primary Care PTSD screen (PCPTSD; Prins et al., 2003). This measure was developed to detect PTSD in medical settings, and
requires an eight grade reading level. It is a four-item measure assessing re-experiencing,
numbing, avoidance, and hyperarousal symptoms. Answer options are dichotomous (yes or no).
The total score ranges between 0 and 4, with a higher score indicating more symptoms.
Participants are asked to report on their symptoms in the past month. Responding “yes” to three
of the four items indicates a positive screen for PTSD.
The PC-PTSD was validated in a veterans affairs (VA) primary care setting (Prins et al.,
2003) and has mainly been used with military samples (Bliese et al., 2008; Calhoun et al., 2010).
However, it has also been used in civilian primary care settings (Freedy et al., 2010). Studies
have shown good reliability and validity (Prins et al., 2003). Prins and colleagues (2003)
identified a clinical cutoff score of 3 with 78% sensitivity and 87% specificity (70% and 81%
respectively for female participants) when comparing it to the CAPS (Blake et al., 1995). Other
researchers have found similar results (Bliese et al., 2008; Calhoun et al., 2010; Freedy et al.,
2010). The avoidance question (item 2) has been found to discriminate between individuals with
moderate versus elevated PTSD levels (Bliese et al., 2008). This item alone had a sensitivity of
.80 and specificity of .84. The PC-PTSD is comparable to the PCL-C in terms of ability to
accurately diagnose PTSD (e.g., specificity and sensitivity; Bliese et al., 2008; Freedy et al.,
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2010). Freedy and colleagues (2010) compared four PTSD measures (i.e., PC-PTSD; Prins et al.,
2003; PTSD Checklist Civilian Version, PCL-C; Weathers et al., 1993; SPAN; Davidson, 2002;
and Breslau’s scale; Breslau et al., 1999) and concluded that the “PC-PTSD was the best single
PTSD screening test for use in civilian primary care [based on] brevity, equivalency to the longer
PCL-C in terms of diagnostic efficiency, sensitivity and specificity, and >80% correct
classification” (p. 621).
Depression
Depression symptoms were assessed using the Patient Health Questionnaire (PHQ-9;
Kroenke et al., 2001). This is a 9-item measure asking about DSM-IV symptoms of depression as
well as level of impairment. Participants are asked about their symptoms in the past two weeks
using answer options ranging from 0 (Not at all) to 3 (Nearly every day). Items are summed to a
total score, with a higher score indicating greater depression. Additionally, a symptom count
score is calculated by dummy coding the items as present (1) or absent (0). Symptoms are
considered present if the participant endorsed items 1-8 at 2 (More than half the days) or 3
(Nearly every day). Item 9 is considered present if endorsed as 1 (Several days) or higher. The
symptom count score ranges from no symptoms to a maximum of nine symptoms.
Kroenke and colleagues (2001) provided evidence for good reliability and validity. They
also identified a cutoff score of 10 that indicated 88% sensitivity and specificity for a diagnosis
of major depressive disorder. Moreover, they identified cutoff scores for mild (5), moderate (10),
moderately severe (15), and severe (20) depression. Other studies have also reported good
reliability and validity for the PHQ-9 (Lowe, Unutzer, Callahan, Perkins, & Kroenke, 2004;
Merz, Malcarne, Roesch, Riley, & Sadler, 2011; Spitzer et al., 1999; Wittkampf et al., 2009;
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Zuithoff et al., 2010). The Cronbach’s alpha coefficients from the current study were .84 at the
pre-treatment assessment and .86 at the post-treatment assessments.
Several studies have included the PHQ-9 as a treatment outcome measure. Lowe and
colleagues (2004) concluded that the PHQ-9 “can be used to establish depression diagnoses,
depression severity, and depression outcome” (p. 1199). Cigrang and colleagues (2011) modified
Foa and colleagues’ PE (Foa et al., 2007; Foa & Rothbaum, 1998) for primary care VA patients
with PTSD. They modified the treatment to 4-6 30-minute sessions with a primary care
psychologist in addition to completing written narratives about the trauma between sessions.
They found significant decreases in PTSD and depressive symptoms (as measured by the PHQ9) from baseline to the one-month follow-up assessment. Another PTSD treatment outcome
study randomly assigned 44 participants to an online CBT treatment for PTSD (n = 23) or a
control group (n = 21; Spence et al., 2011). The online CBT treatment consisted of seven lessons
with homework assignments. Eighty-one percent of participants were women and 57% were
victims of sexual assault. The treatment group reported significant reductions in PTSD and
depressive symptoms (as measured by the PHQ) compared to the control group (effect sizes were
large). The reductions were maintained during the 3-month follow-up period. The group
leader/therapist spend on average 104 minutes per participant.
Anxiety
Participants’ anxiety symptoms were assessed using the 2-item Generalized Anxiety
Disorder scale (GAD-2), a shorter version of the original 7-item scale (GAD-7; Spitzer, Kroenke,
&Williams, 2006). The GAD-7 was developed to detect GAD in primary care settings.
Participants report on their symptoms in the past two weeks. The first item addresses anxiety
while the second question addresses worry. The answer options ranges from 0 (Not at all) to 3
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(Nearly every day). A total score is created by summing the two items together, so that a higher
score indicates greater frequency of anxiety and worry.
Spitzer and colleagues (2006) reported good reliability and validity for the GAD-7.
Kroenke et al. (2007) have also shown high sensitivity and specificity for the GAD-2, using a
cutoff score of 3. The highest sensitivity (.86) and specificity (.83) was found for GAD (in
comparisons to Panic Disorder, .76 and .81; Social Phobia, .70 and .81; and PTSD, .59 and .81).
In the current study, the correlation coefficients between the GAD-2 items were .72 for the pretreatment assessment and .47 for the post-treatment assessment.
Trauma Cognitions
The Posttraumatic Cognitions Inventory (PTCI; Foa et al., 1999) was used to assess for
trauma-related cognitions. This is a 36-item measure with three subscales (negative cognitions
about self, negative cognitions about the world, and self-blame). The answer options ranges from
1 (Totally disagree) to 7 (Totally agree). Mean scores are calculated for the three subscales and
all items are summed for a total score. Higher scores indicate more maladaptive trauma-related
cognitions.
Foa and colleagues (1999) provided evidence of good reliability and validity in a sample
of sexual assault victims. In the current study, the Cronbach’s alpha coefficients at pre-and posttreatment respectively were .95 and .98 for the negative cognitions about self subscale, .83 and
.87 for the negative cognitions about the world subscale, and .84 and .87 for the self-blame
subscale.
Other studies have also shown evidence of good reliability and validity (Beck et al.,
2004; Blain, Galovski, Elwood, & Meriac, 2012; Daie-Gabai, Aderka, Allon-Schindel, Foa, &
Gilboa-Schechtman, 2011; Karl, Rabe, Zollner, Maercker, & Stopa, 2009; Startup,
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Makgekgenene, & Webster, 2007), and support for the three-factor structure (excluding four
items from negative cognitions about self subscale; Beck et al., 2004; Daie-Gabai et al., 2011).
However, there have been some inconsistencies, especially in regards to the self-blame subscale.
In a sample of survivors of motor vehicle accidents (MVAs), Beck and colleagues’ (2004) results
showed good reliability (i.e., internal consistency) and validity (i.e., concurrent, discriminant,
and discriminative) for two of the subscales (i.e., negative cognitions about self and the world)
but low concurrent and discriminative validity for the self-blame subscale. The self-blame
subscale was not significantly associated with PTSD symptoms and did not discriminate between
those with and without PTSD. Other researchers have also reported no association between the
self-blame subscale and PTSD symptoms/ diagnosis in samples of sexual assault victims (Blain
et al., 2012) and CSA and MVA survivors (Cieslak, Benight, & Lehman, 2008). Startup and
colleagues (2007) found a negative association between the self-blame subscale and PTSD
diagnosis/symptoms in a sample of traumatized community members. Some studies have found a
significant association between the self-blame subscale and PTSD symptoms (Daie-Gabai et al.,
2011; Moser, Hajcak, Simons, & Foa, 2007).
Moreover, Blain and colleagues (2012) found that the three PTCI subscales predicted
different PTSD symptom clusters (measured by the CAPS; Blake et al., 1995; and the
Posttraumatic Diagnostic Scale, PDS; Foa, Cashman, Jaycox, & Perry, 1997) in their sample of
sexual assault victims. Using structural equation models (SEMs), Blain and colleagues (2012)
found that the negative cognitions of self predicted re-experiencing symptoms while the negative
cognitions about the world predicted avoidance and hyperarousal symptoms. Both the negative
cognitions about self and the self-blame subscales predicted numbing symptoms. Numbing
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symptoms were positively associated with negative cognitions about the self but negatively
associated with self-blame.
Several studies have found that the negative cognitions about self-subscale is the best
predictor of PTSD symptom severity and symptom change. Negative cognitions about self
before the trauma predicted PTSD symptom severity four years later in a sample of fire fighters
(Bryant & Guthrie, 2007). Other researchers have found that the negative cognitions about self
had the highest correlation with PTSD and depression symptoms (Daie-Gabai et al., 2011; Moser
et al., 2007). Karl and colleagues (2009) found that the self-subscale predicted PTSD severity
even after controlling for depressive symptoms. One study found that women reported
significantly higher scores on this subscale compared to men; however, men’s scores on the selfsubscale had a stronger association with PTSD severity (Daie-Gabai et al., 2011).
Decreases in PTCI scores have been associated with treatment related reductions in
PTSD and depressive symptoms, which were maintained during the follow-up period after
completing the treatment (Foa & Rauch, 2004). Importantly, changes in scores on the negative
thoughts about self-subscale were the only subscale scores that accounted for reductions in
PTSD symptoms. This has been supported by other studies (Karl et al., 2009). In Foa and
Rauch’s (2004) study changes in negative thoughts about the world was also significantly
associated with reductions in PTSD symptoms, but this association became non-significant when
including the negative thoughts about self subscale. The self-blame subscale was not predictive
of reductions in PTSD symptoms.
Group Alliance
MacKenzie’s (1983) Group Climate Questionnaire Short Form (GCQ-S) was used to
address the group alliance. This is a 12-item measure with answer options ranging from 0 (Not at
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all) to 6 (Extremely). The measure has three subscales: Engaged, Conflict, and Avoiding. The
GCQ-S is one of the most frequently used group alliance measure among researchers and studies
have shown good reliability (e.g., Kivlighan & Goldfine, 1991). Studies have also shown that the
Engaged subscale positively predicts treatment outcomes (e.g., Braaten 1989). In the current
study the Cronbach’s alpha coefficients were .20 and .26 for the Engaged (items 1, 2, 4, 8, and
11) and Avoiding subscales (items 3, 5, 7, and 9). The correlation coefficient for the two items (6
and 10) comprising the Conflict subscale was .21.
C. PROCEDURE
This project was initiated while the researcher, a doctoral clinical psychology student,
completed her part-time clinical externship at Peace at Home Family Shelter, which is a
domestic violence shelter located in the Northwest area of Arkansas. Results from focus groups
with female domestic violence victims at the shelter indicated that there was a great need for
therapy groups focusing on sexual trauma. After several failed attempts to start the sexual trauma
group at the shelter (e.g., not enough individuals committed to attending weekly sessions), it was
decided to implement the group at a local correctional facility for women. Peace at Home Family
Shelter staff had led domestic violence support groups at the women’s correctional facility in the
past and expressed interest in supporting the researcher in implementing the sexual trauma group
at the prison. The current group was designed and implemented by the researcher at the
correctional facility starting in January of 2012. Initially, the main focus was to provide
treatment to this underserved and highly traumatized population. Shortly after initiating the
treatment, approval to evaluate pre-to post-treatment outcomes was received from the
Institutional Review Board at the University of Arkansas as well as from Arkansas Community
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Corrections. Participation in the group was not contingent upon participating in the research
study.
Participants were recruited for the treatment group in the following way. During a
mandatory morning or evening meeting of residents at the correctional facility, one of the
treatment group leaders (the researcher) announced the start date for the group. This
announcement occurred approximately one week before the group start date. The group leader
described the group structure (e.g., meet every week for eight weeks, 1.5 hours long sessions,
closed group) and stated that this group was for women who have been victims of sexual trauma,
abuse, or violence. The group leader provided behavioral specific examples of sexual abuse,
violence, and trauma (e.g., being touched when they did not want to, being threatened if they did
not have sex, or being gang raped). The group leader also stated that the group was for women
who experienced some difficulties because of their sexual trauma. Examples provided were
difficulties associated with trust, anger, or sadness. The group was described as a process group
in which the women would talk about their trauma and receive help processing their reactions as
well as learning adaptive coping strategies and sexual behaviors.
Residents who had an interest in participating in the group were encouraged to inform
staff members, most often the treatment coordinator or counselors at the facility. The treatment
coordinator then informed the group leaders of the number of women to expect for each group,
with the maximum number of 10. Although the maximum number was intended to be 10, two
groups exceeded that number. The treatment coordinator also informed the residents whether
they were going to participate in the current group or be placed on the waitlist for the following
group. Women who had not participated in the group were prioritized as well as women who had
earlier release dates. Otherwise, the treatment coordinator decided who should be prioritized. If
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fewer than 10 women wanted to participant in the group, former group participants had the
opportunity of repeating the treatment program. The first woman repeating the treatment group
was in group number 4. There were no investigator exclusion criteria for participating in the
group. Staff at the correctional facility screen the residents for mental illness and send them to a
different correctional facility if they meet criteria for severe mental illness and cannot function in
their program (e.g., they can stay at the facility if they can be stabilized on medications etc.).
Therefore, the researcher did not have any additional exclusion criteria for the group treatment.
During the first group meeting, information about the study was presented to the women.
Following brief introductions, confidentiality, and group norm discussions, the group leaders
informed the participants about the purpose and nature of the research study. After providing
written consent, interested women were invited to complete a packet of questionnaires (PCPTSD, Prins et al., 2003; PHQ-9, Kroenke et al., 2001; GAD-2, Spitzer et al., 2006; PTCI; Foa et
al., 1999). In addition to initial consent, participants were given the option of withdrawing their
consent to the research study once they had completed the pre-treatment questionnaires. Pretreatment data were not collected for group 1 because the research study had not been approved
yet.
Post-treatment data, which include responses to all of the pretreatment questionnaires as
well as the GCQ-S (MacKenzie, 1983), were collected at the end of the last session. Again,
participants were given the opportunity to decline participation in the research study before and
after completing the measures. The researcher provided the treatment participants with several
opportunities to decline participating in the research study as an attempt to increase their sense of
control in a setting (e.g., the prison) in which they typically have less control. The data for the
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current project were from eight groups. The first group started on January 16th, 2012, and the
eight group ended on August 26th, 2013.
In January 2013, the research project was expanded to include a 3-6-month follow-up
assessment using the same measures as for the pre-treatment assessment (e.g., all measures
except for group alliance). The goal was to assess participants three months after completing the
treatment program, with the possibility of assessing them in the time frame of 3 to 6 months after
completing treatment.
D. TREATMENT
Each group consisted of eight weekly 1.5-hour sessions with 8-12 female residents and
two female group leaders/therapists. The group was developed and implemented by the
researcher who is a clinical psychology doctoral student. The co-therapist for the first three
groups was a licensed clinical social worker. The remaining groups were co-led by one other
clinical psychology doctoral student. The group leaders were supervised by a licensed clinical
psychologist. The groups were conducted at a minimum-security community correctional
facility for women. Refer to Table 1 for an overview of the treatment content session by session.
The group treatment was mainly an exposure-based treatment. The group format and
structure were based on Foa and colleagues’ PE therapy (Foa, et al., 2007; Foa & Rothbaum,
1998), with a focus on imaginal exposure. Common victimization themes were also included in
the treatment. These themes (e.g., safety, trust, power and control, esteem, and intimacy) were
based on McCann, Sakheim, and Abrahamson’s (1988) work and are also used in CPT (Resick
& Schnicke, 1992, 1993). The current group aimed at providing a safe environment for women
to discuss and process their sexual trauma memories.
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Although the overall structure and content of the group remained the same, some
procedural changes were implemented. For instance, participants decided their own group norms
and rules for confidentiality. These norms and rules were largely the same across the eight
groups. For example, if someone would breach confidentiality participants decided that the
individual would be excluded from the group and disciplinary actions would be put in place (e.g.,
group leaders would inform the treatment coordinator at facility who would inform the Sergeant
in charge of disciplinary actions). In terms of group norms, all the groups agreed to create a nonjudgmental and supportive atmosphere (e.g., listen to each other, ask permission before one
provides feedback or suggestions).
However, there were also some differences among the groups. Most of the differences
were as a result of situations that arose during treatment. When issues arose in the group, the
participants decided how to proceed with guidance from the group leaders. Some of these issues
were unexpected and/or specific to the current group. One example was a participant who
returned to the group after being absent for several sessions. The group decided to let her
continue in the group and the participant decided that she would like to continue. Another
example was a participant who walked out of the room while someone else was processing her
trauma (e.g., in the middle of an exposure). Again, the group decided how they wanted to handle
the situation at the time and in the future. The above-mentioned issues that arose in different
groups seemed relevant for future groups and were therefore addressed by the group leaders in
the groups that followed. However, other issues were more specific to the group at hand and
were therefore not discussed with other groups. One example was interpersonal conflicts or
disagreements between two or more participants. These conflicts and disagreements may have
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originated before participants were incarcerated or while they were incarcerated, but they were
unrelated to the group content and process.
The treatment structure and content remained the same across groups. The first session
consisted of introductions and discussion of the structure of the group. A session outline was
provided to the participants (e.g., topics covered each session) and confidentiality and group
norms were discussed. Group structure and expectations were also discussed. Next, interested
participants were provided with time to complete pre-treatment measures. Following the pretreatment assessment, participants were asked to define sexual violence, abuse, and trauma.
Psychoeducation followed about common sexual abuse and trauma reactions (e.g., physical and
mental health outcomes). Participants were provided handouts about sexual abuse statistics as
well as physical and mental health outcomes. The first session typically exceeded 1.5 hours due
to the time needed to complete the pre-treatment assessments (e.g., 10-15 minutes).
Starting with the second group, 1-2 participants from the most recently completed group
were encouraged to come and discuss their experiences with the new group in the beginning of
the first session. Previous participants shared their thoughts and emotions prior to starting the
group as well as how they experienced being part of the group. Current group participants were
encouraged to ask questions. Confidentiality was emphasized (e.g., neither past or current
participants could talk about anything they have seen or heard in the group).
The second session was dedicated to psychoeduation about the role of avoidance and the
rationale for exposure therapy (i.e., why they would need to talk about their sexual traumas).
This was mainly based on the rationale behind Foa and colleagues’ PE therapy (Foa, et al., 2007;
Foa & Rothbaum, 1998), which is based on emotional processing theory (Foa & Kozak, 1986).
During the second session, participants were also provided handouts about coping skills, which
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were followed by a discussion on how to cope with reactions in session as well as between
sessions. Throughout the treatment, group leaders and participants shared ideas for coping
strategies (e.g., breathing and grounding exercises) and metaphors were provided to help
participants stay regulated (e.g., emotions are like waves; Linehan, 1993; exposure therapy is
like a wound that needs to be cleaned or a file cabinet that needs to be organized; Foa, et al.,
2007; Foa & Rothbaum, 1998). Participants who were not able to attend at least one of the first
two sessions were asked to stay on the waitlist for the next group.
Sessions 3 and 4 were primarily focused on exposure therapy (e.g., imaginal exposure;
Foa, et al., 2007; Foa & Rothbaum, 1998). Participants described details about one or more of
their most distressing sexual trauma memories. One participant shared at a time and the group
leaders helped that participant process her emotions, thoughts, and reactions to the trauma. The
focus was on facilitating the emotional processing of the trauma to reduce PTSD and other
trauma-related symptoms and thought patterns (Foa, et al., 2007; Foa & Rothbaum, 1998). Once
someone had processed their trauma, the group leaders checked in with all participants before
encouraging another person to share her trauma memory. Group participants were also
encouraged to provide feedback for the person who shared (e.g., commenting on the person’s
strength or abilities, thanking the person for sharing, discussing triggers and/or commonalities
between stories, and suggestions for continuing recovery and healing from the trauma). One to
three participants processed their sexual trauma memories during one exposure session. Each
participant shared once during the duration of the treatment.
Participants continued to share about their sexual trauma during sessions 5-7. However,
common beliefs or themes that emerge following trauma (e.g., difficulties with safety and trust,
issues of power and control, and impacts on self-esteem and intimacy; McCann et al., 1988) were
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also interspersed. Other themes that arose among the group participants were also discussed
(e.g., how to recognize symptoms of sexual abuse in children, how to talk to children about
sexual boundaries, domestic violence, and risk factors for mental illnesses). These additional
themes were at large similar across the groups, although there were some differences. For
instance, one group learned more about dissociation and its relation to trauma because several
participants reported current and past experiences with dissociative symptoms.
The last session focused on increasing coping strategies and self-care as well as defining
healthy sexual relationships. These topics were often intermixed throughout prior sessions. The
last session was also dedicated to discussing what the participants had learned from the group,
what issues they would continue working on, and additional resources that they might benefit
from accessing. Participants were provided with handouts about resources in the community,
how to find a therapist, and information about coping and healthy relationships. All women were
provided with paper certificates for completing treatment. Finally, participants were invited to
complete post-treatment measures.
E. ANALYTIC APPROACH
Paired samples t-tests were used to determine changes from pre-to post-treatment. Pretreatment levels of PTSD, depressive, and anxiety/worry symptoms were compared to posttreatment levels. The same analyses were completed for trauma-related cognitions at pretreatment (total score and mean scores for the three subscales) compared to post-treatment. Eta
squared was used to determine the effect sizes for the paired samples t-tests. Small effect size is
.01, medium is .06, and large is .14 (Cohen, 1988).
Moreover, Jacobson and Truax’s (1991) reliable change index (RCI) was used to
determine the amount of change in participants’ depressive and anxiety/worry symptoms from
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pre-to post-treatment. The reliable change index is calculated by subtracting the pre-treatment
score from the post-treatment score and divide it by the standard error of difference (RC = (x2 –
x1)/Sdiff). The standard error of difference is calculated using the standard error (Sdiff = √2*(SE)2),
which is based on the standard deviation at pre-treatment and the test-retest reliability coefficient
for the measure of interest (SE = s1*√(1 – rxx)). The standard deviations at pre-treatment from the
current study were used to calculate RCI values for the PHQ-9 (SD = 5.93) and the GAD-2 (SD
= 1.79). Additionally, the test-retest reliability coefficients used for the RCI calculations were
from Kroenke and colleagues’ (2001) study (PHQ-9; r = .84) and from Garcia-Campayo and
colleagues’ (2012) study (GAD-2; r = .74). Although test-retest reliability coefficients could
have been calculated from the current study by correlating pre-and post-treatment scores on the
PHQ-9 and the GAD-2, this would have been problematic because the treatment program
implemented in this study was expected to reduce participants’ symptoms from pre-to posttreatment. Therefore, test-retest reliability coefficients from the current study would not reflect
their intended purpose. An RCI above 1.96 is considered clinically and statistically meaningful
and suggests that “it is unlikely that the posttest score is not reflecting real change” (Jacobson &
Truax, 1991, p.14).
For the pre-to post-treatment analyses, treatment outcomes from participants who
completed more than eight sessions (e.g., more than one group) were limited to the first time
they participated. Moreover, participants who completed the treatment were compared to those
who did not in terms of pre-treatment symptom levels (PTSD, depression, anxiety/worry, and
maladaptive cognitions) and demographics (e.g., age, ethnicity, number of children, previous
therapy experiences). Independent t-tests and chi square tests were utilized to compare
completers to non-completers as well as comparing participants who completed pre-and post-
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treatment assessments to those who completed the treatment program but only completed one of
the assessment time points. Treatment alliance was measured as well. Participants’ scores on the
three subscales (Engaged, Conflict, and Avoiding) at post-treatment were compared using paired
samples t-tests.
Moreover, some secondary analyses were conducted as well. One-way repeated measures
analysis of variance (ANOVA) were used to analyze changes in PTSD, depressive, and
anxiety/worry symptoms as well as trauma-related cognitions during treatment and until the
follow-up assessment (i.e., three time points; pre-treatment, post-treatment, and the 3-6 month
follow-up assessment). One-way repeated measures ANOVAs were also used to analyze the
effect of time for participants who completed two groups. Changes in PTSD, depressive, and
anxiety/worry symptoms as well as trauma-related cognitions were assessed over four time
points (i.e., pre-and post-treatment of first group and second group). Effect sizes were
determined using partial eta squared. Small effect size is .01, medium is .06, and large is .14
(Cohen, 1988).
Lastly, comparisons were made between group leaders and treatment outcomes.
Treatment outcomes from the first three groups were compared to treatment outcomes from the
other groups to test for potential impact from using different group leaders. Independent t-tests
were used to compare pre-to post-treatment outcomes from groups 1-3 to groups 4 and beyond.
Change scores were used as the dependent variable (e.g., changes in PTSD, depression,
anxiety/worry, and trauma-related cognitions from pre- to post-treatment). Change scores were
calculated by subtracting each participant’s post-treatment sum score from her pre-treatment sum
score. A positive change score indicates a decrease in symptoms or symptom severity from pre-
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to post-treatment while a negative change score indicate an increase in symptoms or symptom
severity. Mean scores were used to calculate change scores for the PTCI subscales.
F. POWER ANALYSIS
A priori power analysis was conducted using G* Power 3 (Faul, Erdfelder, Lang, &
Buchner, 2007). Expecting at least a medium effect size (Cohen’s d = 0.5) and power of 0.8 (ttest: difference between two dependent means; α - level 0.05; two tails), it was recommended to
use 44 participants.
III.

RESULTS
A. PARTICIPANTS
Table 3 describes basic demographics of the 58 women who consented to the research
study. Data from women who repeated the group (n = 9) is only from the first time they
participated in the study. Participants were between 21 and 61 years old, with a fairly equal
distribution between ages 21 and 44. Two participants were substantially older (58 and 61 years
old respectively). Majority of participants were mothers of at least one child (n = 56, 89.7%),
with a maximum of six children. Almost all participants self-identified as Caucasian (n = 53,
91.4%). Two self-identified as African American, one of which also identified as Latina. Data
about ethnicity is missing for the remaining three participants. Approximately 40% reported that
they are divorced, 25% married, and 20% single. Seventy percent of the sample reported that
they have been in therapy previously. Most frequent experience was with individual therapy, and
38% (n = 22) of participants reported only experiencing individual therapy. Sixteen women
(27.6%) had experience with more than one type of therapy. The “other” category included
receiving treatment from a local rape crisis center (n = 2) or a substance use program (n = 2).
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Table 3 also compares demographics for the women who completed the group (n = 46) to
those who did not (n = 12). Completers were significantly older and had more children than the
non-completers. There were no other significant differences based on demographics between the
completers and non-completers. Refer to Table 4 for comparison between completers and noncompleters on symptom levels at pre-treatment. Non-completers were significantly more
depressed at pre-treatment than the completers. The non-completers reported experiencing a
significantly higher frequency of depressive symptoms (total sum) as well as a significantly
higher number of symptoms (ps < .05). Non-completers also reported marginally significantly
more self-blame at pre-treatment compared to completers (p = .07).
Out of the 46 women who completed the treatment, 34 provided pre-and post-treatment
data, 3 pre-treatment data only, and 9 post-treatment data only (5 of these were from group 1
before the research project was approved). All participants reported their age while only 43
participants answered the other demographical variables. There were no significant differences
on any of the demographical variables between the 34 completers who provided pre-and posttreatment data compared to the other 12 completers who provided pre- or post-treatment data
only (Table 5). See Table 6 for means and standard deviations as well as test statistics for
comparing treatment completers with pre-and post-treatment data to treatment completers with
pre- treatment data only. There were no significant differences between these two groups of
completers at the pre-treatment assessment. However, there were some differences at the posttreatment assessment (Table 7). Participants with post-treatment data only reported significantly
more trauma-related cognitions at post-treatment than the participants with pre-and posttreatment data (p < .05). Completers with post-treatment data only reported significantly more
negative cognitions about self (p < .05) and the world (p < .01) as well as more self-blame (p <
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.05) than completers with pre-and post-treatment data. Interestingly, those with pre-and posttreatment data attended significantly more sessions than those with post-treatment data only (p =
.01).
To summarize, treatment completers who provided both pre-and post-treatment data
attended more sessions than treatment completers who provided the post-treatment data only.
They also reported fewer maladaptive trauma-related cognitions at post-treatment compared to
those with post-treatment data only. It is possible that the treatment completers with posttreatment data only had higher levels of maladaptive trauma-related cognitions already at pretreatment. It is also possible that participants need to attend more sessions in order to target their
maladaptive cognitions. At pre-treatment, there was no difference between treatment completers
who provided pre-and post-treatment data to treatment completers who provided pre-treatment
data only. Overall, these results suggest that there were few differences between treatment
completers who provided pre-and post-treatment data to those who provided pre- or posttreatment data only.
B. PRIMARY TREATMENT OUTCOMES
Table 8 provides descriptive data for each of the measures at pre-and post-treatment for
the treatment completers. Pre-to post-symptom change is determined by paired sample t-test
statistics as well as RCI values (Jacobson & Truax, 1991). Table 9 shows sum scores (pre- and
post-treatment), RCI values, improvement (change pre-post > critical RCI value), and recovery
rates (i.e., above clinical cutoff at pre-treatment and below cutoff at post-treatment) for each
participant who provided pre-and post-treatment data (n = 34). The following analyses focus on
treatment outcomes for women who completed the treatment program (n = 46). However, all pre-
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post assessment comparisons are from the 34 women who provided both pre-and post-treatment
data.
PTSD
Using a cutoff score of 3 (Prins et al., 2003), 71.7% (n = 33) were above the screening
cutoff indicating possible PTSD diagnosis at pre-treatment while 47.8% (n = 22) were above the
cutoff at post-treatment. Out of the 34 women who provided pre-and post-treatment data, 88.2%
(n = 30) were above the screening cutoff at pre-treatment and 44.1% (n = 15) at post-treatment.
Fourteen participants (41.2%) were above the screening cutoff for possible PTSD diagnosis at
pre-treatment but below at post-treatment and are therefore considered recovered (Table 9).
Fifteen participants (44.1%) remained above the clinical cutoff at pre-and post-treatment (two of
them reported an increase in one symptom from pre-to post). Four participants (11.8%) were
below the cutoff at both time points (one reported an increase in one symptom from pre-to post).
Data was missing for the last participant at post-treatment (4 symptoms at pre-treatment).
A paired-samples t-test comparing pre- (M = 3.45, SD = 0.79) and post-treatment scores
(M = 2.33, SD = 1.55) for the 34 women who provided information at both time points was
significant, t (32) = 4.43, p < .001, with a large effect size, η2 = .38.
Depression
Using a cutoff score of 10 (Kroenke et al., 2001), 58.7% (n = 27) participants were above
the clinical cutoff for depression at pre-treatment and 17.4% (n = 8) at post-treatment. Out of the
34 women who provided pre-and post-treatment data, 73.5% (n = 25) were above the clinical
cutoff at pre-treatment and 20.6% (n = 7) at post-treatment. See Table 9 for recovery and
improvement rates for the 34 women who provided pre-and post-treatment data. Fifteen
participants (44.1%) improved and recovered on the PHQ-9, six participants (17.6%) improved
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but did not recover, and three participants (8.8%) recovered but did not improved. The three
participants who recovered but did not improved were above the clinical cutoff at pre-treatment
and below at post-treatment but their symptom change was not large enough to be below the RCI
value. Eight participants (23.5%) neither recovered nor improved on the PHQ-9 and two
participants had missing data at one of the two time points. Importantly, all participants with preand post-treatment data on the PHQ-9 (n = 32) reported some decrease in severity of depressive
symptoms from pre-to post-treatment (e.g., no participants reported an increase in symptom
severity from pre-to post-treatment and no participants reported the same level of symptom
severity at pre-and post-treatment).
A paired-samples t-test comparing pre- (M = 13.34, SD = 5.71) and post-treatment mean
sum scores (M = 5.22, SD = 4.58) for the 34 women who provided information at both time
points was significant, t (31) = 10.98, p < .001, with a large effect size, η2 = .92. Paired-samples
t-test comparing mean number of depression symptoms at pre- (M = 4.59, SD = 2.66) and posttreatment (M = 1.19, SD = 1.67) was also significant, t (31) = 8.28, p < .001, with a large effect
size, η2 = .69.
Anxiety
Using a cutoff score of 3 (Kroenke et al., 2007), 56.5% (n = 26) of participants were
above the clinical cutoff for possible GAD diagnosis at pre-treatment and 26.1% (n = 12) at posttreatment. Out of the 34 women with pre-and post-treatment data, 70.6% (n = 24) were above the
clinical cutoff at pre-treatment and 26.5% (n = 9) at post-treatment. Refer to Table 9 for recovery
and improvement rates for the women who provided pre-and post-treatment data. Twelve
participants (35.2%) improved and recovered on the GAD-2, one participant (2.9%) improved
but did not recover, and five participants (14.7%) recovered but did not improve, which appears
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to mainly be related to lower anxiety levels at pre-treatment. Sixteen participants (47.0%) neither
recovered nor improved on the GAD-2; three of the 16 (8.8%) reported an increase in symptom
severity from pre-to post-treatment.
A paired-samples t-test indicated significant declines in anxiety and worry symptoms
from pre- (M = 3.76, SD = 1.79) to post-treatment (M = 1.56, SD = 1.62), t (33) = 6.54, p < .001,
with a large effect size, η2 = .56. The decreases were significant for both the anxiety item
(question 1; t (33) = 4.48, p < .001, large effect size, η2 = .38) and the worry item (question 2; t
(33) = 7.25, p < .001, large effect size, η2 = .61).
Trauma Cognitions
Refer to Table 8 for descriptive data for the following analyses. Treatment completers
reported significantly more negative cognitions about the world at pre-treatment compared to the
other two subscales (self: t (36) = 10.69, p < .001, large effect size, η2 = .76; self-blame: t (36) =
7.52, p < .001, large effect size, η2 = .61). The same pattern was found at post-treatment
comparing cognitions about the world to cognitions about self (t (42) = 9.52, p < .001, large
effect size, η2 = .68) and self-blame (t (42) = 7.23, p < .001, large effect size, η2 = .55). There
was no significant difference between negative cognitions about self and self-blame at pretreatment, t (36) = 1.42, p = .16. However, at post-treatment, participants reported significantly
more self-blame compared to negative cognitions about self, t (42) = -2.06, p < .05, with a
moderate effect size, η2 = .09.
For the 34 women who provided data at both time points, a paired-sample t-test shows
significant reductions in trauma-related cognitions from pre- (M = 136.58, SD = 43.50) to posttreatment (M = 81.23, SD = 44.30), t (30) = 6.14, p < .001, large effect size, η2 = .56. There were
significant changes from pre-to post-treatment in all three subscales with large effect sizes
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(world: t (33) = 6.69, p < .001, η2 = .58; self: t (33) = 6.51, p < .001, η2 = .56; self-blame: t (33) =
3.23, p < .01, η2 = .24).
Group Alliance
Participants who provided post-treatment data (n = 43) reported significantly higher
levels of engagement (M = 4.94, SD = .70) than avoidance (M = 1.95, SD = .94) and conflict (M
= 0.07, SD = .23), t (42) = 17.68, p < .001, η2 = .88 and t (42) = 39.56, p < .001, η2 = .97. They
also reported significantly more avoidance than conflict, t (42) = -13.03, p < .001, η2 = .80. The
participants who completed pre-and post-treatment assessments (n = 34) had significantly higher
scores on the Avoiding subscale (M = 2.12, SD = .89) compared to the other treatment
completers with post-treatment data only (n = 9; M = 1.30, SD = .87), t (41) = -2.47, p = .02, η2 =
.13. There were no significant differences between the two groups of treatment completers for
the other two subscales (ps > .55).
Zero-order correlations were used to explore possible associations between group alliance
(e.g., three subscales) and treatment outcomes (e.g., post-treatment scores as well as change
scores). The Engaged subscale was negatively correlated with depression sum score (r = -.32, p
= .04) and number of depressive symptoms (r = -.35, p = .02) at post-treatment. The conflict
subscale was positively associated with depression sum score (r = .33, p = .03), number of
depressive symptoms (r = .34, p = .03), anxiety/worry sum score (r = .39, p = .01), and
maladaptive cognitions (total sum score: r = .40, p = .01; negative cognitions about self: r = .42,
p < .01; negative cognitions about the world: r = .32, p = .03; self-blame: r = .46, p < .01) at
post-treatment. The correlations between the group alliance subscales and the change scores
(e.g., changes in PTSD, depression, anxiety/worry, and trauma-related cognitions from pre- to
post-treatment) were non-significant (ps > .08).
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C. SECONDARY TREATMENT OUTCOMES
Follow-Up Period
Seven participants provided follow-up data from groups 5-7. No follow-up data was
collected from group 8 because none of the participants were still at the facility 3 months after
completing the group. One of the seven participants with follow-up data provided these data after
attending two groups and was therefore excluded from these analyses. Thus, the follow-up data
analyses are from 6 women (3 from group 5, 1 from group 6, and 2 from group 7). On average,
these 6 participants completed the follow-up data assessment 111.33 days (SD = 21.27) after they
completed the group treatment, with a range of 98 to 154 days. One-way repeated measures
ANOVAs were used to compare changes across the three time points (pre-treatment, posttreatment, and follow-up assessment).
PTSD
See Figure 1 for individual participants’ PTSD symptom levels at pre-treatment, posttreatment, and the follow-up assessment as well as the mean symptom level at the three time
points. All six participants were above the screening cutoff for possible PTSD at pre-treatment
and three were below at post-treatment. Two of the three participants remained below at the
follow-up assessment, one had an increase in one symptom, and one participant who was above
at pre-treatment was below at the follow-up assessment. Two participants remained above the
screening cutoff for possible PTSD at all three assessment points. The one-way repeated
measures ANOVA did not indicate a significant impact of time for changes in PTSD symptoms
across the three time points, Wilks’ Lambda = .41, F (2, 3) = 2.17, p = .26.
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Depression
Refer to Figures 2 and 3 for individual participants’ depression sum score and number of
depressive symptoms at pre-treatment, post-treatment, and the follow-up assessment as well as
the mean symptom level at the three time points. Five participants were above the clinical cutoff
for depression at pre-treatment; three of the five were below at post-treatment and remained
below at the follow-up assessment. The other two who were above the clinical cutoff at pretreatment remained above at post-treatment, but they were below the clinical cutoff at the followup assessment. The last participant was never above the clinical cutoff for depression but showed
a reduction in symptoms from pre-to post-treatment, which remained unchanged until the followup assessment.
Results from the one-way repeated measures ANOVA indicated a significant impact of
time for changes in depressive symptom severity (sum score) across the three time points, Wilks’
Lambda = .13, F (2, 4) = 13.05, p = .02, multivariate partial eta squared = .87, which is a large
effect size. Bonferroni pairwise comparisons showed significant reductions in the depressive
symptom sum score from pre-to post-treatment (p = .03) as well as from pre-treatment to the
follow-up assessment (p < .01). There were no significant changes from post-treatment to the
follow-up assessment (p = .42). Similar results were found for changes in number of depressive
symptoms across the three time points. The one-way repeated measures ANOVA indicated a
significant impact of time for changes in depressive symptoms, Wilks’ Lambda = .22, F (2, 4) =
7.14, p < .05, multivariate partial eta squared = .78, which is a large effect size. Bonferroni
pairwise comparisons indicated marginally significant reductions in depressive symptoms from
pre-to post-treatment (p = .06) and significant reductions from pre-treatment to the follow-up
assessment (p = .03). There were no significant changes in depressive symptoms from posttreatment to the follow-up assessment (p = .36).
100

Anxiety
Refer to Figure 4 for individual participants’ anxiety and worry sum score at pretreatment, post-treatment, and the follow-up assessment as well as the mean symptom level at the
three time points. All six participants were above the clinical cutoff for possible GAD at pretreatment and four were below at post-treatment and remained below at the follow-up
assessment. One participant remained above at the post-treatment but was below at the follow-up
assessment. The last participant remained above the clinical cutoff at all three assessment points.
A one-way repeated measures ANOVA indicated a significant impact of time for changes
in anxiety and worry symptoms across the three time points, Wilks’ Lambda = .09, F (2, 4) =
19.96, p < .01, multivariate partial eta squared = .91, which is a large effect size. Bonferroni
pairwise comparisons between the three time points showed significant reductions in anxiety and
worry symptoms from pre-to post-treatment (p = .02) as well as from pre-treatment to the followup assessment (p < .01). There were no significant changes from post-treatment to the follow-up
assessment (p = 1.00).
Trauma Cognitions
See Figure 5 for individual participants’ PTCI sum score at pre-treatment, post-treatment,
and the follow-up assessment as well as the mean at the three time points. Results from the oneway repeated measures ANOVA indicated a significant impact of time for changes in traumarelated cognitions across the three time points, Wilks’ Lambda = .14, F (2, 4) = 12.71, p = .02,
multivariate partial eta squared = .86, which is a large effect size. Bonferroni pairwise
comparisons indicated significant reductions in trauma-related cognitions from pre-to posttreatment (p = .04) as well as from pre-treatment to the follow-up assessment (p < .01). There
were no significant changes in trauma-related cognitions from post-treatment to the follow-up
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assessment (p = .85). The same pattern was found for changes in negative cognitions about self
(Figure 6) as well as negative cognitions about the world (Figure 7). There was an overall effect
of time (self: Wilks’ Lambda = .17, F (2, 4) = 9.97, p = .03, multivariate partial eta squared =
.83; world: Wilks’ Lambda = .13, F (2, 4) = 13.50, p = .02, multivariate partial eta squared =
.87), and there were significant reductions in both subscales from pre-to post-treatment (self: p =
.04; world: p = .03) as well as from pre-treatment to the follow-up assessment (self: p = .01;
world: p < .01). There were no significant changes from post-treatment to the follow-up
assessment (ps > .60). There were no significant effects of time for changes in self-blame (Figure
8), Wilks’ Lambda = .38, F (2, 4) = 3.22, p = .15.
Repeaters
Nine women repeated the group. One of these nine women repeated the group twice.
Data from the woman who completed the group twice are from the first two groups she
completed (i.e., excluded data from the third group in which she participated). Out of the nine
women who repeated the group once, eight completed both groups. The analyses below are
based on the eight women who repeated and completed the group treatment twice. Compared to
the women who completed one group (n = 38), the eight women who completed two groups
reported significantly more trauma-related cognitions at pre-treatment (p = .01) as well as
significantly more negative cognitions about self at pre-treatment (p < .01). There were no other
significant differences between these two groups of participants at pre-treatment (Table 10) or at
post-treatment (Table 11). Moreover, there were no significant differences on any of the
demographic variables between the women who repeated and completed the group treatment
twice compared to the ones who completed it once (ps > .28).
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The number of days between completing the first group and starting the second group
varied from 7 to 84 days with a mean of 61.25 days (SD = 34.24). Two participants started their
second group 7 days after completing their first groups while the remaining six participants
started their second group 63 to 84 days after completing their first group. There were no
significant differences between these two participants and the other six on any of the outcomes at
the four measured time points (pre-and post-treatment scores for both groups).
Refer to Figures 9-12 for participants’ PTSD, depression, and anxiety/worry symptoms at
all four time points (i.e., pre-and post-treatment scores from the first group and pre-and posttreatment scores from the second group). Three of the eight participants (37.5%) recovered on all
three measures during the first group (e.g., above cutoff for PTSD, depression, and GAD at pretreatment for the first group but below at post-treatment for the first group). Two participants
(25.0%) recovered on two of the measures (PHQ-9 and GAD-2) after participating in their first
group and on the third measure (PC-PTSD) after participating in their second group. The
remaining three participants did not recover on any of the measures after completing one group.
One of these participants was below the cutoff at pre-treatment for depression and GAD.
However, this person was above the cutoff for PTSD at pre-treatment of the first group and had
recovered by the pre-treatment assessment of the second group. The other two participants
remained above the cutoff on all three measures, but one of them was missing data for the fourth
time point (i.e., post-treatment of second group).
One-way repeated measures ANOVAs were used to compare the pre-and post-treatment
scores for the 8 participants who completed two groups (i.e., four time points). There was no
significant effect of time across the four time points for PTSD symptoms (Wilks’ Lambda = .18,
F (3, 3) = 4.71, p = .12), the depression sum score (Wilks’ Lambda = .01, F (3, 1) = 51.03, p =
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.10), the number of depressive symptoms (Wilks’ Lambda = .02, F (3, 1) = 17.00, p = .18), or the
anxiety and worry sum score (Wilks’ Lambda = .16, F (3, 3) = 5.09, p = .11).
However, there was a significant effect of time for trauma-related cognitions (Figure 13),
Wilks’ Lambda = .001, F (3, 2) = 583.37, p < .01, multivariate partial eta squared = 1.00, which
is a large effect size. Pairwise comparisons with Bonferroni corrections showed significant
reductions in trauma-related cognitions from the first (pre-treatment group 1) to the third time
point (p = .02; pre-treatment group 2) as well as significant reductions from the first to the last
time point (p < .001; post-treatment group 2). Moreover, there was a significant effect for time
related to the negative cognitions about self-subscale (Figure 14), Wilks’ Lambda = .02, F (3, 3)
= 45.85, p < .01, multivariate partial eta squared = .98, which is a large effect size. Pairwise
comparisons with Bonferroni corrections showed significant reductions from the first (pretreatment group 1) to the second time point (p = .02; post-treatment group 1), from the first to the
third time point (p = .02; pre-treatment group 2), and from the first to fourth time point (p = .001;
post-treatment group 2). The time effect for changes in negative cognitions about the world
(Figure 15) was also significant, Wilks’ Lambda = .05, F (3, 3) = 19.04, p = .02, multivariate
partial eta squared = .95, which is a large effect size. Pairwise comparisons with Bonferroni
corrections indicated marginally significant reductions in negative cognitions about the world
from the first (pre-treatment group 1) to the second time point (p = .07; post-treatment group 1)
as well as significant reductions from the first to the fourth time point (p < .01; post-treatment
group 2) and from the third (pre-treatment group 1) to the fourth time point (p < .01; posttreatment group 2). The time effect was not significant for changes in self-blame (Figure 16)
across the four time points, Wilks’ Lambda = .16, F (3, 3) = 5.17, p = .11.
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Group Leaders
The researcher was one of two group leaders during all eight groups. A licensed social
worker was the co-therapist for the first three groups and then a graduate student in the clinical
psychology program at the University of Arkansas was the co-therapist for the remaining five
groups. In order to test for potential therapist effects on the treatment outcomes, the women who
completed one of the first three groups (n = 18) were compared to the women who completed
one of the remaining five groups (n = 28). There were no significant differences between these
two groups of participants on any of the demographic variables (ps > .18). However, both of the
women who self-identified as African-American were in one of the first three groups (p = .06 for
ethnicity).
Participants in the first three groups reported significantly more anxiety and worry
symptoms at pre-treatment (Table 12) and marginally significant more negative cognitions about
self and self-blame at post-treatment (Table 13). When only including participants who
completed pre-and post-treatment assessments (n = 34), women from the first three groups (n =
9) still reported significantly more anxiety and worry at pre-treatment compared to women from
the other five groups (n = 25), t (32) = 2.34, p = .03, η2 = .15. However, the marginally
significant differences at post-treatment became non-significant (ps > .50). Participants in the
first three groups reported a significant greater amount of change in their anxiety and worry
symptoms from pre-to post-treatment compared to participants in the other five groups (Table
14).
IV.

DISCUSSION
In the current sample of predominantly Caucasian, non-violent incarcerated women, the

participants reported a significant reduction in PTSD symptoms, depression symptoms and
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symptom severity, and anxiety/worry symptom severity from pre-to post-treatment. They also
reported a significant reduction in trauma-related cognitions from pre-to post-treatment, which
was significant for all three subscales (i.e., negative cognitions about self, negative cognitions
about the world, and self-blame). All effect sizes were large. These results support the primary
hypothesis that a brief exposure-based treatment targeting the sexual trauma sequelae in
incarcerated women would result in significant reductions in PTSD, depression, anxiety/worry,
and trauma-related cognitions from pre-to post-treatment.
In addition to the paired samples t-test analyses comparing pre-to post-treatment
symptom levels, Jacobson and Truax’s (1991) reliable change index (RCI) was used to determine
individual participants’ improvement rates. Suggested cutoff scores for potential PTSD (≥ 3;
Prins et al., 2003), depression (≥ 10; Kroenke et al., 2001), and GAD diagnoses (≥ 3; Kroenke et
al., 2007) were also used to determine participants’ recovery rates (i.e., above clinical cutoff at
pre-treatment and below at post-treatment). Approximately 40-50% of participants who provided
pre-and post-treatment data recovered and 40-60% improved (e.g., RCI above 1.96). The lowest
recovery rate was for PTSD (41.2%) and the highest was for depression (52.9%). The
improvement rate was 38.2% for GAD and 61.8% for depression. No RCI was calculated for the
PTSD measure because of its dichotomous answer options.
Overall, the primary outcomes from this study would suggest that it is feasible to
implement a brief exposure-based treatment with incarcerated women and that many of them
experienced a significant reduction in a range of psychological symptoms from pre-to posttreatment. However, at post-treatment, approximately half of them remained above the clinical
cutoff for possible PTSD, depression, and/or GAD. This would suggest that participating in this
treatment program could significantly reduce the number of symptoms and/or symptom severity
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but not always to the extent that clients’ symptoms would fall below the suggested clinical cutoff
for PTSD, depression, and GAD. Also, not all participants experienced enough change for it to
be considered clinically meaningful/ significant. However, of note, the majority of participants
with pre-and post-treatment data (82.4%; n = 28) recovered and/or improved on at least one of
the primary symptom measures (e.g., PTSD, depression, and/or GAD).
The primary treatment outcomes from the current study add in important ways to the
existing research literature on trauma-informed treatments for incarcerated women. Previous
studies have shown mixed results. The majority of these studies reported significant reductions in
trauma-related symptoms from pre-to post-treatment (Bradley & Follingstad, 2003; Ford et al.,
2013; Kubiak et al., 2012; Lynch et al., 2012; Paquin et al., 2013; Roe-Sepowitz et al., 2014;
Wolff et al., 2012; Zlotnick et al., 2003, 2009). However, while some treatments outperformed
control groups (Bradley & Follingstad, 2003; Lynch et al., 2012), others did not (Ford et al.,
2013; Zlotnick et al., 2009). For example, Zlotnick and colleagues’ (2009) sample maintained
their gains during a follow-up period post-release from prison but no differences were found
between the treatment (Seeking Safety; Najavits, 2002) and the control group. Additionally, Cole
and colleagues (2007) did not find any support for their treatment. In addition to the mixed
results, the majority of these treatments were lengthy and resource intensive (cf. Ford et al.,
2013) and provided few if any information about clinical significance (e.g., changes in diagnostic
profiles, magnitude of symptom change, improved functioning). Also, the majority of these
studies did not include an exposure component (cf. Bradley & Follingstad, 2003; Cole et al.,
2007), despite research supporting this as an effective treatment for PTSD (Foa et al., 2007; Foa
& Rothbaum, 1998). The findings from the current study provide preliminary evidence
supporting the feasibility and positive outcomes from implementing a brief exposure-based
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group treatment with incarcerated women. The results also include information about clinical
significance and changes in symptoms as well as maladaptive cognitions from pre-to posttreatment.
In addition to the primary analyses, secondary analyses were conducted as well. Six
women who participated in groups 5-7 provided follow-up data 3-6 months after completing the
treatment. Results indicated significant reductions in depression and anxiety/worry symptoms
from pre-to post-treatment and from pre-treatment to the follow-up assessment. Importantly,
there were no significant changes from post-treatment to the follow-up assessment, which
indicates that the participants maintained their treatment gains during the follow-up period. The
results were not significant for PTSD, which suggest that there was no consistent pattern of
changes in PTSD symptoms across the three time points for these six participants. However, the
descriptive data show that half of the sample had recovered at post-treatment; two of them
maintained these gains and an additional person had recovered by the follow-up assessment.
These findings are very preliminary, using a small sample, and should therefore be interpreted
cautiously.
A pattern emerged for changes in trauma-related cognitions across the three time points
similar to the one obtained for depression and anxiety/worry symptoms. Participants reported
significant reductions in trauma-related cognitions from pre-to post-treatment and from pretreatment to the follow-up assessment. This pattern was found for two of the subscales (i.e.,
negative cognitions about self and negative cognitions about the world). These treatment gains
were maintained during the follow-up period. However, there were no effects of time for the
self-blame subscale across the three time points, which might indicate that the current treatment
program was not as effective in targeting self-blame. This would further be supported by some of
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the findings from the larger sample of treatment completers. Although the effect size was large
for the treatment completers’ reductions in self-blame from pre-to post-treatment, it was smaller
(η2 = .24) than for the other two subscales (η2 = .56 and 58). However, it is also important to note
that treatment completers reported significantly less self-blame at pre-treatment compared to the
other two subscales. Because of the lower mean score at pre-treatment and the small sample who
had follow-up data, it is possible that the analysis was underpowered. Moreover, previous studies
found no association between the self-blame subscale and reductions in PTSD symptoms during
the course of treatment (Foa & Rauch, 2004; Karl et al., 2009).
Secondary data analyses were also conducted on outcomes from eight women who
completed the group treatment twice. There was no effect of time across the four time points
(i.e., pre-and post-treatment scores from the first group and pre-and post-treatment scores from
the second group) for changes in PTSD, depression, or anxiety/worry symptoms. This would
suggest that these eight women did not show a consistent change in their symptoms during the
course of completing two treatment groups. However, graphing the mean scores at the four time
points (Figures 9-12) suggest a trend for a reduction in their symptoms across the four time
points, with marginally significant p-values (ps = .10 -.12). It is possible that these analyses were
underpowered. Moreover, the descriptive data show that majority of the participants (62.5%) had
recovered on at least two of the three symptom outcome measures after completing the first
group. Altogether, these findings suggest there were no additional benefits to reduction in
affective symptoms from completing more than one group. However, these results should be
interpreted with caution since the sample size was small.
Interestingly, there was an effect of time for changes in trauma-related cognitions for the
eight women who repeated the group treatment. They reported significant reductions from pre-
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treatment of their first group participation to pre-treatment of their second group participation as
well as to post-treatment of their second group participation. There were significant reductions in
negative cognitions about self and negative cognitions about the world from pre-treatment of
their first group participation to all the other time points (marginally significant from time point
1 to 2 for negative cognitions about the world). There was no significant effect of time for the
self-blame subscale.
The eight women who completed two groups reported significant more trauma-related
cognitions, including negative cognitions about self, at pre-treatment compared to the women
who only completed one group. This might indicate that participants with higher levels of
trauma-related cognitions at pre-treatment might benefit from receiving more than eight sessions
of treatment. It is possible that repeating the group treatment has little impact on symptoms such
as PTSD, depression, and anxiety/worry but maybe more so on maladaptive cognitions,
especially for participants with higher levels of maladaptive cognitions at pre-treatment of their
first group.
Although the secondary data analyses for participants providing follow-up data and data
from repeating the group treatment are preliminary, they support previous arguments about the
feasibility and positive outcomes of implementing a brief exposure-based group treatment with
incarcerated women. More specifically, although the findings are preliminary, they suggest that
there are few if any additional benefits to symptomatic reduction when participating in a second
group. This would suggest that eight sessions are sufficient to affect symptomatic change and/or
that additional sessions are unlikely to result in additional symptomatic reduction. It is possible,
however, that women with high levels of trauma-related cognitions might benefit from additional
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sessions, but it is also possible that the cognitions would decrease with passage of time without
attending additional sessions.
The results from the current study also suggest that exposure-based group treatment is not
effective for everyone. Non-completers were younger, had fewer children, and were more
depressed at pre-treatment compared to completers. It is possible that women with these
characteristics could benefit from receiving another treatment before they participate in the group
or they might benefit from a different type of treatment altogether. Future studies could benefit
from exploring ways to maintain women with these characteristics in the group. Moreover, in the
current study, the attrition rate was 20.1% (n = 12). Although this attrition rate is comparable
with other PTSD treatments (18.3%; Imel, Laska, Jakupcak, & Simpson, 2013), it might be an
indicator that exposure therapy is not effective and/or feasible with all clients. Imel and
colleagues (2013) compared drop out rates from 54 PTSD outcome studies and found that they
varied significantly by modality, number of sessions, and sample size. Drop out rates were
higher for group treatments, treatments with more sessions, and studies with smaller sample
sizes. They found no difference between PE and other treatments, but they found higher drop out
rates in “trauma-specific treatments” (e.g., “explicit retellings of the trauma memory,” p. 398).
In addition to the attrition rates and the difference between completers and noncompleters, not all participants improved or recovered during their participation in the current
study. This would further suggest that this kind of treatment might not be effective for everyone.
Research is limited in understanding why some participants experience more of a response to
PTSD treatments than others. Stein, Dickstein, Schuster, Litz, and Resick (2012) used growth
mixture modeling to determine participants’ trajectories (e.g., changes in PTSD symptoms)
during PTSD treatment. The samples were from RCTs evaluating CPT compared to PE and a
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waitlist (Resick, Nishith, Weaver, Astin, & Feuer, 2002) as well as a dismantling study of CPT
(Resick et al., 2008). The results suggested a two-class fit such that participants were either
classified as responders (87%) or non-responders (13%). Participants with MDD were more
likely to be in the non-responder category. However, of note, the majority of participants with
comorbid MDD were in the responder group (78%). Bluett, Zoellner, and Feeny (2014) reported
that participants with reliable reductions in distress (RCI > 1.96 in subjective units of distress
ratings from first to last imaginal exposure; Jacobson & Truax, 1991) during imaginal exposure
had better PE treatment outcomes than participants with unreliable reductions in distress (Bluett,
Zoellner, & Feeny, 2014). However, there was no difference between the two groups when
examining PTSD diagnostic status at post-treatment. Interestingly, the researchers did not find
any support for habituation between sessions as a predictor of PE treatment outcomes.
Altogether, the findings from the current study and those of Stein et al. (2012) and Bluett
et al. (2014) suggest that some clients do not respond to PTSD treatments. More research is
needed to understand why some clients respond to PTSD treatments while other do not. Several
factors could be involved but some moderators and mediators might have a larger impact in
samples of incarcerated women. There are several trauma-related factors that might play a role.
For instance, types and number of traumas as well as the severity of the trauma(s) could
differentiate women who benefit from exposure-based PTSD treatments to those who do not.
Psychological disorders and comorbidity may also play a role. Women with multiple traumas
and comorbid conditions might respond less well to a PTSD treatment. Moreover, researchers
have suggested that certain mechanisms such as distress tolerance are likely to differentiate
clients who respond to treatment well versus clients who do not. For instance, Vujanovic, BonnMiller, Potter, Marshall, and Zvolensky (2011) found that distress tolerance accounted for
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additional variance in PTSD symptoms after controlling for number of traumas and negative
emotionality in a sample of adult trauma survivors. Therefore, it is possible that clients with
lower distress tolerance respond less to exposure-based PTSD treatments.
The last set of secondary analyses compared outcomes from the first three groups to the
subsequent five groups to test for potential therapist effects in the current study. The researcher
was one of two group leaders during all eight groups; the second group leader changed after the
third group. Participants in the first three groups reported significantly more anxiety and worry
symptoms at pre-treatment and they reported a greater amount of change in these symptoms from
pre-to post-treatment compared to the subsequent group participants. Although these differences
might be related to the change in one of the therapists, there are other potential confounding
factors that could also have impacted the treatment outcomes.
The differences between the first three groups and the subsequent five groups might be
indicative of other changes made to the group treatment, in addition to or instead of the changes
in therapists. For instance, participants were allowed to repeat the group starting with group
number 4. Having someone repeat the group might have had an impact on the other participants’
experience in the group. The repeaters oftentimes served as role models for the others and could
provide specific examples of how the treatment had helped them and others. Another possible
explanation for the effects is the learning curve of the current researcher who was a group leader
for all eight groups. It is possible that the researcher gained experience from the first three
groups, which had an impact on the treatment process for the subsequent group participants.
Maybe the researcher’s experiences helped decrease the anxiety and worry symptoms of group
participants in the last five groups. Moreover, as more participants successfully completed the
group, other residents at the correctional facility might have been informed from multiple
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sources (e.g., treatment completers, staff) that the group can have a positive impact on past
participants’ difficulties, which also might have had an impact on their anxiety and worry
symptoms.
Findings from the current study add to the larger literature on psychotherapy outcome
research. Below follows a discussion about important aspects associated with conducting
psychotherapy outcome research, as an attempt to put the findings from the current study into a
larger context. Limitations, strengths, and future directions related to the current study will be
considered while discussing psychotherapy outcome research in general.
A. PSYCHOTHERAPY OUTCOME RESEARCH
Several factors are important to consider when conducting psychotherapy outcome
studies. These factors include research on efficacy, effectiveness, specific and non-specific
treatment components, researcher allegiance, empirically supported treatments (ESTs), and
evidence-based practice (EBP).
Efficacy and Effectiveness
The current study evaluated a brief exposure-based group treatment for incarcerated
women, which was designed to fit the prison context and the needs of incarcerated women. The
treatment program was developed based on emotional processing theory (Foa & Kozak, 1986)
and Foa and colleagues’ (Foa et al., 2007; Foa & Rothbaum, 1998) PE treatment. PE is an EST
for PTSD that includes both imaginal and in vivo exposure (Foa et al., 2007; Foa & Rothbaum,
1998). Although PE is considered a “gold standard” treatment for PTSD (Rauch, Eftekhari, &
Ruzek, 2012), few studies have reported on implementing PE in a group format (cf. Castillo et
al., 2012) or implementing group based imaginal exposure (cf. TFGT; Schnurr et al., 2003;
GBET; Ready, Vega, et al., 2012; Mott et al., 2013; Sutherland et al., 2012). Also, to date, no
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published studies have evaluated PE or an exposure-based group treatment (i.e., conducting
imaginal exposure in a group setting) with incarcerated women. Altogether, this means that
research is limited about the implementation of exposure-based treatment in a group setting with
incarcerated women.
ESTs mainly focus on efficacy, which means that they have empirical evidence
supporting their theoretical foundations of why and how the treatment works for a specific
disorder or problem. Therefore, efficacy primarily focuses on internal validity. Effectiveness, on
the other hand, mainly focuses on external validity (e.g., if the treatment can be implemented
successfully in other settings and with other populations and comorbid conditions). The current
study evaluated the effectiveness of implementing an imaginal exposure group treatment with
incarcerated women. However, it could also be considered a first step towards evaluating the
treatment program’s efficacy and feasibility based on Onken and colleagues’ (1997) stage model.
Several models have been developed to determined what should qualify as an EST but
fewer models exist for determining how to reach that goal. The National Institute on Drug Abuse
(NIDA) developed the stage model of behavioral therapies research, which outlines the steps
researchers should take to evaluate the efficacy and effectiveness of behavioral therapies (Onken,
et al., 1997). The model consists of three stages. According to Rounsaville, Carroll, and Onken
(2001) “[s]tage I consists of pilot/feasibility testing, manual writing, training program
development, and adherence/competence measure development for new and untested treatments”
(p. 133). Moreover, Onken and colleagues (1997) describes the first stage as “a multistage,
iterative process consisting of all the preliminary work necessary before a well-designed and
controlled clinical trial…can take place” (p. 481). Onken and colleagues believe the first stage is
an important step to acknowledge so that researchers can apply and receive funding for
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developing ESTs. They also acknowledge that the first stage is costly and time consuming and
that many researchers are unable to proceed beyond this stage without funding support. If
researchers cannot go beyond stage one then the development of ESTs will be limited. Onken
and colleagues (1997) further states that “[p]ilot efficacy testing of newly developed and
modified therapies should be considered an integral part of any therapy development process”
(pp. 481-482). Once there is enough evidence supporting that the treatment is feasible and
appears to have a positive impact on the target symptoms, the researchers can proceed to stage II.
Randomized control trials are used in the second stage to test for treatment efficacy. This
stage also includes research on the mechanisms involved in treatment change and replication of
other researchers’ treatment results. Overall, research in the second stage focuses on internal
validity and why the treatment works. According to Onken and colleagues (1997), “[a]t the end
of Stage II, a manualized therapy for a well-defined population should exist that has been shown,
through at least one controlled clinical trial and a replication, to be efficacious” (p. 483). The
third and final stage focuses on “determin[ing] a therapy’s transferability and usefulness in
community-based…treatment programs” (Onken et al., 1997, p. 483). According to Rounsaville
and colleagues (2001) the focus is on “generalizability..., implementation issues…, cost
effectiveness issues.., and consumer/marketing issues” (p. 134).
Based on Onken and colleagues’ (1997) model, the current study would be a stage I
project with a focus on pilot and feasibility testing. In the current study, Foa and colleagues’ PE
treatment (Foa, et al., 2007; Foa & Rothbaum, 1998) was modified to fit the prison context and
the need of women prisoners. One major change was the reduction in the number of imaginal
exposures per participant. In PE, participants continue their individual imaginal exposure for
several sessions while in the current study participants shared their traumatic memories once.
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They were, however, exposed to other participants’ traumatic memories during sessions 3-7.
According to the stage model, the treatment program continues to be shaped and modified during
stage I, and pilot data is collected on the way. The current study would also meet the more
elaborate criteria outlined by Rounsaville and colleagues (2001) for the first part of stage I (e.g.,
“specify theoretical rationale (theory of the disorder).., specify hypothesized causal chain (theory
of change mechanisms)…, specify procedures for supervising and monitoring performance…,
identify target population (heterogeneity/ homogeneity).., and specify measures,” p. 135) as well
as some components of the second part of stage I (e.g., “demonstrate feasibility/describe
feasibility place (e.g., acceptability, safety)…, specify pilot testing procedures…, specify a priori
hypotheses (outcome, predictors, process, etc.)…, specify analysis plan to test hypotheses” (p.
135).
Rounsaville and colleagues (2001) also point out that some researchers will begin stage I
with a written treatment manual “while others beg[i]n…with only an outline of the treatment
procedures in hand” (p. 136). The current treatment was partially based on the PE manual (Foa,
et al., 2007), most specifically the parts about emotional processing therapy and the rationale for
imaginal exposure. The group leaders used an outline for each session, which continued to be
modified to reflect lessons learned from each group (e.g., how to handle situations in which
someone leaves the room in the middle of an exposure). During the pilot phase, the researchers
try to:
[D]emonstrate…patient acceptance of the new treatment (e.g., retention)…,the
investigators’ ability to recruit sufficient numbers of the target population…, feasibility
of treatment delivery with the proposed types of therapists, patients, and treatment
settings…, clinically significant patient improvement over the course of treatment in at

117

least one important outcome domain, and…the likely effect size to be obtained
contrasting the new treatment with a comparison group to be used to determine the
sample size for a stage II trial. (Rounsaville et al., 2001, p. 137).
In the current study, there was evidence for all the components listed above. In terms of evidence
for feasibility, attrition rates and participants’ report of group alliance could be used as measures
of feasibility in the current study. Twelve participants (20.7%) discontinued the treatment
program for unknown reasons. The participants who completed the treatment (n = 46) reported
higher levels of engagement than avoidance or conflict on the alliance measure, suggesting that
they overall experienced a positive group alliance. Previous studies using the GCQ-S
(MacKenzie, 1983) have shown that the Engaged subscale predicted better treatment outcomes
(e.g., Braaten 1989). However, it is important to note that in the current study the internal
consistency was low for the GCQ-S subscales suggesting that this measure was not a reliable
indicator of group alliance in this sample.
Specific and Non-Specific Components
The consideration of specific and non-specific treatment components is another important
aspect of evaluating psychological treatments. Rosen and Davison (2003) suggested that it would
be more valuable to focus on empirically supported principles of change (ESPs) as opposed to
ESTs. Following their argument, it would be more informative to know that imaginal exposure
and in vivo exposure are ESPs for treating PTSD as opposed to knowing that PE is an EST for
PTSD. With a focus on ESPs instead of ESTs, clinicians and researchers would know what
treatment components work for what specific psychological disorders and problems and why
they work. Rosen and Davison’s (2003) ESPs are related to the research literature on
determining specific and non-specific components of psychological treatments.
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Non-specific treatment components are “elements of treatment that are shared across
virtually all therapeutic intervention” such as “a healing setting, education, a treatment rationale,
expectations of improvement, a treatment ritual, and the therapeutic relationship” (DeRubeis,
Brotman, & Gibbons, 2005, p. 174). Specific treatment components, on the other hand, are the
therapeutic techniques designed to target underlying features and mechanisms that are theorized
to maintain the psychological disorder, symptoms, or problems (e.g., Borkovec & Castonguay,
1998).
There are several different types of non-specific factors. One is therapist effects, which is
the therapist’s impact on treatment outcomes. One meta-analysis of treatment outcome studies
has found that therapist effects accounted for 8.6% of the variance in treatment outcomes (CritsChristoph et al., 1991). In a study implementing CPT for PTSD among veterans, the researchers
found that therapist effects accounted for 12% of the variance in treatment outcomes (Laska,
Wislocki, Minami, Smith, & Wampold, 2013). Several hypotheses exist in terms of what
therapist characteristics could account for these effects. Anderson, Ogles, Patterson, Lambert,
and Vermeersch (2009) found that therapists’ ability to facilitate interpersonal skills significantly
predicted treatment outcomes. Examples of facilitative interpersonal skills were the therapists’
“verbal fluency, emotional expression, persuasiveness, hopefulness, warmth, empathy, alliancebond capacity, and problem focus” (p. 759). They included 32 therapists and 1,141 clients at a
college-based counseling center in their study.
Therapist effects include therapeutic alliance, which has also been found to be associated
with treatment outcomes. Therapeutic alliance has been defined as “the collaborative bond
between the therapist and patient” (DeRubeis et al., 2005, p. 178). Meta-analyses have found that
alliance accounts for 5% of the variance in clinical trials (e.g., Horvath & Bedi, 2002).
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Furthermore, studies have shown that this relationship appears unaffected by differences in study
methodologies, types of treatments (CBT vs. non-CBT) implemented, primary diagnosis treated,
and clients’ comorbidity (Fluckiger, Del Re, Wampold, Symonds, & Horvath, 2012;
McLaughlin, Keller, Feeny, Youngstrom, & Zoellner, 2013). According to DeRubeis and
colleagues (2005) there are four different ways that the therapeutic alliance can impact treatment
outcomes. One is the therapist’s ability to form positive working relationships with patients. The
second is the patient’s ability to form a positive working relationship with the therapist. Third is
the interaction between the therapist and the client, and fourth is symptom reduction. Although
several studies have found that there is a significant relation between therapeutic alliance and
symptom reduction, the temporal order of these variables are debated.
In response to DeRubeis and colleagues’ (2005) suggestions for factors impacting the
relationship between alliance and treatment outcomes, Baldwin, Wampold, and Imel (2007)
analyzed data from a larger study involving 45 different college-based counseling centers (N =
80 therapists and 331 clients). They found that some therapists appear to be better at forming
stronger alliances with their patients (i.e., between therapist effects), who consequently also
report better treatment outcomes. They found less support for differences among patients (i.e.,
within therapist effects) and no support for an interaction between therapists and patients. These
results suggest that it is mainly the therapists and not the patients who account for differences in
the therapeutic alliance and treatment outcomes. Because the researchers found a difference
between the within-and between-therapist effects, they concluded that the positive association
between the therapeutic alliance and treatment outcomes is not only due to symptom reductions.
That is, the therapeutic alliance is not purely a result of symptom reduction.
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Barber, Connolly, Crits-Christoph, Gladis, & Siqueland (2009) further elaborated on the
relationship between therapeutic alliance and clinical outcomes in a sample of 88 male and
female outpatient clients who received 16-52 sessions of manualized supportive-expressive
dynamic therapy for depression, GAD, or avoidant-or obsessive-compulsive personality disorder.
The treatment was implemented by 15 therapists with psychodynamic training. Barber and
colleagues found that early reduction in depressive symptoms predicted stronger therapeutic
alliance. However, therapeutic alliance throughout treatment also predicted greater reduction in
depression symptoms. This would suggest that patients with early symptom reduction might
experience stronger therapeutic alliance, which predicts additional treatment gains. Yet another
study found that greater therapeutic alliance predicted a decreased risk for depression relapse one
year after completing a 16-session CBT treatment for depression (N = 80 clients; Weck et al.,
2013).
Few studies have investigated the role of therapeutic alliance in PTSD treatment
outcomes. Importantly though, these studies have shown a positive relationship between
therapeutic alliance and PTSD treatment outcomes. Cloitre, Stovall-McClough, Miranda, and
Chemtob (2004) found that clients with higher alliance ratings earlier in the treatment process
reported better treatment outcomes when participating in a CBT treatment for CSA related
PTSD. Two publications from another research group (Keller, Zoellner, & Feeny, 2010;
McLaughlin et al., 2013) investigated the role of alliance in clients assigned to either receiving
PE (Foa et al., 2007; Foa & Rothbaum, 1998) or medication (i.e., sertraline) for treating PTSD.
McLaughlin and colleagues (2013) reported on results from 116 participants who were randomly
assigned to the PE treatment. They found a positive relationship between alliance and PE
outcomes, which was equally effective for participants with and without comorbid depression
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and/or CSA histories. Participants who were randomly assigned to PE reported a stronger
alliance than participants randomly assigned to take medication (N = 188; Keller et al., 2010).
McLaughlin and colleagues (2013) also found that 46% of the PE participants experienced a
rupture in their alliance during the treatment process (e.g., “a significant drop in the therapeutic
alliance,” p. 6), and that clients with repaired ruptures had better treatment outcomes than those
with unrepaired ruptures. Of note, participants with no rupture also showed a positive association
between alliance and outcomes. Importantly, these findings suggest that there is no negative
impact of exposure therapy for PTSD on the therapeutic alliance, and that building a strong
therapeutic alliance with clients is important when implementing any psychological treatment.
Since studies have shown that psychotherapy outcomes are at least partly due to nonspecific treatment components (Crits-Christoph et al., 1991; Horvath & Bedi, 2002; Laska et al.,
2013), it is important to consider the possibility of such effects in the current study. Although the
research methodology used in the current study limits the ability to determine non-specific
treatment effects, some of the results might be relevant. Overall, participants reported a positive
group alliance, with higher scores on the Engaged subscale compared to the other two subscales
(i.e., Conflict and Avoiding; GCQ-S, MacKenzie, 1983). The Engaged subscale has been shown
to positively predict treatment outcomes (e.g., Braaten 1989). Therefore, it is possible that nonspecific treatment components such as group alliance accounted for some of the outcomes in the
current study. Exploratory analyses using zero-order correlations between the three group
alliance subscales and treatment outcomes showed significant negative associations between the
engagement subscale and depression sum score and number of depressive symptoms at posttreatment. This suggests that greater engagement in the treatment was associated with fewer
depressive symptoms and less symptom severity at post-treatment. There were also significant
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positive correlations between the conflict subscale and depression symptoms, anxiety/worry
symptoms, and trauma-related cognitions at post-treatment. Higher levels of conflict were
associated with more symptoms at post-treatment. There were no significant correlations
between the group alliance subscales and the change scores (i.e., post-treatment score subtracted
from pre-treatment score). Although these preliminary findings might indicate that treatment
outcomes from the current study were partly accounted for by non-specific treatment
components such as group alliance, it is important to note that the internal consistency was low
for the GCQ-S subscales suggesting that this measure was not a reliable indicator of group
alliance in this sample.
Specific treatment effects are also important when evaluating psychotherapy. Borkovec
and Castonguay (1998) suggested a stepwise approach to determine a treatment’s efficacy and
specific components. The first step is to conduct a small n or pilot study. Next the treatment
should be compared to several different types of control groups. The treatment should first be
compared to a wait-list control, then to an attention control, a non-specific control, a component
control (e.g., dismantling design), and lastly to a standard treatment (e.g., an EST). Borkovec
(1993) questioned the validity of comparing two treatments. When researchers find outcome
differences between two treatments, it is difficult to know what to attribute them to since the
treatments differ in many ways (e.g., theoretically, therapeutic techniques). To make valid
comparisons between two groups, researchers need to hold one of the groups constant, but since
both treatments vary on multiple levels it is difficult to make valid comparisons (Borkovec,
1993).
The current study would be considered a pilot study. Due to the limited data on group
based exposure therapy with incarcerated women, the first step would be to conduct a small n or
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a pilot study (Borkovec & Castonguay, 1998). To continue to determine the efficacy of the
current group treatment, the next step would be to compare it to a control group (Borkovec &
Castonguay, 1998). There are many different types of control group and they serve different
purposes. Since the participants in the current study received the treatment program in addition
to other psychological services (e.g., counseling, AA), the most appropriate control group might
be comparing the effects of the current group treatment in combination with treatment as usual
versus receiving treatment as usual only (Rounsaville et al., 2001).
Several researchers have attempted to determine specific and non-specific treatment
components for various types of psychotherapies. Some researchers argue that psychological
treatments are equally effective (e.g., Luborsky, Singer, & Luborsky, 1975), and that the
majority of the treatment outcome effect size can be accounted for by non-specific treatment
components (e.g., Eysenck, 1994). Others have argued that some treatments are more effective
than others. For instance, Smith, Glass, and Miller (1980) found that CBTs had greater effect
sizes than non-CBTs. Tolin (2010) also found that CBT had greater effect sizes than non-CBT
(e.g., psychodynamic treatments), especially for treating disorders related to depression and
anxiety. Similar debates exist in the field of PTSD treatment outcome studies.
Some researchers have concluded that there are few if any differences between PTSD
treatments. Bradley, Greene, Russ, Dutra, and Westen (2005) conducted a meta-analysis of 26
RCTs for PTSD. They found that PTSD treatments (e.g., CBT, behavioral therapy, and EMDR)
were more efficacious than wait-list control and support groups. They found no differences
between the PTSD treatments. Another meta-analysis by Benish, Imel, and Wampold (2008)
included 17 studies comparing two or more bona fide treatments for adult with PTSD. They
found few differences between treatments and concluded that “specific ingredients may not be
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critical for the treatment of PTSD” (p. 754). However, Ehlers and colleagues (2010) were
skeptical of Benish and colleagues’ conclusions. They suggested that Benish and colleagues’
selection of studies for their meta-analysis was biased and that a more appropriate conclusion
would have been that “different forms of trauma-focused psychological treatments have similar
effects” (p. 272), which is not a new finding. Powers, Halpern, Ferenschak, Gillihan, and Foa
(2010) compared PE to other treatments (e.g., CPT, EMDR, cognitive therapy, CT, and stress
inoculation therapy, SIT) in their meta-analysis and did not find any differences between the
treatments.
Nevertheless, some researchers have argued for specific effects within PTSD treatments
showing that some treatments are more effective than others. Bisson and colleagues (2007)
reported on a meta-analysis with 38 RCTs for PTSD. They found that trauma focused CBT
(TFCBT) and EMDR outperformed wait-list and control groups. Although they found few
differences between TFCBT and EMDR they concluded that the evidence was not as strong for
EMDR as for TFCBT. They found some evidence in favor of stress management therapy and
group TFCBT compared to control groups. However, they did not find any support for the nontrauma focused therapies, which included “supportive/non-directive therapy, psychodynamic
therapies and hypnotherapies” (p. 101). Bisson and colleagues’ result would suggest that there
are specific effects in PTSD treatments. According to their meta-analysis, treatments that
included a focus on the clients’ trauma memories and the personal meanings associated with the
trauma are more effective than those without these components. It is possible that Powers and
colleagues (2010) did not find any differences between PE and the other treatments because all
treatments were trauma-focused. Another meta-analysis of 112 RCTs of PTSD treatments found
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the largest effect sizes for CBT and EMDR (Watts et al., 2013). The effect size for CBT groups
was not significant.
The research methodology used for the current study limits the ability to determine any
specific treatment effects. Although specific treatment effects cannot be determined from the
current study, results showed that participants who completed both pre-and post-treatment
assessments attended significantly more sessions and they reported significantly less maladaptive
cognitions at post-treatment compared to the other treatment completers. Previous research has
shown that changes in maladaptive trauma-related cognitions are associated with reductions in
PTSD symptoms (Foa & Rauch, 2004). It is therefore possible that the current treatment was
able to specifically target PTSD and cognitions maintaining PTSD. More research is needed to
determine specific treatment components in the current group treatment. In addition to
considering research about efficacy, effectiveness, and specific and non-specific treatment
components, researcher allegiance is another factor that appears to be associated with treatment
outcomes and will therefore be discussed next.
Researcher Allegiance
Researcher allegiance is another factor that is associated with treatment outcomes
(Gaffan, Tsaousis, & Kemp-Wheeler, 1995; Luborsky et al., 1999, 2002; Munder, Fluckiger,
Gerger, Wampold, & Barth, 2012; Munder, Brutsch, Leonhart, Gerger, & Barth, 2013, Tolin,
2010). Allegiance can be defined as “the preference that authors apparently hold for one therapy
over others” (Gaffan et al., 1995, p. 966). Munder and colleagues (2013) conducted a meta-metaanalysis of 30 previously published meta-analyses exploring the link between allegiance and
treatment outcome. They found a moderate effect size that was unaffected by a range of
moderators (e.g., treatment formats, age group, defined or undefined populations, weighted or
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unweighted meta-analysis, assessment of allegiance, publication year). In a meta-analysis of
trauma-focused treatments (n = 20), Munder and colleagues (2012) found that allegiance
explained 12% of the variance in treatment outcomes.
In Gaffan and colleagues’ (1995) meta-analysis they found that CT for depression
outperformed control groups, other psychotherapy, and medication. Allegiance accounted for a
significant amount of variance in treatment outcomes among the earlier studies (n = 28; 19761987) but not for the more recent studies (n = 37, 1987-1994). The authors suggested that the
researchers in the more recent studies were further removed from the original developers of CT
(Beck, 1979) and therefore allegiance was no longer a significant factor. Importantly, even after
accounting for the allegiance effect in the earlier studies, CT still outperformed the other groups.
In Luborsky and colleagues’ (1999) study they found that positive allegiance had a
stronger association with treatment outcomes than negative allegiance. Moreover, Fluckiger and
colleagues (2012) found that allegiance moderated the relationship between therapeutic alliance
and clinical outcomes early in the treatment process such that research studies with higher
allegiance had a stronger alliance-treatment outcome association. However, later in the treatment
process allegiance did not impact this relationship. Importantly, studies with low allegiance still
showed a significant association between alliance and treatment outcomes. They included 201
published articles in their meta-analysis.
Some researchers suggest that allegiance should be controlled for in psychotherapy
outcomes studies (Luborsky et al., 1999, 2002). Others are more skeptical. Leykin and DeRubeis
(2009), for instance, caution researchers when interpreting the current research evidence linking
allegiance to treatment outcomes. They emphasize that researchers have found an association
between allegiance and treatment outcomes, which does not necessarily indicate a bias that needs
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to be controlled for when doing treatment outcome research. They state that an alternative
explanation is that allegiance to a treatment develops over time because the treatment is superior
to other treatments. It is also possible that the allegiance-outcome association is related to the
researchers being better at implementing the treatment than researchers with no or little
allegiance.
Researcher allegiance is not a particularly important factor to consider in the current
study. Although it is possible that researcher allegiance impacted the treatment outcomes, the
current researcher is not closely connected to the developers of exposure therapy for PTSD (Foa
et al., 2007; Foa & Rothbaum, 1998). This argument would be supported by Gaffan and
colleagues’ (1995) study in which they found that the relationship between allegiance and
treatment outcomes was not significant for studies published by researchers further removed
from the original therapy developer. However, since the current researcher developed the group
treatment believing it would be effective in reducing symptoms associated with the sexual
sequelae, it is still possible that researcher allegiance accounted in part for treatment outcomes.
The researcher based those beliefs on previous research supporting exposure therapy as a
treatment for PTSD (Foa et al., 2007; Foa & Rothbaum, 1998).
So far several important factors associated with psychotherapy outcome research have
been discussed. This discussion will continue with a focus on empirically supported treatments
and evidence-based practice.
ESTs and EBP
ESTs are related to evidence-based practice (EBP). APA (APA Presidential Task Force
on Evidence-Based Practice; 2006) has defined EBP in psychology (EBPP) as “the integration of
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the best available research with clinical expertise in the context of patient characteristics, culture,
and preferences” (p. 273). According to APA:
ESTs start with a treatment and ask whether it works for a certain disorder or problem
under specified circumstances. EBPP starts with the patient and asks what research
evidence (including relevant results from RCTs) will assist the psychologist in achieving
the best outcome. In addition, ESTs are specific psychological treatments that have been
shown to be efficacious in controlled clinical trials, whereas EBPP encompasses a
broader range of clinical activities (e.g., psychological assessment, case formulation,
therapy relationships). As such, EBPP articulates a decision-making process for
integrating multiple streams of research evidence—including but not limited to RCTs—
into the intervention process (p. 273).
According to APA (2006) “[t]he purpose of EBPP is to promote effective psychological practice
and enhance public health by applying empirically supported principles of psychological
assessment, case formulation, therapeutic relationship, and intervention” (p. 280). Spring (2007)
states that “EBP ranges along a spectrum from top-down, normative guidelines to bottom-up,
idiographic decision-making principles” (p. 611). Nomothetic approaches include practice and
policy guidelines as well as ESTs while idiographic approaches include individual clinical
decision-making. APA’s (2006) publication about EBP appears to mainly refer to the latter part.
EBP consists of three components: best available research evidence, clinical expertise,
and patient characteristics (APA, 2006; Spring, 2007). The first component, best available
research evidence, “refers to scientific results related to intervention strategies, assessment,
clinical problems, and patient populations in laboratory and field settings as well as to clinically
relevant results of basic research in psychology and related fields” (APA, 2006, p. 274).
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According to APA, psychologists need to consider and evaluate multiple types of research
evidence (e.g., internal and external validity, study design), and they should recognize that what
constitutes best available research evidence depends on the question they are trying to answer.
The second component, clinical expertise, “refers to competence attained by psychologists
through education, training, and experience that results in effective practice” (APA, 2006, p.
275). Psychologists are scientist-practitioners, which means that they integrate the science with
their clinical work. In other words, they use science to inform their clinical practice and they use
their clinical practice to inform their scientific endeavors. APA suggests psychologists should be
aware of the limits to their clinical expertise and use “[m]echanisms such as consultation and
systematic feedback from the patient” to decrease “biases” (p. 276). APA also suggests that
clinical expertise affects all areas of clinical work (e.g., assessment, case conceptualization,
treatment planning and implementation) and that it “develops from clinical and scientific
training, theoretical understanding, experience, self-reflection, knowledge of research, and
continuing professional education and training” (p. 275). The third component, patient
characteristics, refers broadly to patients’ values, characteristics, preferences, and circumstances
(Spring, 2007). According to Spring (2007), this is the least developed component of EBP. The
basic idea is for psychologists to share the health decisions with their patients in order “to engage
patients more fully in self-management of their own wellness and health care” (Spring, 2007, p.
614). Part of this process is for psychologists “to respect and help patients clarify their own
values and treatment preferences” (p. 614). According to APA (2006), patient characteristics
includes “variations in presenting problems or disorders, etiology, concurrent symptoms or
syndromes, and behavior…chronological age, developmental status, developmental history, and
life stage…sociocultural and familial factors (e.g., gender, gender identity, ethnicity, race, social
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class, religion, disability status, family structure, sexual orientation)…current environmental
context, stressors (e.g., unemployment, recent life event), and social factors (e.g., institutional
racism, health care disparities)…and…personal preferences, values, and preferences related to
treatment (e.g., goals, beliefs, worldviews, treatment expectations)” (p. 279).
The current study could be evaluated in the context of EBP. PE (Foa et al., 2007; Foa &
Rothbaum, 1998) has been established as an EST for PTSD, but, more importantly, numerous
efficacy and effectiveness studies have contributed to researchers referring to PE as the “gold
standard” treatment for PTSD (Rauch et al., 2012). Therefore, the best available research
evidence (e.g., one component of EBP) suggests that psychologists use PE to treat clients with
PTSD. Although, the researcher could have implemented and evaluated PE in the current study,
the decision was made to develop a brief exposure-based group treatment to take into account the
specific contextual factors affecting incarcerated women. The treatment program, while based on
emotion processing theory (Foa & Kozak, 1986) and the research on PE techniques (Foa et al.,
2007; Foa & Rothbaum, 1998), differed in important ways (e.g., no in vivo exposure, no between
session assignments, one imaginal exposure per client). The decision to design the current
treatment program with modifications instead of implementing PE can be understood in the
context of EBP. Considering the other two components of EBP (e.g., clinical expertise and
patient characteristics), it might be important to make some modifications to ESTs for PTSD
when implementing these kind of treatments in correctional facilities for women. As previously
discussed, the prison setting creates some challenges to implementing ESTs such as PE. These
challenges include residents’ limited privacy and autonomy, which could negatively affect
important aspects of PE (e.g., completing between session exposure exercises). It might also
limit the number of imaginal exposure sessions per client. Moreover, incarcerated women share
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many characteristics, which might be important to consider when implementing a trauma
treatment in correctional facilities. The shared characteristics include: low SES, social isolation,
single parenthood, high trauma exposure, and a range of health issues (e.g., Bloom et al., 2004;
Haywood et al., 2000; Lewis, 2006). Additionally, they report high rates of sexual victimization,
especially CSA (Abrams et al., 2008; Browne et al., 1999; Cook et al., 2005; Martin &
Hesselbrock, 2001; McDaniels-Wilson & Belknap, 2008; Mullings et al., 2000, 2003; Raj et al.,
2008; Wolff et al., 2010, 2011). Because of their shared characteristics and the potential benefits
of group treatment for traumatized individuals (Mott et al., 2013; Sloan et al., 2012), the current
treatment project was designed to be implemented in a group setting. Altogether, considering the
best available research evidence (e.g., exposure treatment) and patient characteristics (e.g.,
prison setting, needs and characteristics of incarcerated women), the researcher used her clinical
expertise in combination with the research evidence when deciding to design a brief group
treatment for incarcerated women with histories of sexual victimization.
B. LIMITATIONS
There are several limitations with the current study. Some of these limitations have
already been discussed and will now be summarized. Others have not previously been considered
and will therefore be described in more detail. The first set of limitations refers to the sample.
The sample is relatively small and homogenous. The majority of participants were Caucasian
women and they were all convicted of non-violent felonies. Although the majority of women
prisoners are convicted of non-violent felonies (approximately 65%; Carson & Golinelli, 2013),
there might be other characteristics of the current sample and the community correction facility
in which the study took place that affected the results. Overall, this would limit the
generalizability of the findings. There also might be geographical differences as well as other
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unique features of the current correctional facility that affected the treatment outcomes. For
instance, the current correctional facility offers a range of rehabilitation programs (e.g., AA).
Future studies could benefit from implementing the group treatment with ethnically diverse
samples of incarcerated women who are convicted of a variety of crimes. Future studies could
also benefit from including different geographical locations and facilities.
The measures used in the current study to assess symptomatic characteristics of PTSD,
depression, and anxiety/worry were brief, and, therefore included only a small number of
psychological symptoms. It is possible that certain PTSD, depression, and anxiety/worry
symptoms were not measured, which could have affected the interpretation of the results.
Moreover, the PTSD measure (i.e., PC-PTSD; Prins et al., 2003) only included four items with
dichotomous answer options. It would be important for future studies to include a measure with a
greater range of PTSD symptoms and with answer options indicating symptoms severity. This
would make it possible to investigate changes in symptom severity and to calculate RCI scores
(Jacobsen & Truax, 1991). For instance, future studies could include the PTSD Checklist (PCL;
Weathers et al., 1993) or the PDS (Foa et al., 1997).
Another limitation to the measures used in the current study is the absence of an
assessment of participants’ trauma histories. In the current study, participants self-identified as
being victims of sexual violence and experiencing some difficulties related to their victimization.
However, previous research shows that the majority of incarcerated women have been exposed
to multiple traumas (Cook et al., 2005; Green et al., 2005; Wolff et al., 2011; Zlotnick, 1997).
Therefore, it is possible that other traumas, besides the sexual violence, have impacted
participants’ symptoms and overall functioning. Future studies should incorporate an assessment
of participants’ trauma histories including information about types and number of traumas.
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Moreover, test-retest correlation coefficients for the RCI calculations (Jacobsen & Truax,
1991) were used from previous studies. Both studies used primary care samples, and one of them
included a large sample of patients (N = 212, Garcia-Campayo et al., 2012; N = 6,000, Kroenke
et al., 2001). Garcia-Campayo and colleagues’ sample was from Spain and the GAD-2 had been
translated into Spanish. Therefore, the test-retest correlation coefficients used in the current study
might not be a valid measure of test-retest reliability for the current sample mainly because the
other studies used larger, non-forensic samples, and in one case, a Spanish speaking sample.
Although a test-retest correlation coefficient could have been calculated from the current study
(correlating pre-and post-treatment scores) it would have been problematic as the treatment
program was expected to reduce the scores from pre-to post-treatment. Therefore, even though
there were limitations to the test-retest correlation coefficients used in the current study, they
were a more valid alternative than calculating these coefficients by correlating pre-and posttreatment scores from the current study. Future studies could benefit from evaluating
psychometric properties of measures assessing psychological symptoms in samples of
incarcerated women.
Another limitation with the current study is the absence of a control group. The current
study investigated reductions in symptoms from pre-to post-treatment without including a
control group, such as TAU. This limits the conclusions that can be drawn from the treatment
outcomes and it might impact the validity of the study. Comparing the results to a control group
would control for factors that could have an impact on the treatment outcomes such as passage of
time (e.g., symptom reduction could be an effect of time as opposed to the treatment itself) or
other events outside of the treatment. There might have been other events or situations at the
correctional facility that impacted the treatment outcomes such as participating in other groups or

134

receiving counseling or medical treatment. However, at this stage of treatment evaluation, it is
common and appropriate to utilize a pre-to post-treatment change in participants without a
control group (Onken et al., 1997).
Moreover, as described previously when discussing the results comparing the first three
groups to the other five groups, there were several potential confounding factors that might have
impacted the results. These factors could have impacted the treatment outcomes in general and
not just analyses comparing the first three groups to the subsequent five. Participants who
repeated the treatment a second time might have had an impact on the treatment outcome. Their
presence and potential function as a role model for the other treatment participants might have
impacted the outcomes. Treatment completers and staff at the correctional facility might also
have positively impacted the treatment outcomes by encouraging new participants to join the
group and by informing them of the positive effects the group treatment has had on other
women. Although these are possible confounds, it is unlikely that they completely explain the
results from the current study. Preliminary findings from the first four groups showed significant
reductions in PTSD, depression, and anxiety/worry with large effect sizes (Karlsson et al., in
press). Approximately 60% of the sample had recovered on the PTSD, depression, and/or
anxiety/worry measure (e.g., above the clinical cutoff at pre-treatment but below at posttreatment). These preliminary findings were prior to including repeaters in the groups.
Importantly, in the current study the active components of the treatment (e.g., exposure
therapy) are assumed to be related to the positive treatment outcomes. However, it is possible
that other treatment factors might explain the outcomes. Several non-specific factors might have
impacted the results. For instance, as previously discussed, factors such as therapist effects (e.g.,
Crits-Christoph et al., 1991) and therapeutic alliance have been shown to influence treatment
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outcomes. It is also possible that the support participants received from the group leaders and
each other have impacted the treatment outcomes. Although, it is possible that these non-specific
factors explain the results, several studies have shown that exposure therapy is an efficacious
treatment component for targeting PTSD symptoms and other trauma-related outcomes (e.g., Foa
et al., 2007). Therefore, it is probably more likely that exposure therapy accounted for most of
the variance in the treatment outcomes in the current study and that non-specific factors
accounted for additional, but a smaller part, of the variance. Future studies would benefit from
determining specific treatment effects in samples of incarcerated women (see discussion below
for more details).
Moreover, although the results from the current study show significant reductions in a
range of symptoms and cognitions from pre-to post-treatment and some indication that these
changes can be maintained 3-6 months after treatment, it will be important for future studies to
collect additional follow-up data. At this point it is unclear how well participants would be able
to maintain their treatment gains after completing the group and after leaving the correctional
facility. Unfortunately this is a common limitation with treatment outcome studies. More
research is needed to determine long-term outcomes.
Lastly, 1 in 5 women who signed up for the treatment program did not complete it.
Although this attrition rate is similar to other studies (Imel et al., 2013), it suggests that exposure
therapy is not for everyone who endorses sexual assault experiences. Additionally, not all
treatment completers showed clinically meaningful change (e.g., improvement and recovery
rates). This would further suggest that this type of therapy is not effective for all clients with
sexual abuse histories. More research is needed to understand why some clients benefit from
exposure therapy while others do not. In samples of incarcerated women, it might be beneficial
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to consider trauma chronicity (e.g., number and types of traumas, duration and severity of
traumas) and comorbidity. It might also be beneficial to consider mechanisms such as distress
tolerance (e.g., Vujanovic et al., 2011).
C. FUTURE DIRECTIONS
Some future directions for treatment studies in samples of incarcerated women and
follow-up to the current treatment program have already been discussed. These considerations
will be summarized at this point and some additional suggestions will be shared. First, future
studies could benefit from including a diverse sample of incarcerated women from different
correctional facilities and regions. Moreover, in the current sample non-completers were
significantly younger and had fewer children than the completers. They were also significantly
more depressed at pre-treatment. Therefore, future studies could benefit from exploring ways to
maintain clients with these characteristics in the treatment program and/or explore if they could
benefit from a different type of treatment altogether. For instance, if depression were the primary
diagnosis, then maybe they would benefit from a depression treatment such as cognitive therapy
(Beck, 1976) or interpersonal psychotherapy (Weissman, Markowitz, & Klerman, 2000). There
might also be additional differences between completers and non-completers that were not
assessed in the current study. For instance, trauma histories and comorbid conditions might
differ. There might also be differences in distress tolerance (e.g., Vujanovic et al., 2011).
Because there were several limitations to the measures used in the current study, future
studies could benefit from expanding the number of symptoms measured as well as including a
PTSD measure with severity ratings. In addition to good psychometrics, the measures used in the
current study were selected with considerations of brevity and reading level. This choice was
made primarily to limit the burden on participants. Future studies could benefit from conducting
137

more comprehensive assessments of participants’ trauma histories and psychological symptoms
and diagnoses. More comprehensive assessments would potentially allow for better
understanding of how client characteristics are associated with treatment outcomes. Moreover,
the group alliance measure used in the current study (GCQ-S; MacKenzie, 1983) was potentially
not a valid indicator of alliance (e.g., low internal consistency). Future studies should explore
other measures of group alliance and their relationship to treatment outcomes in samples of
incarcerated women.
Future studies could also benefit from including a follow-up period to assess for
maintenance of treatment gains or any additional treatment gains. Although follow-up data was
collected in the current study, the sample was small. Future studies would benefit from strategic
planning to collect follow-up data from all participants if possible. Furthermore, future studies
would benefit from putting in place plans to collect data after participants leave the correctional
facility. It would also be important to work with the agency to determine if there are ways to gain
access to recidivism rates in order to compare if difference exist in re-offending between women
who have and have not completed treatment.
More research is needed to determine efficacy and effectiveness of the current group
treatment. Using Onken and colleagues’ (1997) model, the next steps would be to write a
treatment manual, incorporate treatment adherence and competence measures, and conduct an
RCT. For the RCT, participants would be randomly assigned to either the treatment program or a
control group. Conducting an RCT would increase internal validity, which would allow
researchers to better determine causation (e.g., if the treatment program is responsible for the
symptom reductions). Since the women in the current study are already receiving treatment at the
correctional facility (e.g., AA, counseling), it might make most sense to compare the current
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treatment protocol to TAU (e.g., exposure therapy plus TAU vs. TAU; Rounsaville et al., 2001).
This would answer the question of whether or not the exposure group treatment would add
anything to the treatment already provided. Another important step would be to determine
specific treatment effects. According to Borkovec and Castonguay’s (1998) procedures, the
group treatment should be compared to a wait-list control, then to an attention control, a nonspecific control, a component control (e.g., dismantling design), and lastly to a standard
treatment (e.g., an EST). The dismantling study would be especially important in order to
determine specific treatment effects. The current researcher would suggest to first compare the
current treatment to TAU, then to a non-specific control (e.g., psychoeducation group), a
component control study, and lastly an EST.
There are some additional questions related to efficacy and effectiveness that are
important to consider when evaluating trauma-specific group treatments as well as treatments
with incarcerated women. One would be to compare the current group treatment to individual
treatment. To date, studies suggest that individual exposure treatment is more effective than
group exposure treatment (e.g., Sloan et al., 2013). However, this research is limited and to date
few studies have explored treatment outcomes that might be specifically relevant to group
treatments as opposed to individual treatments (cf. Mott et al., 2013). Therefore, future studies
could benefit from comparing outcome for PTSD group treatments to individual treatments
beyond symptom change. Examples would be social support, normalization of trauma reactions,
trust, and safety (Sloan et al., 2012).
Another important question related to efficacy and effectiveness would be comparing
different models for treating comorbid PTSD. Although researchers have argued in favor of
using integrated treatments for comorbid PTSD and SUDs, the research is limited (Torchalla et
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al., 2012). Moreover, these treatments are oftentimes resource intensive (e.g., Zlotnick et al.,
2003). Few studies have evaluated sequential and parallel models for treating comorbid PTSD
and SUDs (cf., Berenz et al., 2012; Ouimette et al., 2003). Interestingly, no studies to date have
evaluated PTSD-SUDs treatment outcomes from implementing a PTSD treatment despite the
fact that studies have shown that PTSD oftentimes precedes SUDs (Back et al., 2005; Kessler,
2000; Ouimette et al., 2010), reductions in PTSD symptoms is associated with reductions in
SUDs but not vice versa (e.g., Brown, 2000), and clients with comorbid PTSD-SUDs report
better treatment outcomes after receiving PTSD treatment following a SUDs treatment (Ouimette
et al., 2003). If PTSD treatments could target comorbid PTSD-SUDs, then this could be a more
effective way of treating comorbidity (e.g., less resources needed).
D. CONCLUSIONS
Although men are more likely to be imprisoned than women (Carson & Golinelli, 2013),
since the 1980s, the rate of female prisoners has increased more rapidly than the rate of male
prisoners (Frost et al., 2006). Several researchers have debated the issue of whether this increase
in incarceration of women can best be explained by the war on drugs (e.g., Bloom et al., 2004;
Frost et al., 2006). More importantly, pathways to prison differ by men and women. Sexual
victimization has been described as a pathway to prison for women (Belknap, 2007; Bloom et al.,
2004; Browne et al., 1999, Cole et al., 2007; Salisbury & Van Voorhis, 2009; van Wormer &
Kaplan, 2006). Incarcerated women are disproportionally affected by sexual victimization,
especially CSA (Abrams et al., 2008; Browne et al., 1999; Cook et al., 2005; Martin &
Hesselbrock, 2001; McDaniels-Wilson & Belknap, 2008; Mullings et al., 2000, 2003; Raj et al.,
2008; Wolff et al., 2010, 2011). They report higher rates of sexual victimization than
incarcerated men (Clark et al., 2012; Langan & Pelissier, 2001; McClellan et al., 1997; Wolff et
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al., 2009) and than community samples of women (Severson et al., 2005; Tusher & Cook, 2010).
They are also at high risk for sexual re-victimization both inside (Beck & Johnson, 2012; Wolff
et al., 2008) and outside of prison (Severson et al., 2005; Walsh et al., 2011). Moreover,
incarcerated women are disproportionally affected by physical (Abrams et al., 2008; Kane &
DiBartolo, 2002; Nijhawan et al., 2010; Richie & Johnsen, 1996) and mental health problems
(Blitz et al., 2005; Cloyes et al., 2010; Jordan et al., 1996; Teplin et al., 1996; Trestman et al.,
2007), which are oftentimes associated with the sexual sequelae (Chen et al., 2010; Hillberg et
al., 2011). Although women’s pathway to prison is likely complex, researchers have suggested
that sexual victimization oftentimes precedes problems with substance use, violent relationships,
and prostitution, which can lead to issues with the legal system (Belknap, 2007; Bloom et al.,
2004; Browne et al., 1999; Cole et al., 2007; Grella et al., 2005; Jordan et al., 1996; Salisbury &
Van Voorhis, 2009; van Wormer & Kaplan, 2006). Despite the high rates of sexual victimization
and mental health issues, and their possible connection to women’s imprisonment, few studies
have evaluated psychological treatments targeting these issues in correctional populations.
Most treatment programs in correctional facilities have been developed for men, and
therefore researchers have argued that there is a need for gender specific, sensitive, and
responsive treatments for incarcerated women (Blackburn et al., 2008; Bloom et al., 2004;
Grella, 2008; Lewis, 2006; Mullings et al., 2003; van Wormer & Kaplan, 2006), including
trauma-focused treatments. Some researchers have evaluated trauma treatments with incarcerated
women (Bradley & Follingstad, 2003; Cole et al., 2007; Ford et al., 2013; Kubiak et al., 2012;
Lynch et al., 2012; Paquin et al., 2013; Roe-Sepowitz et al., 2014; Wolff et al., 2012; Zlotnick et
al., 2003, 2009), with mixed results and several limitations. The majority of these treatments
have been resource-intensive (cf. Ford et al., 2013) and lack an exposure component (cf. Bradley
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& Follingstad, 2003; Cole et al., 2007), despite research supporting exposure’s efficacy (Foa et
al., 2007). None of these studies included group-based exposure. Moreover, few studies provided
any information about clinical significance (e.g., changes in diagnostic profiles, magnitude of
symptom change, improved functioning).
The current group was developed based on the conceptual foundation of emotional
processing theory (Foa & Kozak, 1986) and Foa and colleagues’ PE treatment (Foa et al., 2007;
Foa & Rothbaum, 1998). The group treatment was developed specifically to consider adaptations
based on the prison context (e.g., limited privacy and autonomy) and the needs of incarcerated
women. It was designed to be brief (eight sessions) and to specifically target PTSD and traumarelated difficulties among incarcerated women with sexual victimization histories.
Fifty-eight predominantly Caucasian women incarcerated for non-violent felonies
participated in eight separate groups. Participants reported significant reductions in PTSD,
depression, and anxiety/worry symptoms as well as trauma-related cognitions from pre-to posttreatment, with large effect sizes. The majority of participants who provided pre-and posttreatment data (n = 34) showed clinically significant reductions in PTSD, depression, and/or
anxiety/worry during the duration of the treatment. More specifically, of the participants who
were above the clinical cutoff for possible PTSD (n = 30), depression (n = 25), and GAD (n =
26) at pre-treatment, 40-50% were below the clinical cutoff at post-treatment (PTSD: n = 14;
depression: n = 18; GAD: n = 18). Moreover, approximately 60% of participants improved (RCI
above 1.96; Jacobsen & Truax, 1991) on the depression measure and 40% on the GAD measure.
Preliminary findings suggest that these treatment gains were maintained 3-6 months after
completing the group program and that there were few if any additional symptomatic benefits to
completing more than one group. However, these results should be interpreted with caution since
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the sample was small (n = 6 for follow-up data and n = 8 for participants repeating the group
treatment).
Overall, the results from the current study suggest that it is feasible to implement a brief
exposure-based group treatment with incarcerated women who report histories of sexual
victimization. Nevertheless, results also suggest that this treatment might not be effective for
everyone. Approximately 20% (n = 12) of participants did not complete the group treatment. The
non-completers were younger, had fewer children, and were more depressed at pre-treatment
compared to the completers. Moreover, not all treatment completers (n = 46) showed clinical
significant change. On the other hand, of the participants with pre-and post-treatment data (n =
34), only six participants did not improve or recover on any of the measures.
The current study adds in important ways to existing psychotherapy research with
incarcerated women. This is the first study evaluating a brief exposure-based group treatment
with incarcerated women. There were few exclusion criteria, which increase the generalizability
of the results. Participants were women who self-identified as having a history of sexual
victimization and some difficulties related to those experiences. No other inclusion or exclusion
criteria were implemented by the researcher. Additionally, the current study included
information about both statistical and clinical significance (e.g., effect size, recovery rates,
improvement rates). Altogether, the results suggest that it is feasible to implement an exposurebased group treatment with incarcerated women. Future studies should expand by including a
diverse sample of incarcerated women, a control group, and a more comprehensive assessment
battery.
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VI.

TABLES
Table 1
Treatment Content Session by Session

Sessions
1

Content
Introduction (e.g., confidentiality, group norms, treatment structure and content)
Psychoeducation about sexual trauma and its sequelae

2

Treatment rationale (e.g., avoidance and exposure therapy)
Coping skills (e.g., in session and between sessions)

3

Imaginal exposure

4

Imaginal exposure

5

Continue imaginal exposure
Incorporate sexual trauma themes (e.g., safety and trust)

6

Continue imaginal exposure
Incorporate sexual trauma themes (e.g., power and control)

7

Continue imaginal exposure
Incorporate sexual trauma themes (e.g., self-esteem and intimacy)

8

Coping and self-care
Healthy sexual relationships
Lessons learned from the group and relapse prevention
Information and handouts about resources in the community
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Table 2
Overview of Number of Treatment Participants in Each Group as well as Number of Research
Participants in Each Group, Further Categorized by Repeaters, First Time Participants,
Completers, and Non-Completers

Groups

Number of
group
participants

Number of Number
research
of
participants repeaters

First time
participants

Noncompletersa

Completersa

1

10

5b

0

5

0

5

2

10

10

0

10

4

6

3

8

7c

0

7c

0

7c

4

12

11

1

10

2

8

5

11

11

3

8

2

6

6

9

9

2

7

2

5

7

8

8

3

5

2

3

8

8

7

1

6

0

6

76

68

10d

58

12

46

Sum
a

Non-completers and completers only includes participants the first time they participated in the
group (e.g., excluded the second or third time they participated)
b
No pre-treatment data was collected from group 1
c
Eight participants completed group 3 but only seven consented to the research study
d
Eight participants repeated the group once and one participant repeated it twice
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Table 3
Demographic Information for All Participants as well as by Completers and Non-Completers

Variable
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Age
Number of children
Latina
Yes
No
Ethnicity
Caucasian
African-American
Marital status
Married
Divorced
Single
Dating, not married
Other
Previous therapy
Yes
No
Individual therapy
Yes
No
Family therapy
Yes
No
Group therapy

Total sample
N = 58a

Completers
n = 46a

Non-Completers
n = 12a

M (SD) or n (%)

M (SD) or n (%)

M (SD) or n (%)

Test Statisticb

p-value

32.36 (8.16)
2.42 (1.33)

33.50 (8.43)
2.58 (1.40)

28.00 (5.31)
1.83 (.83)

t (56) = -2.14
t (53) = -2.32c
χ2 (1) = .30

.04
.03
.59

1 (1.7%)
57 (98.3%)

1 (2.2%)
45 (97.8%)

0 (0%)
12 (100%)

χ2 (1) = .58

.45

53 (91.4%)
2 (3.4%)

41 (89.1%)
2 (4.3%)

12 (100%)
0 (0%)

χ2 (4) = 4.46

.35

χ2 (1) = .50

.48

χ2 (1) = .83

.36

χ2 (1) = .72

.40

χ2 (1) = .02

.90

14 (24.1%)
22 (37.9%)
10 (17.2%)
2 (3.4%)
7 (12.1%)

11 (23.9%)
17 (37.0%)
6 (13.0%)
2 (4.3%)
7 (15.2%)

3 (25.0%)
5 (41.7%)
4 (33.3%)
0 (0%)
0 (0%)

41 (70.7%)
14 (24.1%)

33 (71.7%)
10 (21.7%)

8 (66.7%)
4 (33.3%)

38 (65.5%)
17 (29.3%)

31 (67.4%)
12 (26.1%)

7 (58.3%)
5 (41.7%)

9 (15.5%)
46 (79.3%)

8 (17.4%)
35 (76.1%)

1 (8.3%)
11 (91.7%)

Yes
No
Couple therapy
Yes
No
Other therapy
Yes
No

13 (22.4%)
42 (72.4%)
4 (6.9%)
51 (87.9%)
4 (6.9%)
51 (87.9%)

10 (21.7%)
33 (71.7%)
4 (8.7%)
39 (84.8%)
4 (8.7%)
39 (84.8%)

3 (25.0%)
9 (75.0%)
0 (0%)
12 (100%)

χ2 (1) = 1.20

.27

χ2 (1) = 1.20

.27

0 (0%)
12 (100%)

Note. N = total sample size; n = number of participant in subsample; M = mean; SD = standard deviation.
a
Only includes participants the first time they participated in the group (e.g., excluded the second or third time they
participated)
b
Test statistics compares completers to non-completers.
c
Equal variance could not be assumed and was therefore corrected for using Levene’s test.
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Table 4
Pre-treatment Symptom Levels for All Participants as well as by Completers and Non-Completers

Measures

168

PC-PTSD
PHQ-9
Sum
Symptom
count
GAD-2
Sum
Item 1
Item 2
PTCI
Self
World
Self-Blame
Total Sum

Total sample
N = 58a
M (SD)

Range

NonCompleters
n = 12a
M (SD)

Completers
n = 46a
M (SD)

Test Statisticb

p-value

3.35 (.97)

0–4

2.92 (1.38)

3.49 (.77)

t (47) = -1.36c

.20

14.02 (5.93)
4.77 (2.63)

1 - 25
0-9

17.27 (4.45)
5.91 (1.64)

13.03 (6.01)
4.42 (2.79)

t (45) = 2.16
t (45) = 2.20c

.04
.04

4.02 (1.79)
1.98 (.92)
2.04 (1.00)

0-6
0-3
0-3

4.75 (1.48)
2.25 (.75)
2.50 (.80)

3.78 (1.83)
1.89 (.97)
1.89 (1.02)

t (47) = 1.66
t (47) = 1.17
t (47) = 1.88

.10
.25
.07

3.88 (1.46)
5.51 (1.21)
3.66 (1.71)
142.33 (40.73)

1.10 – 6.71
1.57 – 7.00
1.00 – 7.00
41 - 223

4.32 (1.31)
5.80 (.85)
4.43 (1.61)
153.50 (33.74)

3.73 (1.50)
5.42 (1.31)
3.41 (1.68)
138.27 (42.73)

t (47) = 1.21
t (47) = .95
t (47) = 1.86
t (43) = 1.11

.23
.35
.07
.27

Note. N = total sample size; n = number of participant in subsample; M = mean; SD = standard deviation; PC-PTSD = Primary
Care PTSD screen, total score ranges between 0 and 4; PHQ-9 = 9-item Patient Health Questionnaire, answer options ranges
from 0 (Not at all) to 3 (Nearly every day); GAD-2 = 2-item Generalized Anxiety Disorder scale, answer options ranges from 0
(Not at all) to 3 (Nearly every day); PTCI = Posttraumatic Cognitions Inventory, answer options ranges from 1 (Totally
disagree) to 7 (Totally agree); Self = negative cognitions about self subscale; World = negative cognitions about the world
subscale; Self-Blame = self-blame subscale.
a
Only includes participants the first time they participated in the group (e.g., excluded the second or third time they
participated).

b
c

Test statistics compares completers to non-completers at pre-treatment.
Equal variance could not be assumed and was therefore corrected for using Levene’s test.
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Table 5
Demographic Information for All Completers as well as Categorized by Completers with Pre-and Post-Treatment Data and
Completers with Pre- or Post-Treatment Data Only
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Ageb
Number of children
Latina
Yes
No
Ethnicity
Caucasian
African-American
Marital status
Married
Divorced
Single
Dating, not married
Other
Previous therapy
Yes
No
Individual therapy
Yes
No
Family therapy
Yes
No
Group therapy

Pre and Post
All completers
data
n = 46a
n = 34a
M (SD) or n (%) M (SD) or n (%)
33.50 (8.43)
33.76 (8.81)
2.58 (1.40)
2.65 (1.28)
1 (2.2%)
45 (97.8%)

1 (2.9%)
32 (94.1%)

41 (89.1%)
2 (4.3%)

33 (97.1%)
1 (2.9%)

11 (23.9%)
17 (37.0%)
6 (13.0%)
2 (4.3%)
7 (15.2%)

10 (29.4%)
13 (38.2%)
3 (8.8%)
1 (2.9%)
7 (20.6%)

33 (71.7%)
10 (21.7%)

27 (79.4%)
7 (20.6%)

31 (67.4%)
12 (26.1%)

26 (76.5%)
8 (23.5%)

8 (17.4%)
35 (76.1%)

6 (17.6%)
28 (82.4%)

Pre or post data
only
n = 9ab
Test Statisticc
M (SD) or n (%)
32.75 (7.57) t (44) = -.36
2.33 (1.87) t (41) = -.59
χ2 (1) = .25
0 (0%)
8 (88.9%)
χ2 (1) = 1.07
8 (88.9%)
1 (11.1%)
χ2 (4) = 6.94
1 (11.1%)
4 (44.4%)
3 (33.3%)
1 (11.1%)
0 (0%)
χ2 (1) = .65
6 (66.7%)
3 (33.3%)
χ2 (1) = 1.55
5 (55.6%)
4 (44.4%)
χ2 (1) = .10
2 (22.2%)
6 (66.7%)
χ2 (1) = .94

p-value
.72
.56
.62

.30

.14

.42

.21

.75

.33

Yes
No
Couple therapy
Yes
No
Other therapy
Yes
No

10 (21.7%)
33 (71.7%)

9 (26.5%)
25 (73.5%)

1 (11.1%)
8 (88.9%)

4 (8.7%)
39 (84.8%)

3 (8.8%)
31 (91.2%)

1 (11.1%)
8 (88.9%)

4 (8.7%)
39 (84.8%)

4 (11.8%)
30 (88.2%)

0 (0%)
9 (100%)

χ2 (1) = .04

.83

χ2 (1) = 1.17

.28

Note. N = total sample size; n = number of participant in subsample; M = mean; SD = standard deviation.
a
Only includes participants the first time they participated in the group (e.g., excluded the second or third time they
participated)
b
Demographic information is missing from three participants, except for age. All participants provided information about their
age.
c
Test statistics compares completers with pre-and post-treatment data to completers with pre-or post-treatment data only.
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Table 6
Pre-Treatment Symptom Levels for Completers with Pre-and Post-Treatment Data and
Completers with Pre-Treatment Data Only
Pre-and post data Pre-data only
n = 34
n=3
Test Statistic
p-value
M (SD)
M (SD)
3.47 (.79)
3.67 (.58)
t (35) = .42
.68

Measures
PC-PTSD
PHQ-9
Sum
13.12 (5.76)
12.00 (10.00)
t (34) = -.31
.76
Symptom count
4.45 (2.74)
4.00 (4.00)
t (34) = -.27
.79
GAD-2
Sum
3.76 (1.79)
4.00 (2.65)
t (35) = .21
.83
Item 1
1.88 (.98)
2.00 (1.00)
t (35) = .20
.84
Item 2
1.88 (.98)
2.00 (1.73)
t (35) = .19
.85
PTCI
Self
3.74 (1.49)
3.63 (1.95)
t (35) = -.13
.90
a
World
5.50 (1.18)
4.48 (2.52)
t (35) = -.70
.56
Self-Blame
3.34 (1.70)
4.20 (1.51)
t (35) = .85
.40
Total Sum
136.58 (43.50) 164.50 (14.85)
t (31) = .89
.38
Note. n = number of participant; M = mean; SD = standard deviation; PC-PTSD = Primary Care
PTSD screen, total score ranges between 0 and 4; PHQ-9 = 9-item Patient Health Questionnaire,
answer options ranges from 0 (Not at all) to 3 (Nearly every day); GAD-2 = 2-item Generalized
Anxiety Disorder scale, answer options ranges from 0 (Not at all) to 3 (Nearly every day); PTCI
= Posttraumatic Cognitions Inventory, answer options ranges from 1 (Totally disagree) to 7
(Totally agree); Self = negative cognitions about self subscale; World = negative cognitions
about the world subscale; Self-Blame = self-blame subscale.
a
Equal variance could not be assumed and was therefore corrected for using Levene’s test.
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Table 7
Post-treatment Symptom Levels and Number of Sessions Attended for Completers with Pre-and
Post-Treatment Data and Completers with Post-Treatment Data only

Measures
PC-PTSD
PHQ-9
Sum
Symptom count
GAD-2
Sum
Item 1
Item 2
PTCI
Self
World
Self-Blame
Total Sum
Number of sessions

Pre-and post data Post-data only
n = 34
n=9
Test Statistic
M (SD)
M (SD)
2.33 (1.55)
3.33 (1.32) t (40) = 1.76

p-value
.09

5.21 (4.51)
1.18 (1.65)

7.38 (5.34) t (39) = 1.18
1.88 (2.53) t (39) = .96

.25
.35

1.56 (1.62)
1.00 (1.04)
.56 (.79)

2.33 (1.50) t (41) = 1.30
1.11 (.60) t (41) = .30
1.22 (1.20) t (41) = 2.00

.20
.76
.052

2.05 (1.29)
3.55 (1.62)
2.27 (1.43)
79.30 (43.58)
7.70 (.59)

3.18 (1.68)
5.35 (.83)
3.44 (1.60)
118.75 (48.33)

t (41) = 2.19
t (41) = 3.19
t (41) = 2.13
t (39) = 2.25

7.11 (.60) t (40) = -2.65

.034
.003
.039
.030
.012

Note. n = number of participant; M = mean; SD = standard deviation; PC-PTSD = Primary Care
PTSD screen, total score ranges between 0 and 4; PHQ-9 = 9-item Patient Health Questionnaire,
answer options ranges from 0 (Not at all) to 3 (Nearly every day); GAD-2 = 2-item Generalized
Anxiety Disorder scale, answer options ranges from 0 (Not at all) to 3 (Nearly every day); PTCI
= Posttraumatic Cognitions Inventory, answer options ranges from 1 (Totally disagree) to 7
(Totally agree); Self = negative cognitions about self subscale; World = negative cognitions
about the world subscale; Self-Blame = self-blame subscale.
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Table 8
Pre-and Post-treatment Symptom Levels for All Treatment Completers

Measures
PC-PTSD
PHQ-9
Sum
Symptom
count
GAD-2
PTCI
Self
World
Self-Blame
Total Sum

Completers
n = 46
Pre
M (SD)
Range
3.49 (.77)

Post
M (SD)
Range
1-4
2.55 (1.55)
0-4

13.03 (6.01)
4.42 (2.79)

1 - 25
0-9

5.63 (4.69)
1.32 (1.84)

0 - 18
0-7

3.78 (1.83)

0-6

1.72 (1.61)

0–5

1.10 – 6.71
2.29 (1.44)
1.57 – 7.00
3.93 (1.66)
1.00 – 7.00
2.52 (1.53)
41 - 223 87.00 (46.68)

1.00 – 5.76
1.00 – 6.71
1.00 – 6.40
33 - 196

3.73 (1.50)
5.42 (1.31)
3.41 (1.68)
138.27 (42.73)

Note. n = number of participant; Pre = pre-treatment; Post = post-treatment; M = mean; SD =
standard deviation; PC-PTSD = Primary Care PTSD screen, total score ranges between 0 and 4;
PHQ-9 = 9-item Patient Health Questionnaire, answer options ranges from 0 (Not at all) to 3
(Nearly every day); GAD-2 = 2-item Generalized Anxiety Disorder scale, answer options ranges
from 0 (Not at all) to 3 (Nearly every day); PTCI = Posttraumatic Cognitions Inventory, answer
options ranges from 1 (Totally disagree) to 7 (Totally agree); Self = negative cognitions about
self subscale; World = negative cognitions about the world subscale; Self-Blame = self-blame
subscale.
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Table 9
Individual Participants’ PTSD, Depression, and Anxiety/Worry Symptom Sum Scores at Pre-and Post-Treatment and Change
Status at Post-Treatment
Participant/
Group number
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8/2
9/2
11 / 2
12 / 2
13 / 2
14 / 3
16 / 3
20 / 3
22 / 3
24 / 4
25 / 4
27 / 4
30 / 4
31 / 4
34 / 5
35 / 5
36 / 5
37 / 5
38 / 5
39 / 5
42 / 6
43 / 6

PC-PTSD
Pre
4
4
1
4
4
3
4
4
4
3
4
4
3
3
3
4
4
4
4
4
4
4

Post
4
1
2
4
2
2
4
1
3
0
4
0
1
2
4
4
4
4
2
4
1
4

Re
No
Yes
No
No
Yes
Yes
No
Yes
No
Yes
No
Yes
Yes
Yes
No
No
No
No
Yes
No
Yes
No

PHQ-9
Pre
12
13
5
22
23
9
17
13
21
11
17
14
12
15
20
25
18
6
11
17
8
13

Post
3
3
2
3
10
1
15
4
13
4
11
5
1
9
5
15
4

RCI
2.68
2.98
.89
5.66
3.88
2.38
.60
2.68
2.38
2.09
1.79
2.68
3.28
1.79
4.47
2.98
4.17

Im
Yes
Yes
No
Yes
Yes
Yes
No
Yes
Yes
Yes
No
Yes
Yes
No
Yes
Yes
Yes

Re
Yes
Yes
No
Yes
No
No
No
Yes
No
Yes
No
Yes
Yes
Yes
Yes
No
Yes

8
9
1
7

.89
2.38
2.09
1.79

No
Yes
Yes
No

Yes
Yes
No
Yes

GAD-2
Pre
3
6
2
6
6
3
6
6
6
2
4
4
5
5
5
6
3
0
6
5
4
5

Post RCI Im
1
1.55 No
0
4.65 Yes
0
1.55 No
0
4.65 Yes
1
3.87 Yes
1
1.55 No
4
1.55 No
2
3.10 Yes
4
1.55 No
0
1.55 No
3
.77 No
0
3.10 Yes
1
3.10 Yes
2
2.32 Yes
5
.00 No
5
.77 No
1
1.55 No
4
-3.10 No
3
2.32 Yes
2
2.32 Yes
0
3.10 Yes
2
2.32 Yes

Re
Yes
Yes
No
Yes
Yes
Yes
No
Yes
No
No
No
Yes
Yes
Yes
No
No
Yes
No
No
Yes
Yes
Yes

44 / 6
45 / 6
46 / 6
50 / 7
51 / 7
53 / 7
54 / 8
55 / 8
56 / 8
57 / 8
58 / 8
59 / 8
% Improved
% Recovered

2
3
2
4
4
4
2
3
4
4
3
3

0
4
1
4

No
No
No
No

0
1
3
2
4
1
0

Yes
No
No
Yes
No
Yes
Yes
41.2%

11
13
1
19
14
16
5
10
10
8
4

2
3
0
12
10
0
0
5
2
0
3
2

2.68
2.98
.30
2.09
1.19
4.77
1.49

Yes
Yes
No
Yes
No
Yes
No

Yes
Yes
No
No
No
Yes
No

2.38
2.98
1.49
.60

Yes
Yes
No
No

Yes
Yes
No
No
61.8%
52.9%

2
4
3
5
3
3
0
2
2
2
2
2

1
0
1
4
2
0
1
3
0
0
0
0

.77 No
3.10 Yes
1.55 No
.77 No
.77 No
2.32 Yes
-.77 No
-.77 No
1.55 No
1.55 No
1.55 No
1.55 No

No
Yes
Yes
No
Yes
Yes
No
No
No
No
No
No
38.2%
50.0%

176

Note. Pre = pre-treatment sum score; Post = post-treatment sum score; Re = recovered (above clinical cutoff at pre-treatment
and below at post-treatment); Im = improved (above the reliable change index; RCI > 1.96); PC-PTSD = Primary Care PTSD
scale; clinical cutoff = ≥ 3; PHQ-9 = 9-item Patient Health Questionnaire; clinical cutoff ≥ 10; GAD-2 = Generalized Anxiety
Disorder scale; clinical cutoff ≥ 3.

Table 10
Pre-Treatment Symptom Levels for Participants who Completed the Group Once and
Participants who Completed the Group Twice

Measures
PC-PTSD
PHQ-9
Sum
Symptom
count
GAD-2
PTCI
Self
World
Self-Blame
Total Sum

Non-repeaters Repeaters
n = 38
n=8
Test Statistic
M (SD)
M (SD)
3.41 (.82)
3.71 (.49) t (35) = -1.10

p - value
.28

12.57 (6.35)
4.11 (2.79)

14.63 (4.63) t (34) = -.85
5.50 (2.67) t (34) = -1.26

.40
.22

3.62 (1.82)

4.38 (1.85) t (35) = -1.03

.31

t (35) = -2.91a
t (35) = -1.59
t (35) = -1.23
t (31) = -2.60a

.008
.12
.23
.01

3.48 (1.55)
5.24 (1.40)
3.23 (1.72)
131.12 (45.97)

4.67 (.82)
6.05 (.62)
4.05 (1.46)
160.63 (18.72)

Note. n = number of participant; M = mean; SD = standard deviation; PC-PTSD = Primary Care
PTSD screen, total score ranges between 0 and 4; PHQ-9 = 9-item Patient Health Questionnaire,
answer options ranges from 0 (Not at all) to 3 (Nearly every day); GAD-2 = 2-item Generalized
Anxiety Disorder scale, answer options ranges from 0 (Not at all) to 3 (Nearly every day); PTCI
= Posttraumatic Cognitions Inventory, answer options ranges from 1 (Totally disagree) to 7
(Totally agree); Self = negative cognitions about self subscale; World = negative cognitions
about the world subscale; Self-Blame = self-blame subscale.
a
Equal variance could not be assumed and was therefore corrected for using Levene’s test.
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Table 11
Post-Treatment Symptom Levels for Participants who Completed the Group Once and
Participants who Completed the Group Twice

Measures
PC-PTSD
PHQ-9
Sum
Symptom
count
GAD-2
PTCI
Self
World
Self-Blame
Total Sum

Non-repeaters Repeaters
n = 38
n=8
Test Statistic
p-value
M (SD)
M (SD)
2.50 (1.56)
2.75 (1.58)
t (40) = -.41
.69
5.15 (4.70)
1.15 (1.83)

8.00 (4.12)
2.14 (1.77)

t (39) = -1.49
t (39) = -1.32

.15
.20

1.57 (1.61)

2.38 (1.51)

t (41) = -1.29

.21

2.15 (1.42)
3.85 (1.63)
2.47 (1.53)
83.00 (45.77)

2.86 (1.49)
4.27 (1.83)
2.70 (1.60)
103.50 (49.84)

t (41) = -1.27
t (41) = -.64
t (41) = -.37
t (39) = -1.12

.21
.53
.71
.27

Note. n = number of participant; M = mean; SD = standard deviation; PC-PTSD = Primary Care
PTSD screen, total score ranges between 0 and 4; PHQ-9 = 9-item Patient Health Questionnaire,
answer options ranges from 0 (Not at all) to 3 (Nearly every day); GAD-2 = 2-item Generalized
Anxiety Disorder scale, answer options ranges from 0 (Not at all) to 3 (Nearly every day); PTCI
= Posttraumatic Cognitions Inventory, answer options ranges from 1 (Totally disagree) to 7
(Totally agree); Self = negative cognitions about self subscale; World = negative cognitions
about the world subscale; Self-Blame = self-blame subscale.
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Table 12
Pre-Treatment Symptom Levels for Participants in Groups 1-3 and Participants in Groups 4 -8

Measures
PC-PTSD
PHQ-9
Sum
Symptom
count
GAD-2
PTCI
Self
World
Self-Blame
Total Sum

Groups 1-3a
Groups 4-8
n = 18
n = 28
Test Statistic p-value
M (SD)
M (SD)
3.60 (.97)
3.44 (.70)
t (35) = .54
.59
14.70 (5.91)
5.00 (2.94)

12.38 (6.04)
4.19 (2.76)

t (34) = 1.04
t (34) = .77

.31
.45

4.90 (1.60)

3.37 (1.76)

t (35) = 2.41

.02

4.30 (1.44)
5.77 (1.29)
4.12 (1.94)
151.20 (45.21)

3.53 (1.49)
5.28 (1.31)
3.14 (1.53)
132.65 (41.37)

t (35) = 1.41
t (35) = 1.01
t (35) = 1.61
t (31) = 1.15

.17
.32
.12
.26

Note. n = number of participant; M = mean; SD = standard deviation; PC-PTSD = Primary Care
PTSD screen, total score ranges between 0 and 4; PHQ-9 = 9-item Patient Health Questionnaire,
answer options ranges from 0 (Not at all) to 3 (Nearly every day); GAD-2 = 2-item Generalized
Anxiety Disorder scale, answer options ranges from 0 (Not at all) to 3 (Nearly every day); PTCI
= Posttraumatic Cognitions Inventory, answer options ranges from 1 (Totally disagree) to 7
(Totally agree); Self = negative cognitions about self subscale; World = negative cognitions
about the world subscale; Self-Blame = self-blame subscale.
a
No pre-treatment data was collected from group 1
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Table 13
Post-Treatment Symptom Levels for Participants in Groups 1-3 and Participants in Groups 4 -8

Measures
PC-PTSD
PHQ-9
Sum
Symptom
count
GAD-2
PTCI
Self
World
Self-Blame
Total Sum

Groups 1-3
Groups 4-8
n = 18
n = 28
Test Statistic p-value
M (SD)
M (SD)
2.88 (1.32)
2.32 (1.68) t (40) = 1.16
.25
6.94 (5.18)
1.63 (2.25)

4.80 (4.24)
1.12 (1.54)

t (39) = 1.44
t (39) = .86

.16
.40

1.88 (1.62)

1.62 (1.63)

t (41) = .53

.60

2.75 (1.59)
1.98 (1.28)
4.36 (1.53)
3.65 (1.70)
3.00 (1.66)
2.20 (1.38)
100.75 (49.59) 78.20 (43.44)

t (41) = 1.75
t (41) = 1.40
t (41) = 1.72
t (39) = 1.53

.09
.17
.09
.13

Note. n = number of participant; M = mean; SD = standard deviation; PC-PTSD = Primary Care
PTSD screen, total score ranges between 0 and 4; PHQ-9 = 9-item Patient Health Questionnaire,
answer options ranges from 0 (Not at all) to 3 (Nearly every day); GAD-2 = 2-item Generalized
Anxiety Disorder scale, answer options ranges from 0 (Not at all) to 3 (Nearly every day); PTCI
= Posttraumatic Cognitions Inventory, answer options ranges from 1 (Totally disagree) to 7
(Totally agree); Self = negative cognitions about self subscale; World = negative cognitions
about the world subscale; Self-Blame = self-blame subscale.
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Table 14
Symptom Change Scores for Participants in Groups 1-3 and Participants in Groups 4 -8
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Measures
PC-PTSD
PHQ-9
Sum
Symptom
count
GAD-2
PTCI
Self
World
Self-Blame
Total Sum

All
completers
Groups 1-3a
Groups 4-8
n = 34
n=9
n = 25
Test Statisticb p-value
M (SD)
Min
Max M (SD)
M (SD)
1.12 (1.45)
-1
4
1.00 (1.41)
1.17 (1.49)
t (31) = -.29
.77
8.13 (4.19)
3.41 (2.33)

1
0

19
9

9.00 (5.05)
3.89 (2.89)

7.78 (3.87)
3.22 (2.11)

t (30) = .73
t (30) = .73

.47
.47

2.21 (1.97)

-4

6

3.44 (1.81)

1.76 (1.85)

t (32) = 2.35

.03

1.69 (1.52)
1.94 (1.69)
1.06 (1.92)
55.35 (50.18)

-3.05
-2.29
-3.40
-97

4.48
5.86
5.60
150

2.04 (2.37)
2.21 (2.35)
1.38 (2.78)
65.22 (76.65)

1.57 (1.11)
1.85 (1.44)
.95 (1.57)
51.32 (36.06)

t (32) = .58c
t (32) = .53
t (32) = .56
t (29) = .52c

.58
.60
.58
.61

Note. Change scores = post-treatment score subtracted from pre-treatment score; a positive change score indicates a reduction
in symptoms or symptom severity from pre-to post-treatment; a negative change score indicates an increase in symptoms or
symptom severity from pre-to post-treatment; n = number of participant; M = mean; SD = standard deviation; Min = minimum
score; Max = maximum score; PC-PTSD = Primary Care PTSD screen, total score ranges between 0 and 4; PHQ-9 = 9-item
Patient Health Questionnaire, answer options ranges from 0 (Not at all) to 3 (Nearly every day); GAD-2 = 2-item Generalized
Anxiety Disorder scale, answer options ranges from 0 (Not at all) to 3 (Nearly every day); PTCI = Posttraumatic Cognitions
Inventory, answer options ranges from 1 (Totally disagree) to 7 (Totally agree); Self = negative cognitions about self subscale;
World = negative cognitions about the world subscale; Self-Blame = self-blame subscale.
a
No pre-treatment data was collected from group 1
b
Test statistics compares symptom change scores for participants in groups 1-3 versus participants in groups 4-8
c
Equal variance could not be assumed and was therefore corrected for using Levene’s test.
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Figure 1. Changes in participants’ PTSD symptoms from pre-treatment to post-treatment and to the follow-up assessment (n =
6), as measured by the Primary Care PTSD screen (PC-PTSD; Prins et al., 2003). Maximum number of PTSD symptoms is
four. The red line is the mean score for all participants at the three time points.
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Figure 2. Changes in participants’ depression sum score from pre-treatment to post-treatment and to the follow-up assessment
(n = 6), as measured by the Patient Health Questionnaire (PHQ-9; Kroenke et al., 2001). The answer options ranged from 0
(Not at all) to 3 (Nearly every day) with a maximum score of 27. A higher score indicates greater depression severity. The red
line is the mean score for all participants at the three time points.
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Figure 3. Changes in participants’ depression symptoms from pre-treatment to post-treatment and to the follow-up assessment
(n = 6), as measured by the Patient Health Questionnaire (PHQ-9; Kroenke et al., 2001). Maximum number of depression
symptoms is nine. The red line is the mean score for all participants at the three time points.
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Figure 4. Changes in participants’ GAD sum score from pre-treatment to post-treatment and to the follow-up assessment (n =
6), as measured by the 2-item Generalized Anxiety Disorder scale (GAD-2; Kroenke et al., 2007). The answer options ranged
from 0 (Not at all) to 3 (Nearly every day) with a maximum score of six. A higher score indicates greater anxiety and worry
symptom severity. The red line is the mean score for all participants at the three time points.

240
210

PTCI Sum Score

180
150
120
90
186

60
30
Pre

Post

Follow up

Figure 5. Changes in participants’ Posttraumatic Cognitions Inventory (PTCI; Foa et al., 1999) sum score from pre-treatment
to post-treatment and to the follow-up assessment (n = 6). The answer options ranged from 1 (Totally disagree) to 7 (Totally
agree) with a maximum score of 231 (33 items). A higher score indicates a higher level of negative trauma related cognitions.
The red line is the mean score for all participants at the three time points.
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Figure 6. Changes in participants’ mean score on the negative cognitions about self subscale (21 items; Posttraumatic
Cognitions Inventory; Foa et al., 1999) from pre-treatment to post-treatment and to the follow-up assessment (n = 6). The
answer options ranged from 1 (Totally disagree) to 7 (Totally agree). A higher mean score indicates more negative cognitions
about self. The red line is the mean score for all participants at the three time points.
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Figure 7. Changes in participants’ mean score on the negative cognitions about the world subscale (7 items; Posttraumatic
Cognitions Inventory; Foa et al., 1999) from pre-treatment to post-treatment and to the follow-up assessment (n = 6). The
answer options ranged from 1 (Totally disagree) to 7 (Totally agree). A higher mean score indicates more negative cognitions
about the world. The red line is the mean score for all participants at the three time points.
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Figure 8. Changes in participants’ mean score on the self-blame subscale (5 items; Posttraumatic Cognitions Inventory; Foa et
al., 1999) from pre-treatment to post-treatment and to the follow-up assessment (n = 6). The answer options ranged from 1
(Totally disagree) to 7 (Totally agree). A higher mean score indicates a higher level of self-blame. The red line is the mean
score for all participants at the three time points.
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Figure 9. Changes in PTSD symptoms for participants who completed two group treatments (n = 8), as measured by the
Primary Care PTSD screen (PC-PTSD; Prins et al., 2003). Maximum number of PTSD symptoms is four. The red line is the
mean score for all participants at the four time points (pre-treatment and post-treatment assessments from the first and second
group the participants completed).
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Figure 10. Changes in depression sum score for participants who completed two group treatments (n = 8), as measured by the
Patient Health Questionnaire (PHQ-9; Kroenke et al., 2001). The answer options ranged from 0 (Not at all) to 3 (Nearly every
day) with a maximum score of 27. A higher score indicates greater depression severity. The red line is the mean score for all
participants at the four time points (pre-treatment and post-treatment assessments from the first and second group the
participants completed).
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Figure 11. Changes in number of depressive symptoms for participants who completed two group treatments (n = 8), as
measured by the Patient Health Questionnaire (PHQ-9; Kroenke et al., 2001). The maximum number of symptoms is nine. The
red line is the mean score for all participants at the four time points (pre-treatment and post-treatment assessments from the
first and second group the participants completed).
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Figure 12. Changes in GAD sum score for participants who completed two group treatments (n = 8), as measured by the 2item Generalized Anxiety Disorder scale (GAD-2; Kroenke et al., 2007). The answer options ranged from 0 (Not at all) to 3
(Nearly every day) with a maximum score of six. A higher score indicates greater anxiety and worry symptom severity. The
red line is the mean score for all participants at the four time points (pre-treatment and post-treatment assessments from the
first and second group the participants completed).
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Figure 13. Changes in the Posttraumatic Cognitions Inventory (PTCI; Foa et al., 1999) sum score for participants who
completed two group treatments (n = 8). The answer options ranged from 1 (Totally disagree) to 7 (Totally agree) with a
maximum score of 231 (33 items). A higher score indicates a higher level of negative trauma related cognitions. The red line is
the mean score for all participants at the four time points (pre-treatment and post-treatment assessments from the first and
second group the participants completed).
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Figure 14. Changes in the mean score on the negative cognitions about self-subscale (21 items; Posttraumatic Cognitions
Inventory; Foa et al., 1999) for participants who completed two group treatments (n = 8). The answer options ranged from 1
(Totally disagree) to 7 (Totally agree). A higher mean score indicates more negative cognitions about self. The red line is the
mean score for all participants at the four time points (pre-treatment and post-treatment assessments from the first and second
group the participants completed).
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Figure 15. Changes in the mean score on the negative cognitions about the world subscale (7 items; Posttraumatic Cognitions
Inventory; Foa et al., 1999) for participants who completed two group treatments (n = 8). The answer options ranged from 1
(Totally disagree) to 7 (Totally agree). A higher mean score indicates more negative cognitions about the world. The red line is
the mean score for all participants at the four time points (pre-treatment and post-treatment assessments from the first and
second group the participants completed).
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Figure 16. Changes in the mean score on the self-blame subscale (5 items; Posttraumatic Cognitions Inventory; Foa et al.,
1999) for participants who completed two group treatments (n = 8). The answer options ranged from 1 (Totally disagree) to 7
(Totally agree). A higher mean score indicates a higher level of self-blame. The red line is the mean score for all participants at
the four time points (pre-treatment and post-treatment assessments from the first and second group the participants completed).

VIII.

APPENDIX
January 11, 2012
MEMORANDUM
TO:

Ana Bridges
Marie Karlsson

FROM:
RE:

Ro Windwalker
IRB Coordinator
New Protocol Approval

IRB Protocol #:

11-12-377

Protocol Title:

Evaluating a Sexual Violence Therapy Group with Incarcerated
Women

Review Type:
Approved Project Period:

EXEMPT

EXPEDITED

FULL IRB

Start Date: 01/11/2012 Expiration Date: 01/08/2013

Your protocol has been approved by the IRB. Protocols are approved for a maximum period of
one year. If you wish to continue the project past the approved project period (see above), you
must submit a request, using the form Continuing Review for IRB Approved Projects, prior to the
expiration date. This form is available from the IRB Coordinator or on the Research Compliance
website (http://vpred.uark.edu/210.php). As a courtesy, you will be sent a reminder two months
in advance of that date. However, failure to receive a reminder does not negate your obligation to
make the request in sufficient time for review and approval. Federal regulations prohibit
retroactive approval of continuation. Failure to receive approval to continue the project prior to
the expiration date will result in Termination of the protocol approval. The IRB Coordinator can
give you guidance on submission times.
This protocol has been approved for 70 participants. If you wish to make any modifications
in the approved protocol, including enrolling more than this number, you must seek approval
prior to implementing those changes. All modifications should be requested in writing (email is
acceptable) and must provide sufficient detail to assess the impact of the change.
If you have questions or need any assistance from the IRB, please contact me at 210
Administration Building, 5-2208, or irb@uark.edu.
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